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ABSTRACT 
The rhythmic expression of an autoregulatory loop of circadian clock genes underlies the 
intrinsic circadian rhythmicity in the central circadian pacemaker of the suprachiasmatic 
nucleus (SCN). Clock genes are also known to be rhythmically expressed outside the 
SCN and outside the brain. While these peripheral circadian oscillators are functional, 
their expression is chiefly coordinated by the central circadian pacemaker of the SCN. 
This thesis presents the first evidence of a functional circadian oscillator in human 
peripheral blood mononuclear cells (PBMCs). Measuring levels of RNA transcripts in 
PBMCs sampled throughout specific behavioural protocols permitted the 
characterization of these peripheral circadian oscillators in humans. The expression of 
clock genes HPER1, HPER2, and HPER3 peaks early after the time of typical 
awakening and demonstrates a significant circadian rhythmicity in PBMCs sampled from 
healthy young men that persists in time isolation and under the constant behavioural 
conditions of a constant routine (CR). The functional circadian oscillator in human 
PBMCs is also observable in the presence of the sleep/wake cycle. Using frequent 
sampling over 72 hours, it was determined that the patterns of HPER1 and HPER2 
expression are comparable when sampled in the presence of a habituai sleep/wake 
cycle or during a CR. The expression of HBMAL 1 in PBMCs was more variable under 
different behavioural conditions. The pattern of light and darkness exposure including 
bright light during night shifts, shielding from morning light and sleep in darkened 
quarters can induce adaptive phase delays in the endogenous circadian rhythms of 
cortisol secretion in night shift workers. In the presence of such a light intervention, the 
cortisol rhythm in night shift workers re-assumes an appropriate temporal alignment with 
the shifted sleep/wake schedule and cortisol levels peak near the shifted time of 
awakening. Following nine days of simulated night shift work, HPER1 and HPER2 
expression in PBMCs is aligned to the shifted sleep/wake schedule of a typical night shift 
worker in the presence of a comparable light/darkness intervention. This thesis will 
consider the implications of a functional clock in human white blood cells in light of the 
demonstration of a functional and shiftable circadian oscillator in human PBMCs. 
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RÉSUMÉ 
L'expression des gènes de l'horloge est à la base de la rythmicité intrinsèque de 
l'horloge circadienne central du noyau suprachiasmatique (NSC). Les gènes de l'horloge 
sont aussi exprimés de façon rythmique dans les tissus à l'extérieur du NSC et du 
cerveau. Ces oscillateurs circadiens périphériques sont fonctionnels, mais leur 
expression est principalement coordonnée par l'horloge du NSC. Cette thèse identifie 
pour la première fois un oscillateur circadien fonctionnel dans les cellules 
mononucléaires du sang périphérique (CMSP) chez l'humain. L'analyse des niveaux 
d'ARN des gènes de l'horloge dans des CMSP prélevées au cours de protocoles 
comportementaux a permis la caractérisation de ces oscillateurs circadiens 
périphériques. Les niveaux d'ARN des gènes HPER1, HPER2, et HPER3 mesurés dans 
les CMSP prélevées de jeunes hommes sains démontrent une rythmicité circadienne 
significative qui persiste même sous les conditions contrôlées de la routine constante 
(RC). Dans ces conditions, les niveaux de HPER1, HPER2 et HPER3 présentent un 
maximum après l'heure habituelle du réveil. L'oscillation des gènes de l'horloge dans les 
CMSP humains peut aussi être observée au cour d'un cycle éveil/sommeil typique. 
L'utilisation de prélèvements sanguins fréquents sur une période ininterrompue de 72 
heures a permis de déterminer que les rythmes d'expression de HPER1 et HPER2 en 
présence d'un cycle éveil/sommeil habituel sont similaires aux rythmes observés durant 
une RC. L'expression de HBMAL 1 dans les CMSP est plus variable sous ces conditions 
expérimentales. L'horaire d'exposition à la lumière et à l'obscurité, incluant l'utilisation de 
la lumière vive durant les quarts de nuit, l'exposition à de faibles niveaux de luminosité le 
matin et le maintien d'un horaire de sommeil en obscurité, peut permettre la 
resynchronization des rythmes endogènes des travailleurs de nuit. En présence de cette 
intervention, le rythme de cortisol des travailleurs de nuit reprend un alignement 
temporel approprié et atteint son maximum après l'heure du réveil. Après neuf jours de 
travail de nuit simulé, les rythmes d'expression de HPER1 et HPER2 dans les CMSP 
sont alignées à l'horaire éveil/sommeil décalé quand cette intervention est appliquée. 
Cette thèse se conclut sur une discussion des implications d'une telle horloge 
fonctionnelle dans les globules blancs. 
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PREFACE 
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(Chapter 6) appears in the bibliography at the end of the thesis. 
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CHAPTER 1 
Introduction 
"From lifes out set, the major environmental cycles of day, /ide, month, and year have 
confronted natural selection with windows of opportunity and hazard that recur with 
precisely predictable frequency,· ... Such programs orrer the clear advantage of 
anticipatory preparation for predictab/y recurrent conditions" 
- Colin Pittendrigh, 1993 [1] 
1.1 Circadian rhythm generation in rodents and humans 
1.1.1 A central endogenous pacemaker coordinates circadian rhythms 
The term "circadian" was first conceptualized in 1959 by Franz Halberg subsequent to 
his observation of an unexplained variability in mouse whole blood cell numbers 
sampled at multiple times of day [2, 3]. This term, from the Latin circa (about) and dies 
(day) encompassed the reliable recurrence of events with an approximate 24-hour 
period, and would eventually come to describe the stable and precise daily rhythmicity 
that had been previously observed in the physiology of a number of different species. 
Daily growth lines on fossilized corals are an indication of a predictable daily 
reoccurrence in the organism [4]. The ancient Greek sculptor Androsthenes (b. circa 440 
BC) noted day/night differences in the opening of the leaves of the tamarind tree [2] 
which foreshadowed de Mairan's 18th century observations on day/night differences in 
the leaves of the heliotrope which persisted even when the plant was kept away from 
sunlight [5]. An endogenous clock has been proposed as a functional entity in a wide 
range of organisms from prokaryotes to humans [4, 6]. It has been suggested that 
synchronizing behavioural and physiological processes to naturally occurring rhythmicity 
in the environ ment makes the organism able to efficiently respond to predictable 
changes in the geophysical environment, and thus more fit from an evolutionary 
perspective [1, 4, 6]. For example, ground squirrels and chipmunks with ablated 
circadian clocks living under naturalistic conditions are more likely to become prey, 
possibly resulting from heightened activity at inappropriate times of day [7, 8). 
1.1.1 a The SCN in non-human mammals 
The early 1970s provided some of the first evidence that the suprachiasmatic 
nucleus- a bilateral cluster of cells on either side of the third ventricle in the anterior 
9 
hypothalamus [2]- was the physical structure responsible for the generation of 
endogenous circadian rhythmicity. Electrolytic les ions of the suprachiasmatic nucleii 
(SCN) of rats resulted in the ablation of circadian rhythms of corticosterone and of 
drinking and activity -results that were not observed with enucleation, lesions in the 
medial preoptic area, or lesions rostral or caudal to the SCN [9, 10]. Subsequent 
experiments in non-human animais came to establish the SCN of the anterior 
hypothalamus as the structure responsible for generating observable endogenous 
circadian rhythmicity [11, 12]. Transplantation of suspensions of foetal SCN tissue is 
sufficient to restore circadian organization to the locomotor activity of behaviourally 
arrhythmic SCN-Iesioned hamsters in the period of the donor animal [13-16]. 
Studies based on recordings in vivo [17], in organotypic slices [18] or in single 
cells [19] have revealed that the SCN demonstrates an intrinsic circadian rhythmicity in 
its electrical activity that is distinct from adjacent hypothalamic structures. The measured 
uptake of radioactive deoxyglucose in the SCN of experimental rats suggested day/night 
differences in the metabolic activity of the neurons of the SCN [20] such that in 
nocturnal, crepuscular and diurnal mammals, peak glucose utilization occurred during 
daylight hours [21]. The firing rates of individual neurons recorded in rat SCN slices or in 
dispersed neurons demonstrate a range of periods in their firing activity (e.g. 16-26 
hours [22]). However, the majority of cells have an approximate 24-hour period such that 
the mean period of firing rates also approximates 24 hours [22, 23]. 
1.1.1b The SCN in humans 
While the identification of the human SCN was initially controversial, post-mortem 
investigations on hypothalamic tissue resulted in the identification of the SCN structure 
in humans [24] with an organization that is analogous to what has been observed in rats 
[25]. Reports of altered sleep/wake patterns following aneurysm near the SCN [26] and 
altered temperature rhythmicity following tumour involving the ventral hypothalamus [27] 
are consistent with the role of the SCN in the generation of circadian rhythmicity in 
humans [28]. 
1.1.2 The expression of SCN-driven rhythms in humans 
ln humans, the SCN consists of a structure of approximately 45,000 cells [29] and 
current technology limits our ability to ethically make in vivo, real-time assessments of 
SCN function. Thus, observed physiological variables, ultimately controlled by the 
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circadian pacemaker, are accepted surrogates for estimating the phase of the 
endogenous biological clock. 
1.1.2a Core body tempe rature 
The rectally-recorded core body temperature rhythm is a weil characterized 
circadian rhythm in humans, which persists even when humans live in time isolation (in a 
research laboratory room or in a cave, for example) over extended periods of time [30-
32]. The variation of the endogenous temperature rhythm is quasi-sinusoidal, with a 
progressive elevation of core body tempe rature in the morning, a maximum a few hours 
before typical bedtime, and a progressive descent in the early night to reach a minimum 
1-2 hours before the habituai time of waking [33-36] (Figure 1.1). Electrolytic lesion of 
the SCN can ablate circadian rhythmicity in recorded core body temperature [37, 38]. 
The SCN may exert control over the core body temperature rhythm via thermoregulatory 
centers in preoptic hypothalamic areas [39, 40], although more studies are needed to 
clarify the precise anatomic relationship that contributes to this circadian rhythm. In the 
broader sense, overall thermoregulation as it is influenced by the regulation of heat 
production [34] and distal vasodilation [41], is also is under some circadian regulation 
[33,42]. The endogenous core body temperature rhythm is easily masked by the effects 
of daily activity, postural changes and sleep, where the observed amplitude would be 
greater than the endogenously generated component [43, 44]. Mathematical paradigms 
have been discussed for unmasking the body temperature rhythm (e.g. [45, 46]). 
However, to date the endogenous core body temperature is arguably most accurately 
measured under the conditions of the constant routine (CR) since putative masking 
effects such as the thermoregulatory response to activity or sleep, for example, are not 
evenly distributed throughout the circadian cycle [47-49]. As discussed in the 
subsequent chapters, the CR protocol conducted in time isolation requires that the 
experimental subject maintains wakefulness in a semi-recumbent posture and remains 
under dim light conditions for extended periods [50-52]. Meals are replaced by frequent 
nutritionally-balanced snacks. Thus, these conditions are designed to limit and more 
evenly distribute the factors that could evoke perturbations in measured endogenous 
rhythms such as body temperature. 
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Figure 1.1. Markers of endogenous circadian rhythmicity observed in humans. The 
typical daily variation in circadian rhythms of core body temperature (upper panel), 
plasma melatonin concentration (middle panel), and plasma cortisol concentration 
(bottom panel) are given in their habituai relationship to the sleep/wake cycle. Circadian 
phase of the tempe rature rhythm may be described as the time of the fitted minimum, 
which normally occurs in the last hours of the sleep episode. Circadian phase of the 
melatonin rhythm may be described as the time of midpoint of peak concentration, which 
typically occurs in the middle of the habituai sleep episode (hatched area). Circadian 
phase of the cortisol rhythm may be described as the time of the fitted maximum, which 
occurs in the early hours of the wake period under entrained conditions. 
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1.1.2b Hormonal rhythms 
Melafonin 
Well-described among hormones that display circadian rhythmicity is the melatonin 
rhythm. The production of melatonin is controlled by the SCN via a neuronal pathway to 
the paraventricular nucleus (PVN). The PVN is an essential relay in the regulation of the 
melatonin rhythm, and its neurons project to the superior cervical ganglion which 
innervates the pineal gland [53, 54]. The variation of plasma melatonin concentration is a 
be"-shaped curve when plotted against time of day, where the peak of melatonin 
concentration typically occurs in the middle of the night and daytime levels are very low 
[55] (Figure 1.1). Lesion of the SCN results in a loss of melatonin rhythmicity at 
intermediate levels suggesting that the normal melatonin rhythm is the result of a 
daytime inhibitory and nighttime stimulatory net input from the SCN [56]. Descriptions of 
the melatonin rhythm are often used as more reliable markers of circadian phase since it 
is less influenced by daily activity than the core body temperature rhythm [57]. Since 
light can rapidly suppress melatonin production in humans [58], this rhythm is also 
reliably assessed under dim light conditions such as in a CR procedure [50]. 
Cortisol 
The daily variation in plasma cortisol levels also demonstrates a strong circadian 
component. Indeed, electrolytic les ion to the SCN abrogates the circadian rhythm in 
plasma corticosterone in rats [59]. The rhythm typica"y has its trough in the early hours 
of the nocturnal sleep episode and peaks at the end of the sleep/darkness episode in the 
morning [55, 60, 61] (Figure 1.1). The human SCN has direct projections to the PVN 
which secretes corticotrophin releasing hormone (CRH), leading to the release of 
adrenocorticotropic hormone (ACTH) by the anterior pituitary and ultimately resulting in 
cortisol release by the adrenals [62]. The PVN may also send autonomie projections to 
the adrenal that also act to control the cortisol rhythm [25, 62]. The endogenous cortisol 
and ACTH rhythms may be altered by early awakening or disrupted sleep [63] and 
experimental sleep loss may raise mean cortisollevels over days [61, 64], although this 
is not a consistent observation [65, 66]. The cortisol secretory rate appears to be 
inversely correlated with the appearance of slow-wave sleep in the 
electroencephalogram (EEG) [67, 68]. Despite the strong circadian component in its 
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regulation, the cortisol rhythm may also be affected by factors such as posture in the 
time of measurement [69], and the timing of meal intake [70]. 
1.1.2c Observable rhythms in multiple systems 
ln a similar fashion, a number of the overt rhythms of a variety of physiological and 
behavioural variables demonstrate an endogenous circadian component when 
measured under controlled conditions or in time isolation. Circadian rhythms in 
subjective and EEG-estimated alertness [71-74], neurobehavioural output [75], mood 
[76], learning [77], electrolyte excretion [78], metabolic rate and respiratory control [79], 
white blood cell numbers in peripheral blood [80-82], cardiovascular and hepatic function 
[2] are consistent with an influence of the endogenous pacemaker in multiple systems. 
The relative contribution of circadian and sleep/wake dependant regulation may 
influence the expression of circadian rhythmicity in hormonal rhythms to varying extents. 
Growth hormone secretion, for example, is mainly influenced by the time of sleep 
occurrence in the day and the presence of slow wave sleep in the EEG [83, 84] and 
demonstrates only a relatively minor circadian component [85]. By comparison, 
melatonin and cortisol are mainly influenced by circadian processes. The repeated 
measurement of multiple circadian rhythms under controlled behavioural conditions such 
as the CR, is a useful tool in the study of human circadian rhythmicity and this is the 
approach that is favoured in the experiments described in the subsequent chapters. 
1 .1.2d The sleep/wake cycle 
Lesion of the SCN in nocturnal and diurnal mammals results in a loss of sleep/wake 
rhythmicity [86], which is consistent with a role for the SCN in the consolidation of sleep 
and waking at fairly predictable times of day. The results of laboratory experiments 
support models of the consolidation of human sleep as the result of a complex 
interaction including homeostatic and circadian components [72, 87-91]. The circadian 
phase at which sleep is initiated, and the time passed since a previous sleep episode 
interact to regulate the sleep episode length [91-93]. Thus, the fraction of the sleep 
episode scored as wakefulness increases throughout the sleep episode [94, 95]. Sleep 
parameters measurable with polysomnography such as sleep propensity, sleep latency, 
sleep efficiency, the fraction of the sleep episode scored as rapid eye movement (REM) 
stage sleep, REM sleep latency, and the fraction of sigma activity (12-15 Hz, i.e. sleep 
spindles) in non-REM sleep co-vary with circadian rhythms of core body temperature or 
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plasma melatonin concentration [73, 91, 93-98]. While sleep is typically initiated shortly 
after to the temperature maximum, on the falling limb of the core body temperature 
rhythm [92], initiating sleep close to the temperature nadir results in abbreviated sleep 
lengths [92, 95, 99, 100]. 
1.1.3 Light is the primary synchronizer of endogenous circadian rhythms 
Arguably, it is not sufficient that an endogenous biological clock simply beats out a 
rhythm for the expression of physiological rhythms. An endogenous circadian 
pacemaker that confers a true advantage to an organism in its environ ment must also be 
able to respond to its environ ment, particularly with respect to the cues or zeitgebers 
which indicate the time or duration of the day. 
1.1.3a Shifting the circadian pacemaker 
ln animais, including humans, the pattern of light exposure is the synchronizer that 
exerts the most powerful influence on the endogenous circadian pacemaker [58, 101-
105]. Retinal ganglion cells and the SCN are directly connected via the 
retinohypothalamic tract, which projects to the SCN [106]. In addition to suppressing 
nocturnal melatonin production [58], the pattern of light exposure can be planned to 
rapidly reset the circadian pacemaker to different phases. 
A "phase response curve" [101, 107-109] describes the response of the 
endogenous circadian pacemaker to light stimuli applied at different times of internai day 
(or, "circadian phases"). In practical terms, it was found that light exposure centered 
before the minimum of the core body temperature cycle (a round 06:00) could result in 
predictable shifts of core body tempe rature, melatonin and cortisol rhythms to later 
times (phase delay) [101, 109-111]. In comparison, a light application centered after the 
temperature minimum could shift the core body temperature, melatonin and cortisol 
rhythms towards earlier times (phase advance) [109, 112]. A light pulse of strong 
enough intensity centered close to the core body temperature minimum could reduce the 
rhythm amplitude and, if applied repeatedly over several cycles, could elicit larger phase 
shifts than those centered further away from the temperature minimum [101, 103, 109]. 
Light applied during the middle of the subjective day may still exert minimal phase shifts 
[113]. Simply advancing or delaying the sleep/wake schedule on a background of dim 
light (10-15 lux) is not sufficient to elicit significant circadian phase shifts and observable 
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rhythms continue to oscillate with the slightly longer-than-24-hour endogenous circadian 
period [96]. 
The intensity of the light stimulus is also relevant for its effect on the endogenous 
circadian pacemaker. The dose-response relationship between the intensity of the light 
stimulus and its resetting effect on the circadian pacemaker is non-linear [102, 104, 105]. 
Thus, while it was initially held that the circadian pacemaker would only respond to bright 
light (> 2,500 lux), it was subsequently found that the biological pacemaker was keenly 
sensitive to light and that resetting and melatonin suppression could also occur with 
simple indoor room light exposure [104, 105, 114-116]. This interpretation is consistent 
with a study from this laboratory, which revealed that the timing of indoor room light of 
-380 lux is sufficient to promote 5-h phase advances of the plasma melatonin and core 
body tempe rature rhythms, as measured with a CR following a simulated Montreal-
London voyage [117] (Figure 1.2). 
There is increasing evidence to suggest that the integration of light information by 
the SCN is sophisticated. Three cycles of a 5-hour exposure to bright light (7,000-10,000 
lux) produce phase shifts of different direction and magnitude depending on the light 
intensity preceding and following the exposure period- even when the bright light pulses 
are ail centered at the same circadian phase [101]. The history of light exposure is 
similarly relevant where the magnitude of light-induced phase advances and delays of 
the dim light melatonin onset is smaller when subjects maintain a short 6-hour 
sleep/darkness episode than when the main sleep/darkness period lasts 9 hours [118, 
119]. In a similar manner, light-induced melatonin suppression is more effective when 
the light pulse is preceded by [120] or presented on a background of [121] dim white 
light compared to brighter light intensities. Additionally, the circadian pacemaker 
integrates light information in such a way that bright light maintains an effect on the 
circadian pacemaker when the light pulse is intermittently interrupted by darkness. 
Delays in the core body temperature and plasma melatonin phase caused by a 5-hour 
bright light pulse timed before the core body temperature minimum are comparable to 
those observed when lights are turned off for -44 minutes of each 90-minute segment of 
the light exposure period [122, 123]. 
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Figure 1.2: An appropriately timed exposure to indoor room light can improve circadian adaptation to simulated jet-Iag. (A) The 
experimental protocol, for late and early light treatment groups, as reported [117]. Upon their admission to the laboratory, subjects 
maintained their habituai sleep/darkness times (black bars) until sleep times were advanced by 5 hours as of experimental day 5 to 
simulate a Montreal-London voyage. The London-based sleep schedule was maintained for 7 days, while participants received a 
daily 6-hour exposure to indoor room light (sun symbols, mean +/- SO: 379+/-10 lux) timed just before bed (late light group) or on an 
advancing schedule (early light group). Circadian phase was estimated during constant routines (grey bars) performed before and 
after one week on the shifted sleep/wake schedule. (8) At the start of the study, both experimental groups demonstrate temperature 
and melatonin rhythms that are appropriately aligned to the Montreal sleep/wake schedule. Typical sleep times on each schedule 
are shown as hatched areas. Following one week of simulated jet lag (London), the endogenous rhythms remained maladapted in 
the late light group (dashed lines; open symbols) while an appropriate temporal alignment is regained in subjects on the advancing 
early light group schedule (solid lines; closed symbols). Figure created from results reported in [117]. 
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1.1.3b Entraining the circadian pacemaker 
The effect of light on the human circadian pacemaker is an essential part of the 
biological role of the central circadian pacemaker. Experimental observations have 
revealed that the period of the endogenous circadian pacemaker (as estimated with core 
body temperature, melatonin, or cortisol rhythms) is approximately 24.2 hours [73, 124]. 
This pacemaker, freed from environ mental time cues, would then free-run and 
physiological rhythms expressed with the endogenous period would become 
desynchronized with 24-hour day/night cycles. Such a situation has been observed in 
some blind individuals. For example, the plasma cortisol rhythm in one blind woman free 
runs with a period between 24 and 24.5 hours as sampled repeatedly during a study 
spanning 5 days [125]. In another individual, the melatonin rhythm cycles with the 
endogenous period and occurs at a slightly later time in every subsequent 24-hour day 
[126]. The core body temperature rhythm of another blind subject free-runs with a period 
of about 24.22 hours despite the maintenance of a 24-hour schedule [47]. A clock that 
gradually drifts out of time with the environ ment poses a problem. Part of the function of 
photic regulation of the SeN is the phenomenon of entrain ment, by which the alignment 
of the circadian pacemaker is constantly reset to the 24-hour geophysical day [127]. 
1.1.3c Spectral sensitivity of the circadian pacemaker 
Recent evidence has demonstrated that conscious light perception is not 
necessary to elicit the response of the circadian system to light. While certain individuals 
lacking conscious visual perception will demonstrate circadian rhythms that are not 
entrained by the pattern of light/darkness exposure and free-run with the endogenous 
period, others can demonstrate melatonin suppression with bright light stimulus [128]. 
Mice that have neither rods nor cones still demonstrate melatonin suppression or phase 
shifts in locomotor activity following light pulse; a response that is eliminated when the 
animal is enucleated [129, 130]. The focus of a number of investigations has been the 
identification of the retinal photopigment that is responsible for the light response of the 
SeN. Melanopsin-containing retinal ganglion cells project to brain regions involved in 
non-visual light responses including the SeN [131-133]. Melanopsin-null mice have a 
reduced, though not abolished, locomotor activity phase shift response to light pulses 
[134]. However, melanopsin-deficient animais lacking rod and cone function have 
activity rhythms that do not entrain to the light/darkness schedule [132, 135]. 
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ln the rat, melanopsin-bearing retinal ganglion cells demonstrate an intrinsic 
sensitivity for light of 484 nm [136] although it has been demonstrated that melanopsin 
expressed in COS-1 cells reconstituted with 11-cis-retinal is most efficiently activated by 
light of 420-440 nm [137]. In the hamster, monochromatic light of 515 or 476 nm more 
efficiently induces phase shifts than light of 574 nm [138]. In mice lacking rods and 
cones, a locomotor activity phase-shifting response is most efficiently generated using 
light of about 481 nm [135]. 
ln humans, plasma melatonin suppression is most efficiently mediated with light 
of wavelengths in the 446-477 nm range [139, 140]. This spectral sensitivity is consistent 
with the identification of melanopsin in human retinal ganglion cells of eyes harvested 
post-mortem [141]. Light of wavelengths below 500 nm more effectively suppress 
melatonin than light of longer wavelengths, even when the irradiance dose is kept equal 
[42, 142]. Lenses equipped with filters that block wavelengths below 540 nm are 
sufficient to counteract the melatonin suppression that would have been incurred by a 
bright full-spectrum light provided at night [143, 144]. Similarly, shorter wavelength light 
(e.g. in the violetlblue visible light range) can more efficiently induce significantly larger 
phase shifts in the tempe rature and melatonin rhythms than light of longer wavelengths 
(e.g. in the green visible red light range) [145, 146]. Therefore, the evidence is consistent 
with the observation that light perception by the circadian system is mainly mediated by 
non-rod non-cone photoreceptors with sensitivity for wavelengths in the blue visible light 
range. 
1.1.3d Other synchronisers of the circadian pacemaker 
Other cues can reset the oscillation of the circadian pacemaker. Certain individuals 
lacking both conscious visual and circadian light perception with endogenous periods 
close to 24 hours can be entrained to a 24-hour sleep/wake schedule [147]. Exercise 
has been proposed as one of the non-photic signaIs that can entrain circadian rhythms 
in animaIs [148, 149]. Indeed, appropriately-timed exercise may induce larger phase 
delays [150, 151] or phase advances of the plasma melatonin rhythm [49] than those 
induced by shifts of the sleep/wake schedule on an indoor room light background alone. 
There is evidence to suggest that other non-photic cues such as food intake 
[152], auditory stimuli [153] or exogenous melatonin [154] can significantly affect 
endogenous circadian rhythms in humans. The effect of these factors on resetting is still, 
in large part, being established since light exposure was not always carefully controlled 
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in several early studies [155]. Yet, the influence of non-photic synchronisers on the 
central circadian pacemaker cannot be completely dismissed. 
1.2 Molecular bases of circadian rhythmicity 
1.2.1 A functional molecular clock underlies SCN function 
The characteristic endogenous rhythmic activity of the neurons of the SCN is dependant 
on the expression of so-called circadian clock genes. The molecular components of the 
circadian clock are now known to include, but are not limited to, Clock [156] and Small 
[157], three Periodgenes (Per 1,2, 3) [158,159], and two cryptochrome genes (Cry 1, 
L? [160] (Figure 1.3). The expression of these genes is organized in a series of auto-
regulatory loops, with both positive and negative limbs, in a manner that is somewhat 
conserved throughout evolution [161-163]. In mammals, CLOCK and BMAL1 proteins 
are transcription factors that dimerize and promote the expression of the Per and Cry 
genes as weil as clock-controlled genes that are the output of the pacemaker (e.g. 
neuropeptides [164]). The PER and CRY proteins, in turn, associate in the cytoplasm 
and act to repress their own transcription in the nucleus [160, 165, 166]. The 
CLOCK:BMAL 1 protein dimer is also thought to promote the transcription of orphan 
nuclear receptors Rev-erb (a and fJ) and Ror (a and fJ), which in turn modulate the 
activity at the Small promoter [167-170]. Specifically, the REV-ERB protein binds the 
retinoic acid response element in the Small promoter to repress its transcription [167, 
171], while ROR activates Small transcription [168, 170, 171]. This is such that within 
the SCN, molecular loops are expressed with the endogenous circadian period of the 
animal, and individual clock genes demonstrate a circadian rhythm in the levels of 
transcripts in the cell. In the rodent SCN, the expression of Pertranscripts peaks in the 
mid to la te part of the light period, Cry expression peaks towards the end of the light 
period and Small transcript expression peaks in the middle of the dark phase. 
Interestingly, this temporal organization is maintained relative to the light/dark cycle in 
diurnal rodents [172]. 
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Figure 1.3. The molecular dock. The transcription of dock genes Per1, Per2, Per3 and 
Cry 1, Cry2 is induced at their respective promoter E boxes by the CLOCK:BMAL 1 
protein dimer (C:B symbol). The activity of PER and CRY proteins is modulated post-
translationally by phosphorylation and ubiquitination. In this manner, the casein kinases 
1 (0 and E) play an important role in the regulation of the molecular clock. The PER and 
CRY protein products then enter the nucleus and negatively regulate their own 
transcription by acting on the CLOCK:BMAL 1 dimer. CLOCK:BMAL 1 also regulates the 
rhythmic transcription of clock controlled genes (e.g. vasopressin production), which may 
be specifically related to the cell's function. In another arm of the regulatory loop, the 
activity at the response element Smal1 promoter is modulated by retinoic acid-related 
orphan nuclear receptor response elements (RORE). Specifically, the retinoic acid-
related orphan nuclear receptors (RORs) positively modulate activity at the Smal1 
promoter. The orphan nuclear receptors REV-ERBs repress Smal1 transcription by 
acting at the RORE of the Smal1 promoter. Inset: The regulatory loops result in a 24-
hour rhythmicity in the observed levels of clock gene transcripts. Clock genes Per1 and 
Smal1 demonstrate rhythms that are in anti-phase to each other. 
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As a result of the dependence of the SeN on a functional molecular clock, 
deleting or mutating to the components of the molecular clock may incur observable 
effects on circadian rhythms. Mice bearing mutations in the Perl gene have reduced 
periods of locomotor activity [158, 159, 173]. 8mal1 mutant animais are arrhythmic [157] 
and Per2 mutant animais display short periods in locomotor activity and become 
arrhythmic under constant conditions [158, 174]. Animais with a Clock mutation 
demonstrate long periods under constant darkness (DD) conditions and altered clock 
gene expression rhythms in the SCN [164, 175]. One of the first circadian mutants 
serendipitously identified was the tau hamster mutant which displayed a short period of 
locomotor activity of approximately 20 hours [176]. The tau hamster encodes a mutant 
casein kinase (le) that is deficient in its ability to phosphorylate the PER proteins, thereby 
profoundly altering the regulation of the period of the molecular clock, and ultimately the 
period of recorded locomotor activity [177]. Analogous to what had been observed in 
SCN-Iesioned animais, transplanting foetal SCN grafts of genetic clock mutants confers 
the behavioural phenotype of the donor in the partial rescue of locomotor activity 
rhythms [178]. Transplanting SCN to genetic mutant animais rescues locomotor activity 
and clock gene expression in the period of the donor animal [179]. 
Similar to what is observed in animais with mutations of clock genes, certain 
aspects of human sleep preference and disorders have also been associated with 
circadian clock genes. Familial advanced sleep phase disorder is characterized by 
advanced circadian phase and sleep times [180] and is associated with nucleotide 
substitutions in the CKIJ and HPER2 genes. These substitutions result in a reduced 
period in transgenic mice [181, 182] although this appears to be genetically 
heterogeneous [183]. A haplotype of HPER3 has been associated with the delayed 
sleep phase disorder in a Japanese population [184]. The N408 allele of CKIê is a 
marker for other circadian rhythm sleep/wake disorders such as delayed sleep phase 
disorder and the non-24-hour sleep/wake disorder based on samples drawn from -135 
patients [185]. Similarly, diurnal preference has been associated with polymorphisms in 
HCLOCK[186, 187], HPER2[188] and HPER3[189, 190]. 
1.2.2 Functional circadian cJocks are also present outside the SCN 
A rhythmic expression of components of the molecular clock has also been 
demonstrated in non-SCN brain regions and non-neuronal tissues. Temporarily exposing 
fibroblasts to media rich in horse serum (in a so-called "serum-shock" experiment) can 
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induce the rhythmic expression of Per1 and Per2transcripts [191]. It would then appear 
that the molecular machinery in non-SCN tissue is functionally similar to that in the SCN. 
ln the SCN, just as in peripheral tissues including the heart, eye and lung in rodents, 
Per2 and Smal1 mRNA levels peak in anti-phase to each other [192-194]. Per 
transcripts oscillate in neuronal extra-SCN and in non-neuronal tissues with peaks 
occurring several hours after that observed in SCN culture [191, 195-203]. 
ln an analogy to SCN graft studies, Pando et al [204] established a method of 
transplanting mou se embryo fibroblasts within a collagen pellet to a new host. By 
varying the genotype of the graft and the host, they determined that in the presence of a 
host with a functional clock, grafted fibroblasts will display the characteristics of 
peripheral oscillators of the host, such that a host-derived signal may rescue some 
phenotypes in the graft. The abolition of diurnal differences in Per expression in 
peripheral tissues following SCN ablation [205] supports this view. SCN-Iesioned mice 
do not demonstrate day/night differences in mRNA levels of Per1, Per2 or Smal1 in the 
liver or kidney, until their blood stream is physically connected to SCN intact animais 
whereupon the differences in clock gene expression are restored [206]. Similarly, 
fibroblasts plated in the presence of SCN cells demonstrate a coherent rhythm in their 
clock gene expression that is delayed relative to that of SCN cells, and that is lost when 
they are plated in the absence of SCN neurons [207]. 
Cell cultures derived from tissues of SCN and extra-SCN origin can demonstrate 
rhythmic expression of Per transcripts, which may be particularly robust in certain 
tissues (such as the pituitary or the liver) [195, 208]. That clock gene expression in non-
SCN tissue could not be observed over sustained periods was thought to signify that the 
SCN was necessary for the sustained function of these peripheral clocks. 
Recent evidence has served to challenge the notion that the function of 
peripheral oscillators is singularly dependant on the central circadian pacemaker. Rat-1 
fibroblasts transfected with a luciferase reporter fused to the Smal1 or Per2 genes 
revealed that individual cells demonstrate independant expression of clock gene-driven 
luminescence, with periods that averaged close to 24 hours but that varied between -19 
and 30 hours [209]. Contrary to the dampening in amplitude that was thought to occur, 
rhythmicity in these cells became synchronised to each other with serum shock, and 
then gradually desynchronized from each other [209]. Increasing time in culture 
accounted for a loss in mean estimated amplitude [209]. Similarly, individual fibroblasts 
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demonstrate circadian rhythms in clock gene expression wh en a fluorescent reporter is 
fused to the rev-erba gene [210]. The rhythmicity in the expression of a modified clock 
protein can be maintained over several cycles in multiple tissues even when the 
peripheral organs are harvested from SCN-Iesioned animais [211]. Instead, the phase 
of peak PER2:LUCIFERASE expression is desynchronized between many explants from 
SCN-Iesioned mice leading to an apparent loss of rhythmicity within the tissue [211]. 
Similarly, fluorescence reporting associated with 8mal1 transcription has been used to 
demonstrate sustained rhythmic activity in the liver over 3 weeks [200]. In culture, the 
expression of a reporter fused to the 8mal1 gene is out of phase in individual fibroblasts 
and this accounts for the loss in mean amplitude over time [210]. This evidence is 
consistent with the truly functional nature of peripheral circadian oscillators. The SCN is 
currently proposed as the mechanism by which the cells constituting peripheral clocks 
are synchronized. 
Proposed mechanisms for the mediation of SCN direction have included 
diffusible factors from the SCN [212], adrenergic innervation [213], signalling via 
glucocorticoid receptors [214] or hormone-induced interaction with retinoid receptors 
[215]. Interestingly, although dominance may be ultimately relegated to the SCN, the 
nature and mode of control of a diffused factor on the expression of peripheral clock 
genes may be tissue-specifie [202, 215]. For example, transplanting the SCN from a 
genetic mutant hamster results in the ablation or restoration of clock gene rhythms in 
certain tissues but not in others [179]. The existence of functional circadian oscillators in 
the SCN and in the periphery does not preclude the importance of the relationship 
between them. 
1.2.3 Identifying human peripheral circadian oscillators 
Zanello and colleagues first showed the expression of clock genes in the human 
periphery by detecting HCLOCK and HPER1 transcripts and proteins in human 
keratinocyctes, fibroblasts and melanocytes [216]. Biopsied colonie crypts also contain 
HPER1 and HPER2mRNA and their protein products [217]. Just like non-human tissue 
culture, human tissue culture can demonstrate rhythmic clock gene activity. 
Neuroblastoma cells transfected with an HPER1 promoter-Iuciferase reporter exhibit 
promoter show continued rhythmic oscillation during two cycles following stimulation with 
serum-rich medium [218]. 
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Table 1.1 Expression of clock genes in human peripheral tissues. 
Abbreviations: PBMCs- Peripheral blood mononuclear cells, LD- Light/Darkness cycle; CR- constant routine) 
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2001 Oral mucosa, - 4-hour sampling for 24- HPER1, HBMAL 1, Significant circadian rhythmicity in HPER1, HBMAL 1, HCRY1, HTIM, HCRY1 transcript levels. Greater variability, lower [219J skin hours HCLGCK amplitude in skin 
2002 PBMCs Sampling at 09:00 and 21:00 HCLGC/(, HPER2 Morning/evening differences in HPER2expression [220J 
2003 PBMC -2-hour sampling during 35- HPER1-3 HDEC1 Signi~icant circadian rhythmicit~ .in transcript levels [Ch. 2J hour CR ' sustalned under constant conditions 
2004 Mono and -2-hour sampling during 26- Significant circadian rhythmicity in transcript levels in both polymorpho- HPER1 cell subpopulations. Secondary peak in HPER1 expression [221J 
nuclear cells hour modified CR in polymorphonuclear cells 
2005 PBMCs -4-hour sampling during 24 HPER2, HBMAL 1, Peaks in HPER2and HBMAL 1 expression segregate into [222] hours HREV-ERB morning and late molecular chronotypes 
2006 -2 hour sampling during 72 HPER1,HPER2, Comparable circadian rhythmicity in HPER1, HPER2 
[Ch. 3J PBMC hours HBMAL1 transcript levels in habituai sleep/wake cycle and under 
constant conditions 
Culture of human biopsies 
Skin, hair root, HBMAL1 Inter-tissue variability in amplitude of c10ck gene keratinocytes, Primary cell culture luciferase reporter expression; inter-individual variability in period of 
expression 
2005 Whole blood Patient with non-24 hour HPER1-3, Combined therapy including bright light (2,500-3,000 lux), 
[224J cells sleep/wake syndrome HCLGC/(, exercise, melatonin, methyl B12., methylphenidate HBMAL1 hydrochloride alters clock gene expression 
2005 PBMCs Sampling before and after HBMAL1, HCRY1 Inter-individual variability in measured levels [225J 24-hour blue light exposure 
2006 PBMCs Simulated night shift work HPER1,HPER2, Re-alignment in melatonin, cortisol and c10ck gene 
with liqht intervention HBMAL1 expression after nine 
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Serum shock performed in human fibroblasts from different cell lines (Iung, myeloid, 
epithelioid) resulted in an immediate increase in HPER1, HPER2 transcripts with an 
intermediate increase in HBMAL 1 [226]. HPER1 transcription is induced in autopsied 
human bronchial epithelia cells in culture stimulated by fenoterol and procaterol (~­
adrenoreceptor agonists) for 1 h [227]. Dexamethasone stimulates HPER1 expression 
in human bronchial epithelial cells and in PBMCs in vitro [228]. The serum shock 
response of human tissues in culture is also evident in the induction of HPER2 
oscillation in vascular smooth muscle cells or the phase shift in this rhythm with retinoic 
acid [215]. 
Using human skin biopsies and oral mucosa punches obtained under local 
anaesthesia at 4-hour intervals, Bjarnason and colleagues have ascertained that 
HPER1, HCRY1, and HBMAL 1 ail oscillate rhythmically in human peripheral tissues 
[219]. More precisely, in oral mucosa they identified a peak expression of HPER1 early 
in the active (light) period, a peak of HCRY1 later in the active period and a peak of 
HBMAL 1 at almost 12 hours from that of HPER1. In skin, the time of peak HBMAL 1 
expression was similar, while the expression of HPER1 occurred later. More recently, 
Takata and colleagues [220] have described the expression of HPER2 in human 
peripheral blood mononuclear cells (PBMCs) at two time points during the day. They 
determined in a group of 9 healthy volunteers that the expression of HPER2 in PBMCs 
at 09:00 was significantly greater than that determined at 21 :00 hours. Using a modified 
CR, Kusanagi and colleagues confirmed the results discussed in Chapter 2 of this thesis 
by sampling white blood cells and determined HPER1 expression in mononuclear and 
polymorphonuclear white blood cell subsets [221]. Teboul and colleagues have shown 
that a significant circadian variation in the expression of HREV-ERBa, HBMAL 1 and 
HPER2 mRNA in human PBMCs using sampling in medical residents during their 
habituai sleep/wake schedule with the exception of being briefly awakened for night 
samples [222]. Studies on human clock gene expression (with an emphasis on clocks in 
circulating blood ce Ils) are summarized in Table 1.1. 
1.2.4 Synchronizing peripheral circadian oscillators 
Shifts in the lightldark cycle resynchronize peripheral oscillators more slowly than 
the SCN and phase shifts in peripheral tissues may follow shifts observed in the SCN by 
several days [195, 208, 229, 230]. As a result, desynchronization may exist between 
tissues or between the SCN and peripheral clocks following a shift in the lightldarkness 
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schedule. This presents an interesting concept in its similarity to the desynchronization 
that exists between hormonal and behavioural rhythms following transmeridian flight or 
shift work. It remains unclear whether the light responsiveness of clock gene expression 
occurs in the SCN only. Thirty minutes of exposure to 2,000 lux white light can induce 
Perl expression in the adrenals of transgenic mice [231]. However, this induction is 
abrogated in SCN lesioned animais which suggests that the responsiveness of at least 
some peripheral tissues is SCN-dependant. 
Very IiUle evidence on the effect of light on human peripheral clocks is available. 
HCRYl and HBMAL 1 expression in PBMCs sampled from neonates before and after 24 
hours of blue light exposure with covered eyes suggests a slight decrease in the 
transcription of HBMAL 1 and an increase in HCRYl transcription [225]. However, this 
experiment reported only two time points, and the experimental results include a 
reduction in melatonin levels that suggest that a change in melatonin secretion (either 
suppression or a phase shift) was induced by light [225]. Thus, interpretation of these 
results is difficult. It was also recently demonstrated that levels of HPER2 transcripts in 
oral mucosa are greater in the presence of a nocturnal blue light pulse (460 nm) than 
when participants were exposed to green light (555 nm) or darkness in the same period 
[232]. 
ln experiments with nocturnal rodents, it has been demonstrated that the 
restriction of food-availability to the light period results in a shift in the liver expression of 
Perl,2,3, Cryl and clock-controlled genes [233-235]. Observed shifts in peripheral 
tissues such as the liver or kidney may be modulated by the presence of glucocorticoids 
since phase shifts occur more rapidly in adrenalectomized animais and animais lacking 
functional glucocorticoid receptors [236]. Daytime restricted feeding also results in 
changes in Perl and Per2 transcripts and PER2 protein expression in brain areas 
including the cortex, hippocampus and limbic forebrain [237, 238]. Importantly, the 
restricted feeding regimen in these experiments elicited no phase shifts in SCN clock 
gene expression. Considering the mechanisms by which the SCN may contribute to the 
coordination of peripheral clocks, it is noteworthy that an artificial environ mental 
temperature cycle, designed to oppose the light and darkness phase (with warmer 
temperatures during darkness and cooler temperatures during the light period) can shift 
the expression of Per2 and Cryl in mouse liver, without any significant effect on their 
expression in the SCN [239]. These results are consistent with the hypothesis that 
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peripheral oscillators may become synchronized by inputs from the SCN (as suggested 
by the effect of light to which the SCN would be sensitive [232]) or by the direct effect of 
non-photic synchronizers. 
Krauchi and colleagues have examined the effects of early and late 
carbohydrate-rich meals on circadian phase of core-body temperature, heart rate and 
salivary melatonin [152]. While they observe significant differences between groups in 
the core body temperature and heart rate rhythms in the intervention group, no 
differences were observed in the time of onset of melatonin and it remains difficult to 
discern which elements of these changes may be accounted for by masking effects of 
meals administered immediately before the evaluation. Nevertheless, these results do 
not preclude the possibility that non-photic cues such as food intake may also influence 
peripheral oscillators in humans. 
1.3 Shift work: A case of circadian misalignment 
Humans may be unique in their capacity and desire to deliberately counteract the 
endogenous circadian clock and sleep at atypical circadian phases. This is the case for 
night shift workers who remain affected by a circadian misalignment with their atypical 
sleep/wake schedule. This may not be without consequences: night shift work has been 
associated with an increased risk for cardiovascular pathology [240, 241], the 
development of insulin-resistance markers (Le. hyperglycaemeia, hypertension, 
hypertriglyceridemia) [242] and gastrointestinal iIInesses [240, 243], cancer [244-246], 
pregnancy complications [247] or high numbers of events for which they were 
hospitalised or required medical consultations [248]. 
The number of shift workers who reveal appropriate circadian phase shifts in the 
absence of a circadian intervention are in the minority. In most individuals, circadian 
adjustment of cortisol and melatonin circadian rhythms remains incomplete [249-253]. 
This is particularly true on the first night shift worked in which endogenous core body 
temperature and endocrine rhythms continue to display their habituai entrainment to a 
day-oriented schedule. Maladaptation to the night shift may persist despite consecutive 
shifts worked: nurses working two consecutive night shifts with no intervention 
demonstrate persistently day-oriented rhythms of plasma cortisol and urinary excretion 
rate of 6-sulfatoxymelatonin [254] and night guards continue to demonstrate high 
nighttime plasma melatonin levels and elevated plasma cortisol towards the end of the 
night shift despite a week of consecutive night shifts [250]. 
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A number of studies have applied the phase and dose response curves to light to 
promote circadian adaptation to night shift work. Initial laboratory studies demonstrated 
that an appropriately timed bright light stimulus (5,000-12,000 lux) could induce a phase 
shift of the circadian pacemaker to adjust to the schedule of a typical night worker [255, 
256]. Light exposure planned in conjunction with times of light avoidance (with the use 
of sunglasses or a stable sleep/darkness schedule) is also associated with appropriate 
circadian phase shifts in simulated night shift work and jet-Iag [257, 258]. Bright light of 
1,000-4,000 lux presented during three simulated night shifts in the laboratory results in 
a 6.25-hour delay in the core body temperature rhythm in middle-aged (40-60 years) 
subjects [259]. Medium intensity light of -1,230 lux for six simulated night shifts is 
sufficient to shift the core body tempe rature minima into the daytime sleep/darkness 
period [260]. Gradually delaying bright light exposure together with the sleep/darkness 
period that follows it results in delays in the core body temperature and acrophase of 6-
suphatoxymelatonin that are comparable to the shift in the sleep/wake cycle [261]. As 
suggested by the sensitivity of the human circadian pacemaker, intermittent exposure to 
bright light (5,000 lux) during simulated night shift work such that one third of each hour 
is spent in indoor room light (of 500 lux) was sufficient to delay temperature minima into 
the daytime sleep period [262]. Similarly, the proportion of subjects demonstrating large 
delays in the temperature rhythm was larger when either a 3 or 6-hour bright light pulse 
was used compared to when participants remained in room light throughout the 
simulated night shift [263]. 
ln a manner that is consistent with the effect of light on the endogenous circadian 
pacemaker, the pattern of light and darkness spontaneously selected by night shift 
workers can be associated with adaptive phase delays that permit the alignment of 
physiological rhythms with the shifted sleep/wake cycle. Specifically, the times selected 
for sleep are important in determining the magnitude of phase shifts induced by night 
time bright light exposure [264]. Nurses who demonstrate appropriate delays in 6-
sulphatoxymelatonin secretion were more likely to go to bed in the morning and 
consequently avoid daylight at times of day that could counteract circadian adaptation 
[265]. Similarly, night shift workers who maintain stable bedtimes (thereby controlling 
the pattern of light/darkness exposure throughout the day) are more likely to 
demonstrate adapted salivary cortisol rhythms [253]: workers who avoided morning 
bright light exposure had further delayed circadian rhythms of cortisol and melatonin 
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[251]. A number of studies have stressed the importance of protection from morning light 
on the commute home [264, 266] since bright light exposure at that time could enforce 
the maintenance of a day-oriented circadian alignment. Field studies on the night shift 
worker population have been of fundamental importance in demonstrating the efficacy of 
bright light in the workplace and the importance of the pattern of IighUdarkness exposure 
for adaptation to atypical work schedules [265, 267, 268]. Using various combinations of 
sunglasses, darkened sleep quarters and bright light during night shifts results in longer 
daytime sleep and improved performance and vigilance measures during simulated and 
real night shifts [269, 270]. 
Together, night shift work and the use of the IighUdark schedule to shift the 
central circadian pacemaker in the SCN provide a useful and practical background on 
which to explore the expression of a human peripheral circadian oscillator when 
challenged to adapt. Shifted sleep/wake and lighUdark schedules can provide useful 
paradigms to explore the relationship of central and peripheral circadian oscillators in 
humans. An abrupt change in the sleep/wake cycle may reveal differences in the 
resetting capacity of peripheral oscillators relative to the central circadian pacemaker of 
the SCN. Establishing the existence of a functional circadian oscillator in the human 
periphery th en provides a novel context in which the consequences of an internai 
desynchronization between oscillators can be explored. 
1.4 Thesis rationale and goals 
At the time that these experiments were started, very little information existed on the 
expression of peripheral circadian oscillators in humans. The experiments described in 
this thesis test the general hypothesis that an observable rhythmic expression of 
circadian clock genes exists in the human periphery. Specifically, clock gene expression 
in white blood cells isolated from seriai blood samples was measured. These peripheral 
blood mononuclear cells (PBMCs) include monocytes and lymphocytes but not 
polymorphonuclear cells [271]. There is a demonstrated circadian rhythm in the numbers 
of PBMCs with a peak in cell numbers during the habituai sleep episode [81, 82]. These 
cells are easily isolated from whole blood on a density gradient and thus provide an ideal 
means by which to sample the clock throughout a circadian cycle. The experiments are 
designed to first measure the expression of clock genes under constant conditions and 
in the presence of a standard sleep/wake cycle, and to establish the relationship of these 
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peripheral oscillators with the SCN-driven rhythms of core body temperature and plasma 
melatonin secretion. As described for the initial identification of endogenous circadian 
rhythmicity in humans, it was expected that the presence of a functional peripheral 
circadian oscillator in PBMCs in vivo would manifest itself as a rhythm detectable under 
different behavioural and environmental conditions. This study had not yet been carried 
out in a putative peripheral circadian oscillator in humans. The resetting capacity of 
peripheral circadian oscillators in PBMCs was also then tested in a night shift work 
simulation with a bright light intervention expected to realign SCN-driven rhythms. To 
my knowledge, this is the first time that peripheral clock gene expression has been 
measured in humans following a shifted sleep/wake schedule. Thus the nover 
hypotheses behind the work presented here are: 
1. A significant circadian expression of circadian clock genes exists in human 
PBMCs. This significant circadian expression of clock genes could be detected 
under constant behavioural and dim light conditions wh en the masking effect of 
sleep, activity and meal intake is minimized. The expression of clock genes in 
the peripheral oscillator of PBMCs would demonstrate a stable relationship with 
the endogenous melatonin circadian rhythm as detected in plasma. Chapter 2 
(Circadian c/ock genes osci//ate in human periphera/ b/ood mononuc/ear ce//s) 
describes the expression of HPER1, HPER2, HPER3 and HDEC1 detected in 
PBMCs at -120-minute intervals during a 35-hour constant routine procedure. 
Il. The significant circadian expression of circadian clock genes in human PBMCs 
could be measured in the presence of a habituai sleep/wake cycle. Clock gene 
expression would maintain a stable relationship with SCN-driven rhythms of 
plasma melatonin and cortisol secretion. Chapter 3 (Expression of c/ock genes 
in human periphera/ b/ood mononuc/ear ce//s throughout the s/eep/wake and 
circadian cycles) compares the expression of HPER1, HPER2 and HBMAL 1 
quantified under both constant routine conditions and in the presence of a 
habituai sleep/wake cycle. 
III. The peripheral oscillator in PBMCs could become realigned to a shifted 
sleep/wake schedule in the presence of a light intervention known to shift 
endogenous circadian rhythms of melatonin and cortisol. Chapter 4 (Contro//ed 
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exposure to light and darkness realigns the salivary cortisol rhythm in night shift 
workers) de scribes the effect of a light intervention designed to significantly delay 
the SCN-driven en doge nous cortisol rhythm. Chapter 5 (Entrainment of circadian 
rhythms of melatonin, cortisol and clock gene expression to simulated night shift 
worR) describes a laboratory experiment of simulated night shift work, with a light 
intervention. The expression of HPER1, HPER2 and HBMAL 1 transcripts is 
quantified in cells sampled at the beginning, the middle and the end of nine days 
on a night shift worker's schedule. 
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2.1 Preface 
At the time that this investigation was initiated, the presence of a circadian oscillator had 
been established in oral mucosa and skin (12). Testing HPER2 expression in PBMCs 
sampled in the morning and the evening, suggested a diurnal difference in clock gene 
expression, but could not establish whether a circadian rhythm was present (13). The 
object of the present investigation was to perform repeated measurements of clock gene 
expression in PBMCs sampled from research participants living under constant 
conditions to test the hypothesis that a significant circadian expression of circadian clock 
genes exists in human PBMCs. 
2.2 Abstract 
ln mammals, it is weil documented that observable circadian rhythms are controlled by a 
central oscillator that is organized in transcriptional and translational feedback loops 
involving several clock genes. Although recent studies have demonstrated that clock 
genes oscillate in many peripheral tissues, their characteristics in the human immune 
system remain unknown. The present study investigates whether circadian clock genes 
function in human peripheral blood mononuclear cells. On the basis of studies derived 
from 3 human subjects under controlled conditions, circadian clock genes HPER1, 
HPER2, HPER3, and HDEC1 are expressed in a circadian manner in human peripheral 
blood mononuclear cells (PBMCs), with the peak level occurring during the habituai time 
of activity. The demonstration of functional circadian machinery in human PBMCs 
suggests that peripheral blood cells may be useful for the investigation of human 
circadian rhythms and their associated disorders. 
2.3 Introduction 
ln humans, as in other animal species, most physiological and behavioural functions are 
expressed rhythmically across days and nights. These daily rhythms, referred to as 
circadian, are controlled by self-sustained biologie oscillators. In mammals, primary 
neuronal cultures as weil as ablation and transplantation studies indicate that the central 
component of this complex oscillatory system resides in the suprachiasmatic nuclei 
(SCN) of the anterior hypothalamus (1,2). Molecular components of the circadian 
oscillator in the mouse have been found to involve transcriptional-translational feedback 
loops of at least 10 genes, namely, mPer1-3, mCry1-2, Clock, SMal1, Tau (casein 
kinase 110), NPAS2, and Dec1-2. Of these, mPer1-2, mCry1-2, and Dec1-2 are negative 
regulators, whereas SMal1 and Clock/NPAS2 are positive regulators (3-5). In addition, 
34 
Tau (casein kinase 110) binds and phosphorylates period proteins (PERs), thereby 
posttranscriptionally regulating their stability. 
Studies from rodents have shown that the molecular clock mechanisms oscillate 
not only in the central nervous system, but also in peripheral organs, such as the liver, 
kidney, and fibroblast cells (6). Given that the many immune parameters, such as 
cytokine synthesis and white blood cell counts, fluctuate in a circadian fashion (7), we 
hypothesized that a veritable circadian expression of functional clock components may 
be observed in human peripheral blood mononuclear cells (PBMCs) and, therefore, may 
play certain roles in controlling the immune circadian physiology. 
ln this brief report, we present the expression profile of circadian clock genes 
HPER1, HPER2, HPER3, and HDEC1 in human PBMCs from 3 human subjects studied 
in a time-free environment. As human blood is widely used in clinical settings, our 
approach may not only provide a useful tool to elucidate the molecular mechanisms of 
human circadian rhythms, but also prompt the investigation of new means to diagnose 
and treat sleep/wake cycle and mood disturbances associated with jet lag, shift work, 
and a variety of medical and psychiatric disorders. 
2.4 Study design 
Three physically and mentally healthy young men, aged 20, 22, and 27 years, were 
recruited from the community. Each provided an informed consent in accordance with 
the guidelines of the Douglas Hospital Research Ethics Board (Montreal, QC, Canada). 
For 3 weeks prior to their admission, subjects kept regular sleep times, restricted to a 
single 8-hour nocturnal sleep episode. This procedure served to ensure that the 
circadian pacemaker was weil stabilized relative to the sleep/wake schedule. 
Each subject was studied individually in a time-free, light-controlled laboratory 
room for at least 5 consecutive days. After 3 baseline days on their habituai schedule, 
subjects underwent a 35-hour constant routine procedure designed to unmask the 
endogenous circadian oscillation of physiological parameters. This procedure consists of 
a regimen of enforced waking, in a semirecumbent posture, under very dim light 
conditions (approximately 4 lux), with minimal levels of activity and with nutritional intake 
divided into hourly snacks. Indeed, the expression of physiologic markers known to be 
controlled by the circadian pacemaker may be confounded by levels of light exposure, 
meals, or postural changes. Thus, sampling for approximately 1.5 days under these 
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conditions allows us to investigate at least one complete circadian cycle with limited 
masking of the endogenous circadian expression. 
Plasma melatonin concentration was determined by means of commercially 
available radioimmunoassays (Stockgrand, Surrey, United Kingdom). Every 120 
minutes, PBMCs were isolated from heparinized blood samples by means of 
Histopaque-1077 (Sigma, St Louis, MO) gradient centrifugation, washed, and 
subsequently frozen at BO°C. The total RNA of each sample was extracted by means of 
Trizol reagent, and the cDNA was generated with Superscript Il reverse transcriptase. 
We performed a TaqMan quantitative real-time reverse-transcription polymerase chain 
reaction (RT-PCR) to determine the level of HPER1, HPER2, HPER3, and HDECI 
expression relative to the housekeeping gene HCDK4 by means of the standard protocol 
described by Applied Biosystems (ABI, Foster City, CA).(9) 
On the basis of the published sequences,(10) the primer sets for HPER1, 
HPER2, HPER3, HDEC1, and HCDK4 are designed as follows: 
HPERI forward primer, 
5' -TTCCTGACGGGCCGAA T-3'; 
HPERI reverse primer, 
5' -CGCTTGCAACGCAGCA-3'; 
HPERI TaqMan probe, 
5' -FAM-TCTACA TTTCGGAGCAGGCAGCCG-Tamra-3'; 
HPER2forward primer, 
5' -CCACGAGAA TGAAA TCCGCT -3'; 
HPER2 reverse primer, 
5' -CCCGCACCTTGACCAGG-3'; 
HPER2TaqMan probe, 
5' -FAM-CCACCCCTTCCGCATGACGC-Tamra-3'; 
HPER3 forward primer, 5'-TTTCCT AA TGTCGCCGAAGAG-3'; 
HPER3 reverse primer, 
5' -CCTGGTATGTCATGAGAA TGCG-3'; 
HPER3TaqMan probe, 
5'-FAM-ATCTGGAGAATGATACGGCAGACACCTGA-Tamra-3'; 
HDECI fo rwa rd primer, 
5' -GAGAA TCGGAGAAGGGCGAC-3'; 
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HDEC1 reverse primer, 
5' -GCGTCCGTGGTCACTTTTG-3'; 
HDEC1 TaqMan probe, 
5' -FAM-TGCGCAGTGAGCAGCCGTGC-T amra-3'; 
HCDK4 fo rwa rd primer, 
5' -GAGGCGACTGGAGGCTTTT -3'; 
HCDK4 reverse primer, 
5'-GGATGTGGCACAGACGTCC-3'; 
HCDK4TaqMan probe, 
5' -FAMAGCA TCCCAA TGTTGTCCGGCTGA-Tamra-3'. 
A dual-harmonic regression model was used on individual curves for the expression of 
each gene with the use of a period search from 23.91 to 24.45 hours (11). As reported 
previously (12), a 12/24-hour composite model explains a greater amount of variance in 
the data. The circadian variation of transcriptional expression was considered significant 
if the 95% confidence interval (CI) describing the amplitude of the first harmonic did not 
include the zero axis. We also performed cross-correlation analyses between the 
variation in the expression of clock genes and that of the plasma melatonin secretion, a 
reliable circadian marker. 
2.5 Results and discussion 
Regression analyses indicated that transcripts of ail clock genes studied displayed a 
daily rhythm that was significantly different from zero with the exception of the 
expression of HDEC1 for subjects S 13 and S20 (Table 2.1). Peak clock gene expression 
was observed mostly during the usual time of activity and light exposure. Transcript 
levels of ail 4 genes were found to correlate positively and significantly with the secretion 
of plasma melatonin, a reliable circadian marker. Peak clock gene expression followed 
the peak of melatonin concentration by a maximum of 9 hours (Figure 2.1). These 
results are consistent with animal studies since the oscillation of clock genes in 
peripheral tissues often lags several hours behind that of the SCN of the central nervous 
system. 
Our findings of a significant oscillation of HPER mRNA levels across circadian 
phases in PBMCs of human subjects are consistent with the results of a prior study (12) 
conducted under ambulatory conditions on oral mucosa and skin biopsies. One study 
also revealed that the expression of HPER2 in PBMCs is significantly different in the 
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morning and the evening.(13) The enforcement of constant conditions in the present 
study implies that the significant circadian oscillation we observe is not explained by 
postural changes, alteration in exposure to light, food intake, or the stress induced by 
needle insertion or biopsy punches. The use of the constant routine procedure also 
reveals that the oscillation of clock genes in PBMCs is present even in the absence of 
sleep/darkness episodes, an observation that supports its endogenous nature. While 
interindividual variability may account for the reduced regression amplitude observed for 
HDEC1 transcripts in 2 subjects, it is possible that the period of awakening associated 
with the constant routine may have influenced our observations. Further investigation 
into the expression of clock genes under a variety of conditions will elucidate the 
influence of sleep and waking on clock gene expression in humans. 
Although limited to a few subjects, our results support the presence of a 
significant and cyclic transcription of clock genes in peripheral PBMCs of healthy 
controls. They also demonstrate the feasibility of studying PBMCs as an accessible 
surrogate for the identificatiol1 of rhythmic clock gene expression in humans. 
Experimental tools using this technique could thus be refined in humans to investigate 
the effects of various drugs on the sleep/wake cycle and endogenous circadian rhythms. 
Future studies should clarify the time relationship of clock gene expression in the SCN 
and PBMCs in lower mammals and extend these findings to humans. 
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Table 2.1 
Expression of eloek gene mRNA in human PBMCs based on dual-harmonie regression 
analysis 
~··1';,; :!:~~:'~1jl/i!llflili~il'!·r~~1:,~j~~<:~t,~'~~.;·:1i~i~~~!t~~_;'~: :'~<;tzr~t;{~"1h~~~~~,~~};(~'" 
S12 22.566 7.598 - 37.533 
S13 2.773 -0.203 - 5.75 
S20 1.723 -0.399 - 3.845 
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Time of fitted 
maximum 
09:22 
12:19 
hPel1 hPer2 I1Dee1 MLT 
912 
813 
S20 
Figure 2.1 
Circadian variation of clock gene mRNAtranscripts in human PBMCs. Transcript 
expression of HPER1, HPER2, HPER3, and HDEC1 for each subject is shown with a 
solid line and the dual-harmonie regression with a dotted line. The y-axis represents the 
relative intensity of mRNA expression. The value of the lowest mRNA expression is 
designated 1, and the levels of mRNA expression at ail other time points are calibrated 
to this value. Error bars indicate the standard deviation on the basis of the mRNA 
samples assayed in triplicates. The x-axis indicates the time, in hours, under the 
constant-routine procedure. In the melatonin (ML T) panel, the y-axis represents plasma 
melatonin concentration (picograms per milligram) in each subject. For the purposes of 
illustration, times where subjects are habitually asleep are projected as open rectangles 
(0). 
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3.1 Preface 
The previous experiment (Chapter 2) demonstrated that levels of clock gene transcripts 
oscillated in a circadian fashion in human PBMCs sampled under a constant routine. A 
functional circadian oscillator therefore exists in these cells. The present experiment 
develops and extends these observations. It was important to establish that measuring 
the expression of these clocks in individuals was possible over sustained periods. It was 
also important to describe the pattern of clock gene expression under entrained 
conditions and to compare it with data acquired under constant conditions. The 
experiments described in this chapter were designed to test the hypothesis that the 
significant circadian expression of clock genes in human PBMCs could be measured in 
the presence of a habituai sleep/wake cycle. 
3.2 Abstract 
Rhythmic expression of circadian clock genes in the neurons of the suprachiasmatic 
nucleus (SCN) is necessary for the manifestation of endogenous circadian rhythmicity in 
behaviour and physiology. Recent evidence demonstrating rhythmic clock gene 
expression in non-SCN tissues suggests that functional clocks exist outside the central 
circadian pacemaker of the brain. In this investigation, we evaluate the nature of an 
oscillator in peripheral blood mononuclear cells (PBMCs) by assessing clock gene 
expression throughout both a typical sleep/wake cycle (LD) and during a constant 
routine (CR). Six healthy men and women aged (mean ±SEM) 23.7 ±1.6 years 
participated in this 5-day investigation in temporal isolation. Core body tempe rature and 
plasma melatonin concentration were measured as markers of the central circadian 
pacemaker. The expression of HPERI, HPER2, and HBMAL 1 was quantified in PBMCs 
sampled throughout an uninterrupted 72-hour period. The core body temperature 
minimum and the midpoint of melatonin concentration measured during the CR occurred 
2:17 ±O:20 and 3:24 ±O:09 hours before habituai awakening, respectively, and were weil 
aligned to the sleep/wake cycle. HPERI and HPER2 expression in PBMCs 
demonstrated significant circadian rhythmicity that peaked early after waketime and was 
comparable under LD and CR conditions. HBMAL 1 expression was more variable, and 
peaked in the middle of the wake period under LD conditions and during the habituai 
sleep period under CR conditions. Using sampling every 2 hours over 3 consecutive 
days, our results compare for the first time clock gene expression in a human peripheral 
oscillator under different sleep/wake conditions. 
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3.3 Introduction 
The suprachiasmatic nucleus (SCN) of the anterior hypothalamus is the central circadian 
pacemaker and generates observable daily rhythmicity in physiology and behaviour. 
Wh en humans live in a time-free environ ment, centrally-driven rhythms of core body 
temperature, melatonin and cortisol persist with a period of approximately 24 hours (18, 
22, 35, 74, 75). The average -24-hour rhythmicity in the firing activity of the neurons of 
the SCN (38, 71, 77) correlates with behavioural rhythmicity (45) and is thought to be the 
result of the expression of circadian clock genes in an autoregulatory feedback loop (19). 
ln this molecular loop, core clock genes such as Period(Per) 1 and 2 and Cryptochrome 
(CIJ1 1 and 2 are induced following the binding of a CLOCK:BMAL 1 protein dimer to 
elements in their respective promoter sequences. PER and CRY proteins form dimers 
and enter the nucleus where they inhibit their own transcription. In addition to this, the 
REV-ERBa protein, whose gene transcription is also activated by CLOCK:BMAL 1, 
enters the nucleus and represses the transcription of the Smal1 gene. A consequence of 
these feedback loops is the rhythmicity in messenger RNAs from many of these genes. 
For example, in the SCN of diurnal and nocturnal rodents Per1 and Per2 expression 
peaks during the subjective day (1, 5, 15, 19, 73, 82) while Smal1 expression peaks in 
anti-phase during the subjective night (15,19,60,64). 
The observation that circadian clock genes also rhythmically oscillate in cultured 
fibroblasts (7, 76) has led to the suggestion that functional circadian oscillators may exist 
outside the SCN. Indeed, rodent studies have confirmed the presence of circadian 
pacemakers in multiple physiological systems and rhythmic clock gene expression is 
present in, among other tissues, the liver (57,81), the stomach (78), the lung (81), the 
bone marrow (20, 31), the vasculature (50, 55) and the adrenal glands (39, 58). 
Rhythmic clock gene expression has also been identified in non-SCN brain regions 
including the pineal (1), the olfactory bulb (3, 30) as weil as regions of the forebrain (4, 
42) and the hypothalamus (1). Lesion of the SCN results in the desynchronization in the 
cellular rhythms in peripheral oscillators (82) or an ablation of gene expression in certain 
tissues (4, 33). Thus, despite the presence of multiple oscillators, the SCN is still 
regarded as a master circadian pacemaker. 
ln an analogy to what has been observed in animal studies, clock gene products 
are present in human skin tissue culture (83), and rhythmic clock gene expression may 
be induced in cultured human vascular smooth muscle cells (40, 50), fibroblasts (53) and 
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neuroblastoma cell lines (48). To date, only a few human peripheral oscillators have 
been identified in vivo. HPERI and HBMAL 1 expression demonstrate significant 
circadian rhythmicity in the skin and oral mucosa sampled from healthy young men (8). 
HPER2expression in human peripheral blood mononuclear cells (PBMCs) displays day-
night differences with two-point sampling under habituai sleep-wake conditions (68). In a 
prior study including three healthy young men studied under controlled conditions in a 
time-free environment, we have demonstrated a significant circadian expression of 
HPERI and HPER2 in PBMCs (9). These results were confirmed by other studies 
conducted either in similar conditions (41) or during a regular sleep-wake cycle (69). 
Peripheral circadian oscillators in humans have the potential to become a valuable tool 
in the understanding of the circadian contribution to various medical disorders. To date, 
little information exists on the capacity for frequent sampling of peripheral clocks in 
PBMCs over extended periods. Moreover, IiUle is known on the expression of peripheral 
oscillators under different behavioral conditions. In this investigation, clock gene 
expression was quantified in PBMCs sampled every two hours over three consecutive 
days under both habituai sleep/wake and constant routine conditions. 
3.4 Materials and Melhods 
Subjects 
Six healthy participants (four men aged ± SEM: 24.4 ± 2.4 years, and two women aged 
22.5 ± 0.4 years) were empanelled in this investigation between January and August 
2004 (Table 3.1). Potential candidates were recruited via ads placed in local 
newspapers, and selected candidates were remunerated for their participation in the 
study. This investigation was performed with the approbation of the Douglas Hospital 
Research Ethics Board. Ali participants provided informed consent prior to their 
empanelment in the study. 
Inclusion/Exclusion Criteria 
Ali candidates were verified to be in good physical health following a complete medical 
interview and examination including electrocardiogram and haematological screen. 
Calculated body mass indices (BMI) were ail within normal ranges. Participants were 
drug-free, nonsmokers at the lime of study and eliminated the intake of ail alcoholic or 
caffeinated beverages in the three weeks preceding the start of the investigation. 
Candidates had no history of night work or transmeridian travel (a cross >2 time zones) in 
the 3 months prior to investigation. 
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Selected candidates had no evidence of psychopathology on structured interviews 
(Structured Clinicallnterview for DSM-IV). They also had no history of sleep pathologies 
or disturbances, as confirmed following interview with a sleep disorders physician. Five 
participants scored as intermediate chronotypes and one participant scored as a 
morning type on the Horne-Ostberg morningness-eveningness questionnaire (37, Table 
3.1). Ali reported good sleep quality with sleep latencies less than 15 min and the 
absence of nocturnal awakenings or premature morning awakenings. 
Both of the female participants had no history of gynecological pathology and 
reported no pregnancies in the 6 months preceding the study. Menstrual cycles had a 
duration of 28 and 30 days with a maximum monthly variation of 3 days. Normal 
ovulation was confirmed by midluteal phase progesterone levels. The investigation was 
planned during the follicular phase of the menstrual cycle. 
S/udy Pr%col 
The investigative protocol took place in the facilities of the Centre for Study and 
Treatment of Circadian Rhythms. Subjects were admiUed to windowless, sound-proof 
and climate-controlled suites each equipped with a private bathroom and a section for 
meals and leisure. Subjects lived therein for the duration of the investigation without 
knowledge of Ume. 
Study participants each maintained stable sleep/wake schedules for at least 14 
days prior to their admission to the laboratory. The sleep/wake schedule included a 
single, nocturnal 8-hour sleep episode and naps were prohibited. In order to verify 
adherence to the sleep/wake schedule, participants were required to cali the laboratory 
voicemail at bed and wake times in addition to completing sleep/wake logs. The 
sleep/wake schedule was also verified using wrist actigraphy (Actiwatch 64, MiniMitter, 
Bend, OR, USA) in the last week preceding the study start. The purpose of the imposed 
sleep/wake schedule was to stabilize the entrainment of the endogenous circadian 
pacemaker and limit the inter-individual variability in phase relationships between the 
endogenous circadian pacemaker and the sleep/wake schedule. 
The laboratory investigation contained two separate behavioural conditions within 
the five-day laboratory study. Upon admission to the laboratory, participants maintained 
the sleep/wake schedules kept in the preparatory phase of the investigation (Figure 3.1). 
Specifically, the midpoint of 8-hour laboratory sleep episode corresponded with the 
midpoint of reported sleep/darkness times in the pre-study period. Ambient light intensity 
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measured in the angle of gaze with a research photometer (IL 1400A, International Light, 
MA, U.S.A.) during wake periods was (mean ± SEM) 118 ± 8 lux and participants slept 
in darkness (-0.03 lux). This segment of the experiment was designed to evaluate 
central and peripheral clocks in the presence of a light/darkness schedule (LD). Upon 
awakening on experimental day three, participants maintained wakefulness throughout a 
32-hour Constant Routine (CR) procedure (described below). A final, ad libitum sleep 
episode fo"owed the CR. Equipment failure resulted in the interruption of blood sampling 
in subject S02. The participant subsequently returned to the laboratory to undergo a 
complete CR procedure, and the resulting data is discussed herein. 
Constant Routine 
Sleep, meal consumption and light exposure are among the conditions that may mask 
the endogenous expression of markers of the endogenous circadian pacemaker. The 
CR is a procedure designed to systematica"y limit potential masking effects on 
measured rhythmicity (21, 26, 52). Participants were required to maintain wakefulness 
throughout the CR procedure. Levels of activity were limited and participants maintained 
a semi-recumbent posture in bed throughout. Ambient light intensities remained constant 
and dim (mean ± SEM: 4 ± 004 lux), and meals were replaced by sma", nutritiona"y-
balanced hourly snacks. Daily calorie requirements, adjusted for reduced activity levels, 
were evaluated for each individual by a registered dietician and evenly distributed across 
snacks throughout the CR. 
Sampling 
Throughout the experiment, we sampled markers of both the central circadian 
pacemaker and the peripheral cJock in PBMCs. For each research participant, we 
co"ected whole blood samples at regular intervals throughout a 72-hour period for the 
subsequent assay of plasma melatonin concentration and PBMC cJock gene expression. 
Upon admission to the laboratory on experimental day 1, each participant had an 
indwelling catheter inserted in a forearm vein. Our blood sampling system included an 
intravenous extension which permitted frequent blood sampling for an extended duration 
without interruption of the participants' sleep. In between blood samples, an infusion of 
heparinized saline (7 lU/cc at 30cc/hr) was used to reduce the risk of clotting at the 
catheter insertion site. The volume drawn throughout a" blood sampling periods did not 
exceed 610 mL. Basal plasma melatonin concentrations co"ected during habituai wake 
periods were not significantly altered throughout the 72-hour period (see individual 
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plasma melatonin results in supplementary figures) suggesting that important changes in 
total blood volume were unlikely. 
Core body temperature, a marker of the central circadian pacemaker was 
continuously sampled via a 10-cm rectal sensor (Rectal-esophageal temperature probe, 
Cincinnati Sub Zero, Cincinnati, OH USA) and stored to a data acquisition system. For 
the assay of plasma melatonin concentration, another marker of the central circadian 
pacemaker, 2.5 ml whole blood samples were collected into K2EDTA-coated 
Vacutainers (7.2 mg K2EDTA, Becton Dickinson, Franklin lakes, NJ, USA) every -60 
minutes, placed on ice for 15 minutes and centrifuged at 4°C for 15 minutes. Plasma 
was stored at -80°C until time of assay. Melatonin concentration was determined in 
duplicata using a radioimmunoassay kit (Stockgrand, Guilford, Surrey, UK), using a 
standard curve with a concentration range of 2.5- 250 pg/0.5 ml and a least detectable 
dose of 2.5 pg/mL. 
Peripheral blood mononuclear cells were isolated from 10 ml who le blood 
samples drawn every -120 minutes. Who le blood was collected into heparin-coated 
Vacutainers (86 USP units Sodium Heparin, Becton Dickinson, Franklin lakes, NJ, USA) 
and centrifuged for 30 minutes on a density gradient (Histopaque-1077, Sigma-Aldrich 
Canada, Oakville, ON, Canada). As specified by the manufacturer, the ce Il layer retained 
for analyses excluded polymorphonuclear cells such as neutrophils, basophils and 
eosinophils and included mononuclear cells su ch as monocytes and lymphocytes. 
Isolated PBMCs were subsequently washed with a phosphate buffered saline solution 
(PBS) and stored at -80°C in Trizol reagent (Invitrogen Canada, Burlington, ON, 
Canada). RNA was subsequently extracted and precipitated from each sample 
according to the manufacturer's instructions, and verified for its concentration on an 
agarose gel. Complementary DNA was reverse transcribed from extracted RNA using 
MultiScribe Reverse Transcriptase (TaqMan Reverse Transcription Reagents, Applied 
Biosystems, Foster City, CA, USA). Quantification of c10ck gene expression was 
performed by real-time PCR using SYBR Green chemistry (Applied Biosystems, Foster 
City, CA, USA) on an AB5700 cycler (Applied Biosystems, Foster City, CA, USA). The 
PCR program used included two minutes at 60°C and 10 minutes at 950C followed by 
40 cycles of 95°C for 15 seconds and 60°C for one minute. The expression of the c10ck 
genes HPER1, HPER2, HBMAL 1 were described relative to the expression of HCDK4 
(cyclin-dependent kinase 4) (9) using the following primers: 
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HPER1 
Forward: 5'-TG G CTATCCACAAGAAGATTC-3 , 
Reverse: 5'-GGTCAAAGGGCTGGCCCG-3' 
HPER2 
Forward: 5'-GGCCATCCACAAAAAGATCCTGC-3' 
Reverse: 5' -GAAACCGAA TGGGAGAA TAGTCG-3' 
HBMAL1 
Forward: 5' -GGCTCA TAGA TGCAAAAACTGG-3' 
Reverse: 5' -CTCCAGAACA T AA TCGAGA TGG-3' 
HCDK4 
Forward: 5'-ATCCCAA TGTTGTCCGGCTG-3' 
Reverse: 5'-TGATCTCCCGGTCAGTTCGG-3' 
ln order to avoid amplification of genomic DNA within extracted RNA samples, primer 
sets were designed to overlap junctions between successive exons, thereby conferring 
to the reaction a preference for the amplification of reverse transcribed cDNA. The 
concentration of primers used in reaction mixtures was adjusted for each primer such 
that the efficiency of amplification for each primer set was comparable over a range of 
possible cDNA concentrations. The specificity of the amplification with each primer set 
was ensured by the verification of the dissociation tempe rature of each reaction product. 
Each amplification reaction was performed in triplicate. 
Statistica/ Ana/ysis 
The core body temperature phase for each individual was defined as the time of fitted 
minimum of temperature data collected under CR conditions. The first five hours of 
temperature data collected during the CR were removed for analysis to account for the 
possible masking effect of the preceding sleep episode. The temperature phase was 
determined following the application of a dual-harmonic regression model to the data 
(11) with parameters set for a search within two standard deviations of the expected 
period of the central circadian pacemaker (22) and without seriai correlated noise. Due 
to the possible masking effects of a sleep/wake schedule on the expression of the 
endogenous temperature rhythm, core body temperature data collected during the LD 
subsegment of the investigation could not be reliably used as a marker of the central 
circadian pacemaker. 
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The phase of the plasma melatonin rhythm was defined as the midpoint between 
times when melatonin concentrations rose above and fell below 24-hour average 
concentrations (84). Typical indoor light intensities may be sufficient to mask the 
endogenous expression of the melatonin rhythm (85). Thus, melatonin data collected 
during the CR most reliably estimates the endogenous phase of the melatonin rhythm. 
Relative clock gene expression was determined from real-time PCR results expressed in 
cycles required to cross the detection threshold. 
Fold change in gene expression of each clock gene was determined for each 
sample relative to HCDK4 expression using the 2-MCT calculation (47). Fold change in 
gene expression for each sample was then expressed as a proportion of maximum 
expression for each behavioural condition of the study (i.e. LD or CR). The maximum 
fold change in gene expression determined for each participant during LD and CR 
subsegments were compared using paired t-tests. In order to determine whether we 
could detect a significant circadian expression of clock genes in PBMCs, we performed a 
dual-harmonic regression on each individual's gene expression profile per experimental 
condition within a period search of 23-26 hours corresponding to the range of period 
found in the expression of HBMAL 1 in human fibroblasts (12). As described previously, 
we defined a statistically significant circadian oscillation where the 95% confidence 
interval for the amplitude of the expression did not include the zero value (9). These 
regression analyses also provided an estimate of the fitted amplitude of clock gene 
expression which represents the mean to trough difference in the first harmonic. 
Amplitude fits were compared between conditions using paired t-tests. The phase of 
clock gene expression in PBMCs was defined as the time of fitted maximum of 
expression as determined by dual-harmonic regression analyses. Circadian phase of 
clock gene expression during LD and CR were compared using paired t-tests. 
To describe the relationship between circadian phase markers and the sleep-
wake cycle, we calculated phase angles as: (Wake-time)-(Phase), where as described, 
circadian phase was defined as the time of fitted temperature minimum, midpoint of peak 
melatonin expression, and fitted maximum of HPER1, HPER2, and HBMAL 1. Calculated 
phase angles during LD and CR were compared using paired t-tests. 
ln order to compare the relationship between the expression of circadian markers 
and the sleep/wake cycle, we calculated a profile of the expression of each circadian 
marker across a total of six wake or sleep 4-hour bins corresponding to the 24-hour day. 
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Individual data for clock gene expression, determined on a sample-by-sample basis, 
were first aligned to the time of habituai awakening, and data was assigned to one of 
four bins corresponding to the habituai wake period (W1-W4) or to one of two bins 
corresponding to the habituai sleep period (S1-S2). The selection of 4-hour analysis bins 
permitted us to analyse individual dock gene data in a meaningful way with respect to 
the sleep/wake cycle. Group means represent the average of individual subject means 
per bin and ail participants are included in each 4-hour bin average. Expression profiles 
during CR and during LD were compared using two-factor ANOVA for repeated 
measures (factors: time of day and experimental segment). 
Results are expressed as mean ± SEM. 
3.5 Results 
Participants maintained steady sleep/wake schedules in the pre-study period, such that 
mean sleep period lengths were 8:03 ± 0:01 hours. The longest and shortest average 
reported sleep period lengths were within five minutes of the indicated 8-hour sleep 
period length. Average bedtimes and waketimes in laboratory were 23:22 ± 0:09 and 
07:22 ± 0:09, respectively. 
Ali available data points for markers of central and peripheral circadian oscillators 
during the 3-day sampling period are shown for each individual in supplementary 
Figures 3.81-3.86. Figure 3.2 iIIustrates the mean expression of circadian markers 
aligned to each individual's habituai waketime (assigned a relative clock hour of 08:00). 
The time of the fitted minimum of the core body tempe rature rhythm, as determined 
during the CR evaluation, occurred 2:16 ± 0:20 hours before habituai awakening (Figure 
3.2 A). The midpoint of peak plasma melatonin concentration measured during the CR 
occurred 3:24 ± 0:09 hours before the time of habituai awakening (Figure 3.2 B). 
Dual harmonie regression analyses performed on the expression of HPER1 in PBMCs 
revealed a significant amplitude of oscillation in ail cases during LD conditions (Figure 
3.2C). Four of six individuals (801, S02, S06, S07) demonstrated a significant circadian 
oscillation during CR. The average maximum fold change in HPER1 expression in the 
group of participants was 3.5 ± 0.8 during LD conditions and 3.6 ± 0.7 during CR 
conditions (p=0.8). Dual harmonie regression analyses revealed that the fitted amplitude 
of HPER1 expression was also comparable between LD and CR conditions (p=0.2). The 
time of fitted peak HPER1 expression was comparable between conditions and occurred 
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2:36 ± 1 :45 hours after awakening during the LD condition and 1 :49 ± 2:11 hours after 
the time of projected awakening under CR conditions (p=0.8). 
Four of the six participants (S01, S02, S03, S08) demonstrated a significant 
oscillation in HPER2 expression in PBMCs during the LD subsegment of the study, while 
the amplitude of oscillation was statistically significant in ail cases under CR conditions 
(Figure 3.2 D). The average maximum fold change in HPER2 expression during LD and 
CR conditions were 2.8 ± 1.4 and 1.8 ± 0.2, respectively, and comparable between 
conditions (p=O.4). The fitted amplitude of HPER2 expression was also comparable 
between LD and CR conditions (p=0.5). Under LD and CR conditions, peak HPER2 
expression in PBMCs occurred 1 :55 ± 1 :43 hours before awakening and 0:04 ± 1 :22 
hours after habituai awakening, respectively. These times were comparable between LD 
and CR conditions (p=0.3). 
The circadian rhythmicity of HBMAL 1 expression in PBMCs was statistically 
significant in four of six subjects under both LD and CR conditions (Figure 3.2 E). Under 
LD conditions participants S01, S02, S07, and S08 demonstrated a significant circadian 
rhythmicity, while under CR conditions the amplitude of expression was significant in 
participants S02, S03, S06, and S08. The mean maximum fold change in HBMAL 1 
expression was 2.5 ±1.4 during LD conditions and 1.6 ±0.1 during CR conditions and 
comparable between conditions (p=0.5). Similarly, the fitted amplitude of HBMAL 1 
expression was comparable during LD and CR (p=0.8). Under LD conditions, the time of 
peak HBMAL 1 expression occurred 6:00 ± 2:27 hours after awakening, while under CR 
conditions, HBMAL 1 transcript levels peaked 2:08 ± 2:05 hours before habituai 
awakening. A trend towards a significant difference in calculated phase angles was 
observed between both conditions (p=0.06). 
ln order to compare the daily expression of circadian markers under LD and CR 
conditions, we calculated a profile of the expression of each marker across six wake or 
sleep bins corresponding to the 24-hour day (Figure 3.3). Core body temperature and 
plasma melatonin concentration varied significantly throughout the day (p<0.001 and 
p<0.001, respectively), while no significant difference was observed between LD and CR 
conditions (Figure 3.3 A, B). The expression of HPERI and HPER2 in PBMCs also 
demonstrated a statistically significant variation over time (p=0.03, and p<0.01, 
respectively), where expression profiles were comparable during LD and CR (p=0.8 and 
p=0.7, respectively; Figure 3.3 C, D). The variation in HBMAL 1 expression over time 
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was not statistically significant (p=O.8) and no significant differences were detected 
between LD and CR conditions (p=O.2; Figure 3.3 E). 
3.6 Discussion 
The inclusion of a 40-hour segment performed under normal sleep/wake conditions (LD) 
and a 32-hour segment performed under constant conditions (CR) within our blood 
sampling session demonstrates the possibility of assessing the function of peripheral 
circadian oscillators in human PBMCs with frequent sampling over an extended period. 
The sustained rhythmic expression of clock gene rhythmicity under constant conditions 
implies that the observed rhythmicity is not generated by behavioural or postural 
changes. The core body temperature and plasma melatonin rhythms measured under 
CR conditions confirmed a normal alignment of the central circadian pacemaker to the 
habituai sleep/wake schedule. As expected under conditions of normal entra in ment, the 
core body temperature minimum occurred in the last hours of the habituai sleep period 
and the midpoint of peak plasma melatonin concentration occurred near the middle of 
the habituai sleep episode. Our observation of peak HPERI expression in PBMCs just 
after the time of habituai awakening is in accordance with previous observations that we 
have made under CR conditions (9) and with those of others made under modified CR 
conditions (41). The morning peak of HPER2 expression in PBMCs is consistent with 
our prior observations under CR conditions (9) and those of others made in the presence 
of a sleep/wake cycle (68). The mean expression profile of HBMAL 1 in our individuals 
displays a less prominent rhythmicity than HPERI or HPER2 (Figure 3.2E). While the 
alignment of HPERI and HPER2 expression to the sleep/wake cycle were comparable 
under our LD and CR conditions, HBMAL 1 expression displayed a trend towards a 
difference in its expression under these conditions. Only during LD conditions did the 
mean daily variation in HBMAL 1 expression approximate a peak in anti-phase from peak 
HPERI and HPER2 expression. The early morning fitted peak of HBMAL 1 expression 
under CR conditions and the low amplitude mean rhythm relative to the sleep/wake 
cycle suggest an inter-individual variability that obscures a coherent mean rhythm in 
HBMALI. 
Inter-subject variability in the expression of clock genes in PBMCs has previously 
been reported. Teboul and colleagues sampled HPER2 and HBMAL 1 expression in 
PBMCs fram who le blood sampled at 4-hour intervals for 24 hours (69). The inter-
individual variability in times of peak HBMAL 1 expression was greater than that for 
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HPER2 expression, similar to what we have observed. They additionally noted that the 
times of peak clock gene expression segregate their experimental group into apparent 
molecular chronotypes. While we noted no such differences in our experimental group, 
the error values we calculated for the group mean phase of clock gene expression were 
larger than those calculated for the phase of core body temperature or plasma 
melatonin. Interestingly, when the period of HBMAL 1 expression is monitored in biopsied 
human fibroblasts, the intra-subject standard deviation is 8 times smaller than the inter-
subject variability in the period of clock gene expression (12). The contribution of post-
transcriptional events must also be considered. When Per2 is constitutively expressed in 
mou se fibroblasts, PER2 protein may continue to display circadian rhythmicity (80). In 
the mou se liver, almost half of the rhythmically expressed proteins do not have 
correspondingly rhythmic RNA levels (61). Thus, post-transcriptional events may also 
significantly contribute to the function of peripheral oscillators in PBMCs. 
Environmental changes may have specific effects on the function of peripheral 
oscillators. The feeding schedule, for example, can reset rodent peripheral oscillators 
independently of the SCN (24, 34, 65). Thus, although CR conditions are sufficient to 
reduce inter-individual variability in centrally-driven rhythms, they may have a negligible 
effect on peripheral oscillators in PBMCs. The factors that permit the SCN to coordinate 
peripheral rhythms are yet unknown, but may be specific to each peripheral oscillator 
(13, 32, 57, 79). A number of hormonal rhythms are driven by the central circadian 
pacemaker, and are potential signais for entrainment. There is evidence to suggest that 
melatonin is an immune modulator, where lymphocytes and PBMCs would exhibit 
transcription of genes encoding enzymes for melatonin synthesis (16, 27) as weil as 
melatonin receptors (17). Glucocorticoids have also been associated with an 
immunomodulatory function and the trafficking of lymphocytes in peripheral blood (2, 28, 
36). Glucocorticods can stimulate HPER1 expression in human PBMCs in vitro and in 
vivo (14, 29). As we previously reported for PBMCs (9), observed rhythms of HPER1 
and HPER2 are in stable relationships with melatonin, a centrally-driven circadian 
rhythm. Future investigation will be required to elucidate the specific relationship of these 
centrally-driven rhythms to the synchronization of peripheral clocks in PBMCs. 
Significant circadian rhythmicity has been observed in the numbers and relative 
proportions of white blood cell subsets. In particular, PBMCs were shown to peak in 
number during the sleep period (10, 51, 63, 70). By our method, the PBMCs include 
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lymphocytes and other mononuclear cells. However, each of these distinct white blood 
cell populations may display a unique rhythmicity in their cell numbers and proportions 
such that relative abundance of each cell subpopulation within sampled PBMCs may 
vary throughout the day (2, 10) or even across seasons (44). Our use of a non-rhythmic 
internai control gene in addition to the input of identical RNA amounts in each real-time 
PCR reaction controls for daily changes in total RNA resulting from diurnal or seasonal 
changes in total cell numbers. Nevertheless, our results point to the heterogeneity of the 
peripheral circadian oscillators in PBMCs, and the possibility that different immune cell 
subsets may have clocks that are individually regulated in a distinctive manner. Indeed, 
Kusanagi and colleagues demonstrated that although the rhythms of HPERI expression 
are comparable in human polymorphonuclear and mononuclear cells (41), 
polymorphonuclear cells demonstrated a secondary HPERI peak towards the end of the 
wake period that did not occur in the mononuclear population (41). Moreover, in PB MC 
tissue culture, the induction of HPERI by a systemic dose of corticosteroids is greater in 
monocytes than it is in lymphocytes, suggesting that the response of cell subpopulations 
to the cellular environment may not be the same (29). 
Although it is likely that inter-individual differences play a role in the variability in 
PBMC clock gene expression, the mechanism is yet unclear. Glucocorticoids and sex 
hormones may interact in modulating the activity of the immune system (23). As 
lymphocytes and monocytes express estrogen receptors (43), the sex of the participants 
may have contributed to the variability in clock gene expression. However, of ail the 
phase markers we analyzed, female participants in follicular phase differed from male 
participants only in the time of fitted peak of HBMAL 1 expression during the CR 
(p=0.005). The eight cases of non-significant circadian amplitude observed under both 
behavioral conditions were observed in a total of five individuals (including both female 
participants), suggesting that the regulation of clock genes in PBMCs is more complex 
than simple sex-based differences. Prior studies have shown that 24-hour mean core 
body temperature is comparable between men and women (6). Our selection of women 
in the follicular phase of the menstrual cycle was meant to limit sex-based inter-
individual variability that could have occurred by including women ta king oral 
contraceptives or in the luteal phase of their menstrual cycle (6). A non-significant 
amplitude in circadian expression of clock genes in PBMCs may not necessarily signify 
the absence of a functional molecular clock in individual cells (54, 72). Rather, a lack of 
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coordination between the clock gene expression in PBMC subpopulations may result in 
an apparent reduction in the amplitude of the observed rhythm. A greater understanding 
of the components that contribute to the organization of peripheral oscillators in PBMCs 
will significantly contribute to our ability to interpret peripheral clock gene expression in 
humans. 
The results of microarray studies showed that most clock-controlled genes 
display rhythmicity in a tissue-specifie manner (25, 49, 56, 59, 62, 66). This situation 
raises the possibility that clocks in peripheral tissues exert local control over a tissue's 
function while the central circadian pacemaker SCN orchestrates overall rhythmicity. A 
recent report showed that Per2-deficient mice have an increased survival rate as weil as 
an altered NK cell-mediated cytokine response to LPS-induced endotoxic shock (46). 
Moreover, Bma/1-defficient mice demonstrate a deficiency in B lymphocyte development 
(67). These data indicate a functional role for the molecular clock in the immune system. 
Further study of clock genes and clock-controlled genes in human PBMCs and other 
tissues will provide important information on the associations between sleep/wake cycle 
disorders and overall health. 
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Subject Sex Age Chronotype Bedtime Waketime Month of Study (37)[272] 
S01 M 19.6 1 ntermed iate 23:25 07:25 January 
S02 M 21.9 Morning 22:57 06:57 January/February* 
S03 M 25.4 Intermediate 23:59 07:59 February 
S06 F 22.9 Intermediate 23:32 07:32 March 
S07 M 30.5 1 ntermed iate 23:00 07:00 July 
S08 F 22.0 Intermediate 23:24 07:24 August 
Table 3.1 
Study Participants. * This subject completed the experiment in two separate laboratory 
visits. See Methods for details. 
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Figure 3.1 
Experimental protocol. Blood samples, co"ected repeatedly over a continuous 72-hour 
period beginning on experimental day 1, were assayed for their melatonin concentration 
and for the expression of clock genes in PBMCs. At the start of the study, participants 
lived on their habituai sleep/wake schedule. Wake episodes were spent in normal indoor 
light intensities (mean ± SEM: 118± 8 lux), and sleep episodes took place in total 
darkness (-0.03 lux). A 32-hour Constant Routine (CR) procedure was initiated upon 
awakening on experimental day 3 (mean intensity ± SEM: 4 ± 0.4 lux; see Methods for 
details on the CR procedure). 
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Circadian expression of central and peripheral markers for LD and CR experimental 
subsegments. Mean fitted core body temperature (CBT) minimum and midpoint of peak 
plasma melatonin (ML T) concentration are shown in panels A and B. Fitted maximum 
expression of HPERI, HPER2 and HBMAL 1 in PBMCs are shown in panels C-E, 
respectively. Mean circadian phase for each marker is indicated within panels as a 
triangle. Ali error bars represent SEM. Although ail subjects are included in the analyses, 
the fraction of the study group for whom a significant circadian amplitude in clock gene 
expression was detected is shown in panels C-E. Mean expression of circadian markers 
was calculated from individual subject data first aligned to habituai wake time. For 
visualisation purposes, bedtime and waketime are assigned the relative clock hours of 0 
and 8, respectively. 
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Daily profile expression of central and peripheral circadian markers. The 24-hour day is 
represented as 4-hour bins corresponding to habituai wake (W1 - W4) or sleep times 
(S1, S2) for ail six participants. ANOVA for repeated measures revealed no significant 
differences between LD and CR conditions. P values for the time effect are shown in the 
upper left hand corner of each panel. 
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Equipment failliTe during the Lü portion of the investigation resulted in missing core body temperature data. 
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Controlled exposure to light and darkness realigns the salivary cortisol rhythm in night 
shift workers. 
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4.1 Preface 
The present experiment describes the manipulation of the pattern of light/darkness to 
phase delay and consequently realign the endogenous cortisol rhythm in night shift 
workers. This study included real night shift workers on their actual work schedules. 
Thus, principles established in laboratory experiments could be applied in the field. This 
investigation provides a demonstration of light-induced shifting of the central circadian 
pacemaker. As a prelude to the investigation of the effects of simulated night shift work 
on PBMC oscillators (Chapter 5), it is established here that a light/darkness intervention 
can promote the appropriate circadian alignment of the SCN-driven cortisol rhythms of 
night shift workers. 
4.2 Abstract 
The efficacy of a light/darkness intervention designed to promote circadian adaptation to 
night shift work was tested in this combined field and laboratory study. Six full-time night 
shift workers (mean age ± SD: 37.1 ± 8.1 years) were provided an intervention 
consisting of an intermittent exposure to full-spectrum bright white light (-2,000 lux) in 
the first 6 hours of their 8-hour shift, shielding from morning light with tinted lenses 
(neutral gray density, 15% visual light transmission), and regular sleep/darkness 
episodes in darkened quarters beginning 2 hours after the end of each shift. Five control 
group workers (41.1 ± 9.9 years) were observed in the presence of a regular 
sleep/darkness schedule only. Constant routines (CR) performed before and after a 
sequence of -12 night shifts over 3 weeks revealed that treatment group workers 
displayed significant shifts in the time of peak cortisol expression and realignment of the 
rhythm with the night-oriented schedule. Smaller phase shifts suggesting an incomplete 
adaptation to the shift work schedule were observed in the control group. Our 
observations support careful control of the pattern of light and darkness exposure for the 
adaptation of physiological rhythms to night shift work. 
4.3 Introduction 
Despite years of night work experience, circadian maladaptation to night work may 
persist. Spontaneous adjustment of the core body temperature rhythm, and of melatonin, 
cortisol, thyroid stimulating hormone, or prolactin secretion to shifts in the rest-activity 
cycle are reported in a minority of shift workers (Sack et al., 1992; Roden et al., 1993; 
Koller et al., 1994; Weibel et al., 1997; Weibel and Brandenberger, 1998; Goh, 2000). 
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Appropriately-timed nocturnal bright light has proven an effective intervention to promote 
the realignment of endogenous rhythms of core body temperature, melatonin, and 
cortisol to a nocturnal reorientation of the work schedule in laboratory simulations 
(Czeisler et aL, 1990; Dawson et aL, 1993; Martin and Eastman, 1998; Horowitz et aL, 
2001; Crowley et aL, 2003). Field studies have confirmed this finding, where the 
presence of higher light intensities during the night shift have been associated with 
circadian adaptation (Stewart et aL, 1995; Gibbs et aL, 2002; Boivin and James, 2002). It 
has been further demonstrated that control of the pattern of light and darkness exposure 
throughout the day, including limited exposure to bright light during the morning 
commute home, are important in the adjustment of circadian phase (Eastman et aL, 
1994; Buxton et aL, 2000; Dumont et aL, 2001; Crowley et aL, 2003). 
ln a previous investigation (Boivin and James, 2002), we determined that a 
comprehensive lightldarkness intervention including phototherapy in the workplace, 
shielding from bright morning light and the maintenance of a stable diurnal 
sleep/darkness period could promote circadian adaptation in nurses working full-time 
night shifts. In this report, we present an evaluation of the circadian rhythm of salivary 
cortisol collected in 11 of the 15 nurses participating in our previous study. Sampling was 
performed both before and after the period of night shift work under controlled laboratory 
conditions. 
4.4 Methods 
Subjects 
Eleven nurses working full-time night shifts (at least 8 shifts /15 days) consented to this 
investigation designed to test the efficacy of a lightldarkness intervention for the 
alignment of the circadian pacemaker with a schedule of night shifts. Night shifts were ail 
of an 8-hour duration and started either at 23:30 or 00:00 hours. Ali workers were 
screened for medical and psychological conditions in an interview with a physician. None 
of the female subjects used birth control pills. The group of workers included 6 males 
(age ± SD: 40.7 ± 8.4 years) and 5 females (36.9 ±9.7 years) and was comprised of a 
subgroup of subjects for whom results have previously been reported (Boivin and 
James, 2002). 
On average, workers drank 1.4 ± 1.1 cups of coffee and less than one serving of 
alcohol daily. Those who smoked (3 control group workers, 2 treatment group workers), 
consumed an average of 8.2 ±7.8 cigarettes daily. Alcohol consumption was prohibited 
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on work days and minimal « 1 drink 1 day) on days off. Consumption of these products 
was comparable between groups. Informed consent was obtained prior to the 
experiment start in accordance with the procedures of the Douglas Hospital Research 
Ethics board, and the hospital sponsoring the participation of the nurses, where 
applicable. 
Investigation Protoco/ 
ln order to establish a baseline condition, each worker was studied following a vacation 
period lasting at least 10 days. During this period, subjects lived on a day-oriented 
schedule, kept regular sleep times, and avoided daytime napping. Times in bed were 
noted in appropriate logs and were confirmed by wrist actigraphy monitoring (Actiwatch-
64, or Actiwatch-L, Mini-Mitter, Bend, OR, USA) and daily telephone calls in the week 
prior to admission to the laboratory. Subsequent to the vacation period, workers were 
admitted to the laboratory for an initial evaluation of circadian phase. (Figure 4.1). 
Circadian phase was assessed via the constant routine (CR) procedure designed 
to unmask the endogenous expression of the circadian system (Czeisler et aL, 1986; 
Milis et al. 1978). In this laboratory procedure, subjects maintained wakefulness in a 
semi-recumbent posture for 36 hours. Light intensities within the laboratory suite, as 
measured in the angle of gaze (IL 1400A, International Light, MA, U.S.A.), were dim « 7 
lux), and emitted from ceiling-mounted banks of full-spectrum cool-white fluorescent 
fixtures (4100 OK, TL80 F32T8/TL841 from, Philips, U.S.A., and Octron 800, F032/841 
from Sylvania, U.S.A.) covered with lenses emitting less than 1 % radiant energy up to 
400 nanometres (K-S-H Uvalite Plus, K-S-H Inc., U.S.A.). Research assistants were 
present to assist the participant in staying awake. 
Subsequent to the evaluation of circadian phase, ail workers returned to their 
regular schedule of 11-12 night shifts over a 19-20 day period. The distribution of night 
shifts and days off varied according to the habituai practices of the place of employment. 
Workers were readmitted to the laboratory following the last night shift worked for a 
second 36-hour CR and the evaluation of circadian phase. The final CR was performed 
after an average of 4.7 ± 2.0 consecutive night shifts. The number of nights worked prior 
to the final CR was comparable between groups (p=0.6). 
Light/darkness intervention 
The 6 nurses (2 female, 4 male) studied in the treatment condition were provided an 
intervention designed to carefully control exposure to light and darkness throughout the 
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day. In the first 6 hours of each night shift, treatment group workers were intermittently 
exposed to full-spectrum bright, white light (mean intensity measured with a portable 
light meter in the angle of gaze ± SD: 2,590 ± 1,317 lux) via portable lamps (Sunbox 
Company, Gaithersburg, MD, USA) set up at the nursing station. Workers were 
instructed to remain under bright light as much as the workload permitted and to look 
into the lights as much as possible. In the final two hours of the night shift, the portable 
lights were shut off, and the workers remained in their habituai lighting environments 
(mean intensity ± SD: 104 ± 58 lux). Workers in the treatment group were also given a 
pair of goggles with neutral grey density lenses (Astrospec 3000 or Flashback both with 
SCT-gray lens tint, 15% visuallight transmission, Uvex, Smithfield RI, U.S.A), and were 
instructed to wear them during the morning commute home. Control group workers (3 
female, 2 male) received no bright light in the workplace (mean intensity ± SD: 131 ± 
122 lux) and wore clear, UV-excluding goggles during the commute home (Astrospec 
3000 or Flashback both with clear lens, 90% visual light transmission, Uxex Smithfield 
RI, U.S.A.). Ali workers were instructed to maintain stable sleep/darkness schedules 
including a single 8-hour diurnal sleep episode beginning 2 hours after the end of the 
night shift. Adherence to the sleep/darkness schedule was verified using sleep/wake 
logs, wrist actigraphy monitoring (Actiwatch-64, or Actiwatch-L, Mini-Mitter, Bend, OR, 
USA) and daily telephone calls to the laboratory at bed and wake times. In exceptional 
circumstances where the sleep/darkness period was abbreviated or interrupted (-12% of 
ail diurnal sleep observations), workers wore darkened goggles throughout the period 
corresponding to the assigned sleep/darkness period and noted this in appropriate logs. 
Treatment group workers had their sleeping quarters deliberately darkened with opaque 
material covering the windows. It was observed, however, that control group workers 
also slept in dark bedrooms. 
Measuremenfs and analyses 
During CRs, saliva samples destined for the assay of cortisol concentration were 
collected at 60-minute intervals and stored at -20°C until the time of assay. Salivary 
cortisol concentration was determined in duplicata via radioimmunoassay (Diagnostic 
Systems Laboratories, Webster, Texas). The kit had cross-reactivities of 100% for 
cortisol, 33% for prednisolone, 9.3% for corticosterone, and 1.4% for prednisone. Kit 
sensitivity was to 0.01 mg/dl. The salivary cortisol rhythm was characterised with the 
application of a single harmonic regression model to each subject's data. The amplitude 
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of the rhythm was defined as the mean to trough difference of this harmonie. Times of 
fitted maximum and fitted minimum were both used as circadian phase markers in our 
analyses. By convention, phase (<1» shifts in the cortisol rhythm were calculated as <1> 
[initial] - <1> [final], such that adaptive phase delays were expressed as negative values. In 
order to ascertain the alignment of the cortisol rhythm with the sleep/wake cycle, we 
calculated phase angles as the difference: (bedtime) - (time of fitted maximum of the 
cortisol rhythm). Thus, a negative phase angle would indicate that peak cortisol values 
were observed after bedtime. Sleep times for the analysis of data from the first CR were 
based on mean times in bed for the week prior to laboratory admission, scaled to an 8-
hour length. In order to determine adaptation to the night shift work schedule, daily 
reported bedtimes for the ambulatory night-shift period were used for the calculation of 
phase angles in the final CR. Between and within group differences were analysed 
using non-parametric analyses. Analysis of reported sleep/darkness times revealed that 
the assigned schedule was weil maintained. 
Unless specified, ail error values represent SEM. 
4.5 Results 
Baseline 
Mean cortisol concentration during initial and final CRs is shown in Figure 4.1 (Iower 
panels). At the time of the initial CR, times of maximum and minimum cortisol 
concentration were comparable between groups (Table 4.1). The fitted amplitude of the 
cortisol rhythm was also comparable between groups. In the control and treatment 
groups, the peak of the cortisol rhythm occurred 8:32 ± 1 :37 and 9:51 ± 0:18 hours after 
bedtime, respectively. 
Final 
Following the period of night shift work, the time of maximum cortisol concentration in 
the control group was shifted by -3:03 ± 2:07. The treatment group displayed a 
significantly larger shift of -11 :04 ± 1 :16 (P=0.02). Similarly, observed shifts in the time of 
minimum concentration were -3:41 ± 2:09 in the control group and -11 :26 ± 1 :26 in the 
treatment group, for a significant difference between groups (P= 0.03). The interval 
between the times of the maximum and minimum were comparable between groups for 
the initial and final CRs. Compared to the initial CR, a 39-minute reduction of this interval 
was observed in control group workers (P=0.08) compared to a 22-minute reduction in 
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treatment group workers (P=0.2). No differences between or within groups in 24-hour 
mean cortisollevels were detected. 
Following the period of night shift work, peak cortisol concentration occurred 1: 15 
± 2:10 after bedtimes in the control group, whereas peak levels of cortisol concentration 
occurred 11 :38 ± 1 :22 after bedtimes in the treatment group, for a significant difference 
between groups (P=0.009). 
4.6 Discussion 
Following a day-oriented vacation period, the shift workers empanelled in this 
investigation displayed cortisol rhythms well-adapted to day-oriented life. As expected, 
peak cortisol secretion occurred in the hours following the time of habituai awakening, 
and lowest concentrations were observed close to the onset of night time sleep (de 
Lacerda et al., 1973; Van Cauter, 1990). Following the period of night shift work, workers 
who remained in their habituai light environments displayed a misalignment between the 
endogenous circadian cortisol rhythm and their sleep/wake schedule. This resulted in 
higher cortisol concentration near diurnal bedtimes whereas minimal levels were 
detected near the start of the nocturnal active period. Conversely, workers who received 
the intervention displayed peak cortisol levels after awakening in the evening, prior to the 
start of their work shifts, and lowest levels in the morning close to their new bedtimes. 
The phase angles between peak cortisol levels and bedtimes in the treatment 
group were comparable before and after 12 night shifts worked over a -3-week period. 
This indicates a circadian re-entrainment with the shifted sleep and work schedule in this 
group. This result is consistent with the reentrainment of core body temperature and 
salivary melatonin rhythms in these subjects (mean shifts of -8: 15 ± 1 :08 and -10:33 ± 
1 :05, respectively). The smaller phase delay shift in the cortisol maxima of the control 
group (Table 1) suggests that a partial adaptation of this rhythm has occurred in the 
absence of the full intervention provided. Indeed, consistent phase shifts were detected 
in the core body temperature and salivary melatonin rhythms in these subjects (mean 
shifts of -2:46 ± 2:10 and -2:10 ± 2:38, respectively). This partial adaptation supports our 
prior interpretation (Boivin and James, 2002) that judicious timing of the schedule of 
sleep/darkness can induce adaptive phase delays of smaller magnitude compared to the 
three-tiered intervention of the treatment group. 
The use of the constant routine procedure combined with a workplace 
intervention allowed us to accurately quantify circadian phase in nurses working nights. 
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The consistency of observed phase shifts between three reliable circadian markers 
assessed during CR reinforces our conclusion on the efficacy and usefulness of the 
intervention provided. 
Weibel and colleagues previously reported on the rhythm of plasma cortisol in 
night shift workers (Weibel et aL, 1996) sampled under controlled postural conditions. 
Their analyses revealed that shifts observed in the time of the acrophase were over 
twice the magnitude of changes in the timing of the quiescent period. Other groups have 
also reported on changes in the shape of the cortisol rhythm following an abrupt shift 
(Desir et aL, 1981; Caufriez et aL, 2002). In order to document changes in the shape of 
the cortisol secretion curve in the present study, we evaluated the interval between the 
peak and the nadir of salivary cortisol secretion for each subject (Table 4.1). No 
significant differences in this calculated interval were detected in either group of workers. 
However, it is possible that our sample size is insufficient to detect small modifications in 
the shape of the cortisol rhythm following night shifts. lnterestingly, the night shift 
workers studied in the Weibel investigation had a wider variability in their sleep and 
wake times on work days than our workers. This, may have contributed to additional 
variability in the timing of peak and low cortisol secretion. In our study, workers of both 
groups went to bed two hours after the end of their night shifts and remained in darkness 
for comparable periods. Variability in the number of consecutive shifts worked 
immediately preceding the final CR (minimum 2 shifts, maximum 8 shifts) may also have 
contributed to some of the variability in the cortisol rhythm. Nevertheless, the mean 
number of consecutive shifts worked prior to the final CR was comparable between 
groups. 
A lack of entrainment of melatonin and/or cortisol to a night-oriented schedule is 
reported in a number of studies despite a series of shifts (Sack et aL, 1992; Roden et al., 
1993; Koller et al., 1994; Costa et al., 1997; Hennig et al., 1998). The control group 
workers in this study demonstrated greater variability in the alignment of their cortisol 
rhythm with the sleepwake schedule than treatment group workers. This resulted in an 
apparent reduction in the mean amplitude of the cortisol rhythm in the control group 
following a work period including -12 night shifts (Figure 4.1, lower panels). This change 
is secondary to the averaging of data points for iIIustrative purposes, since our analyses 
of individual curves revealed that circadian amplitude was maintained in both groups 
(Table 4.1). 
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The sampling interval used in the present study is large compared to the 10-20 
minute sampling interval of plasma cortisol used in some prior studies (Weibel et aL, 
1996; Weibel and Brandenberger, 1998; Weibel and Brandenberger, 2002). It is thus 
possible that our longer sampling interval has introduced some variability in the reported 
results. Nevertheless, the cortisol data are consistent with those of salivary melatonin 
(sampled 1/hour) and core body temperature data (sampled 1/minute) also collected 
during CRs. 
Populations of workers much like ours are described as having varying degrees 
of circadian adaptation, where some report no adaptation at ail. The pattern of light 
exposure maintained by night shift workers who spontaneously adapt to a night shift 
work schedule are notable for the stability of sleep times (Roden et aL, 1993), limited 
exposure to bright sunlight in the morning (Koller et aL, 1994), brighter light during shift 
hours combined with sleep times in darkness (Dumont et aL, 2001), and limited 
exposure to light throughout the day in Antarctic studies (Midwinter and Arendt, 1991). In 
particular, shift workers displaying adapted rhythms of salivary cortisol over a series of 
consecutive night shifts also reported stable morning sleep times (Hennig et aL, 1998). 
Circadian adaptation of the cortisol rhythm in shift workers is worthy of 
investigation for a number of reasons. The demonstration of reduced memory 
performance with pharmacological reduction of cortisol levels, and increased 
performance and cognitive efficiency in the presence of exogenous cortisol (Lupien et 
aL, 2002), suggests that a misalignment in the cortisol rhythm resulting in lower levels 
during the waking episode could contribute to the observed reduction in performance in 
the workplace (Akerstedt, 1995). 
Indeed, the administration of exogenous glucocorticoids has resulted in reduced 
subjective ratings of fatigue in emergency room physicians on night shifts (Whitcomb et 
aL, 2000) and increased objective measures of vigilance as assessed via 
polysomnography during repeated nap opportunities (Meixner et aL, 2003). Thus, an 
appropriate alignment of peak cortisol levels with the start of the night shift (as achieved 
by the treatment group) seems to the worker's advantage. 
As is weil known, sleeping at inappropriate circadian phases as in shiftwork may 
result in an abbreviation of the sleep period (Foret and Benoit, 1974; Kurumatani et aL, 
1994; Rosekind et aL, 1994; Sallinen et aL, 2003). The accumulation of sleep debt over 
a number of consecutive night shifts worked, for example, may in turn result in elevated 
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basal cortisollevels (Leproult et al., 1997; Charloux et al., 2001). In our small sample of 
workers, we were unable to detect significant between group differences in mean 
salivary cortisol levels. The long-term consequences of a misalignment between the 
endogenous cortisol rhythm and the sleep/wake cycle are largely unknown, but could 
contribute to the increased risk of metabolic disorders, induding diabetes, associated 
with shift work (Karlsson et al. 2001, Koller et aL, 1978; Knutsson, 2003). This is 
particularly true in light of the hypothesis that cortisol may directly affect glucose 
metabolism (Van Cauter et aL, 1992, 1997; Dinneen et aL, 1993;). More specifically, the 
elevation of cortisol levels at inappropriate times of day results in profiles of insulin 
secretion and plasma glucose concentration that are consistent with a temporary insulin 
resistance (Lund et aL, 2001 ; Plat et al., 1999). 
ln summary, the present study is in line with previous observations on the 
efficacy of careful control of light and darkness throughout the day as a practical means 
to promote reentrainment to a schedule of night work. Where persistent maladaptation to 
shiftwork may explain how working non-standard schedules can be predictive of the 
development of a chronic disorder (Shields, 2002), promoting the circadian adaptation of 
shift workers, or at least those on full-time night shifts, may be a worthy approach. 
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Figure 4.1 
Experimental protocol and mean pattern of expression of salivary cortisol during CRs. 
Upper panels show the protocol for the experimental groups. Successive days are 
shown side-by-side and along the vertical axis. Sleep/darkness periods are indicated as 
black bars. Hatched bars indicate CR evaluations. Dark grey bars indicate periods of 
night shift work performed in habituai lighting. In the treatment group, intermittent 
exposure to bright light during the first 6 hours of night shifts is shown as light grey bars. 
ln lower panels, mean salivary cortisol concentration per 4 hours is shown (±SEM) in 
both groups of workers for initial (CR 1) and final (CR2) CRs. The times of fitted cortisol 
maxima relative to sleep/darkness episodes are shown for each group as solid triangles 
in upper panels. Mean cortisol concentration was averaged across groups based on 
hours of awakening into each constant routine. To facilitate visualization, workers were 
assigned relative clock times of awakening of 08:00 for the initial CR and 18:00 for the 
final CR. 
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Initial CR Final CR P 
Amplitude (OC) 
Control group 0.06 ± 0.01 0.07 ±0.02 0.5 
Treatment group 0.05 ± 0.01 0.07 ± 0.02 0.3 
P 0.7 0.8 
Time of fitted maximum 
Control group 08:00 ± 1:12 11 :03 ± 02:02 0.1 
Treatment group 10:13 ± 00:38 21: 17 ± 01:21 0.03* 
P 0.1 0.009* 
Time of fitted minimum 
Control group 19:52 ± 0:58 23:33 ± 2:05 0.1 
Treatment group 21 :48 ± 0:48 09:14 ± 1:23 0.03* 
P 0.3 0.004* 
Phase angle calculated between bedtime and fitted maximum 
Control group -8:32 ± 1:37 -1 :15 ± 2:10 0.04* 
Treatment group -9:51 ± 0:18 -11 :38 ± 1 :22 0.2 
P 0.8 0.009* 
Interval between maximum and minimum 
Control group 12:08 ± 0:16 11 :29 ± 00:20 0.08 
Treatment group 12:25 ± 0:17 12:03 ± 0:18 0.2 
P 0.7 0.2 
24-hour mean concentration (Jlgldl) 
Control group 0.08 ± 0.02 0.1 ± 0.03 0.3 
Treatment group 0.07 ± 0.01 0.1 ± 0.02 0.07 
P 1.0 0.4 
Table 4.1 
Characteristics of endogenous salivary cortisol rhythm measured during CRs. For the 
calculation of phase angles, bedtimes in the first constant routine are based on mean 
sleep times during the preceding vacation period, scaled to an 8-hour length. Phase 
angles trom the second constant routine are based on reported bedtimes during the 
night shift work period. By convention, negative phase angles indicate that the fitted 
cortisol maximum occurs after bedtime. Signiticant comparisons are marked with *. 
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CHAPTER5 
Entrainment of circadian rhythms of melatonin, cortisol and clock gene expression to 
simulated night shift work. 
Francine O. James, Nicolas Cermakian and Diane B. Boivin. 
Submitted to the J Clin Endocrinol Metab, September 2006. 
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5.1 Preface 
Having established the sustained circadian rhythmicity in the expression of clock genes 
in PBMCs (Chapters 2 & 3), the next test in the investigation was to determine whether 
these functional clocks could be shifted. In this case, the shift in the sleep/wake 
schedule simulates night shift work. Phase shifts in the expression of hormonal markers 
controlled by the SCN would be induced by judicious exposure to light and darkness, as 
observed in Chapter 4. It was hypothesized that the expression of peripheral oscillators 
in PBMCs could become realigned to a shifted sleep/wake schedule, in the presence of 
a light intervention that could shift endogenous rhythms of melatonin and cortisol. 
5.2 Abstract 
Context: Judicious light and darkness exposure throughout the day can promote the 
appropriate alignment of hormonal circadian rhythms to night shift work. The 
resynchronization of human peripheral circadian oscillators is largely unknown to date. 
Objective: Evaluate clock gene expression in peripheral blood mononuclear cells 
(PBMCs) with respect to the simultaneous resetting of plasma melatonin and cortisol 
rhythms throughout simulated night shift work. 
Participants: Five healthy candidates aged 18-30 years. 
Design and Setting: Participants were placed on a 1 O-hour delayed sleep/wake schedule 
simulating nighttime "work" followed by a daytime sleep episode. Baseline, intermediate 
and final circadian evaluations were performed in the temporal isolation laboratory. 
Intervention: Full-spectrum white light of (mean ±SEM) 6,036±326 lux during night shifts; 
dim light exposure after each night shift; maintenance of a single 8-hour sleep/darkness 
episode beginning two hours after the end of each night shift. 
Outcome Measures: Circadian rhythms of plasma melatonin and cortisol. Circadian 
rhythms of expression of clock genes HPER1, HPER2and HBMAL 1 in PBMCs. 
Results: Following nine days on the night schedule, hormonal rhythms were adapted to 
the shifted schedule. HPER1 and HPER2 expression in PBMCs displayed significant 
circadian rhythmicity, also appropriately aligned to the shifted sleep/wake schedule. 
Conclusions: This is the tirst demonstration of the simultaneous entrainment of 
peripheral circadian oscillators in PBMCs and centrally-driven hormonal rhythms 
following a shifted schedule. The study of peripheral circadian oscillators has important 
implications for understanding the medical disorders affecting night shift workers. 
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5.3 1 ntroduction 
The rapid reorientation in the sleep/wake schedule brought about by night shift work 
results in a misalignment between the output of the endogenous circadian pacemaker 
and the shifted schedule. Night shift workers typically display hormonal circadian 
rhythms that are maladapted to a night-oriented schedule (1) . Light is the primary 
synchronizer of the endogenous circadian pacemaker of the suprachiasmatic nucleus 
(SCN), and careful control over light and darkness exposure throughout the day 
effectively promotes circadian adaptation of workers to night shifts (2, 3). The rhythmic 
expression of circadian clock genes required for the intrinsic rhythmicity of the SCN is 
also present in non-SCN tissue (4, 5), and the SCN coordinates the expression of 
cellular rhythmicity within peripheral tissues (6). Rhythmic clock gene expression has 
been observed in human oral mucosa and skin samples (7) and in peripheral blood 
mononuclear cells (PBMCs) (5, 8-10). Under constant conditions, the expression of core 
clock genes HPERI and HPER2 displays a significant circadian oscillation in PBMCs 
with expression peaks a few hours after that of plasma melatonin concentration (10). 
The aim of this simulated night shift work experiment is to document the circadian 
alignment of clock gene expression in PBMCs when a light intervention that shifts 
plasma melatonin and cortisol rhythms is provided. 
5.4 Methods 
Four male and one female candidate, ail healthy, non-smoking and drug-free (group 
mean age ±SD: 24.9 ±4.8 years) with normal BMI (23.4 ±1.6 kg/m2) gave informed 
consent to their participation in this study approved by the Douglas Hospital Research 
Ethics Board. Selected candidates had no history of night shift work or travel across time 
zones in the three months preceding the study. The female participant had regular 
menses with an average cycle duration of 32 days. The study took place within the 
follicular phase of her menstrual cycle. 
For two weeks before the start of the investigation, subjects maintained a stable 
8-hour night-time sleep/darkness period and took no naps during the day (Table 5.81). 
Meal-times were standardized throughout the study and subjects took breakfast at 30 
minutes after awakening, lunch at 5 hours after awakening, dinner at 11 hours after 
awakening and an evening snack at 13.5 hours after awakening. 
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The experimental protocol for the 12-day investigation is shown in Figure 5.1. 
After a baseline assessment on their habituaI schedule (experimental days 1-2), subjects 
underwent a 9-day simulated night shift work procedure during which their sleep episode 
was delayed by 10 hours. Circadian phase was reevaluated after 4 simulated night shifts 
in the laboratory (on experimental days 5-6) and after additional 5 simulated night shifts 
at home (on experimental days 11-12). Evaluations were performed in a time-free 
laboratory and circadian rhythms of melatonin, cortisol and clock gene expression in 
PBMCs were determined from blood sampling via an indwelling catheter. Each 24-hour 
sampling period included a 16-hour constant posture (CP) period of limited activity 
where participants maintained a semi-recumbent posture in bed. Meals were replaced 
by hourly, nutritionally balanced snacks. 
Circadian phase of the plasma melatonin rhythm was defined from hourly whole 
blood samples as the midpoint between the upward and downward crossing of the 24-
hour average of plasma melatonin concentration (2). The phase of the cortisol rhythm 
was defined as the time of the fitted maximum of cortisol concentration, based on a 
single harmonie regression applied to hourly sampling data (3). RNA was extracted from 
PBMCs isolated from whole blood samples drawn every -120 minutes (Extraction 
procedure detailed in supplementary material). Quantification of HPERI, HPER2, 
HBMAL 1 expression was determined relative to HCDK4 (10) expression using SYBR 
Green chemistry (Applied Biosystems, USA). 
Fold change in gene expression of each clock gene for each sample was 
determined using the 2-MCT calculation (11) and then expressed as a proportion of 
maximum expression for each blood sampling evaluation. A statistically significant 
circadian oscillation was observed where the 95% confidence interval for the amplitude 
of the expression estimated by a dual-harmonie regression analysis with a period search 
of 23-26 hours (12) did not include the zero value (10). The phase of clock gene 
expression in PBMCs was defined as the time of fitted maximum of expression. For each 
laboratory evaluation, we determined a profile of the expression of each circadian 
marker across a total of six wake or sleep bins corresponding to the 24-hour day. Two-
factor ANOVA for repeated measures (time-of-day and sampling session) were 
performed on binned values. 
Results are expressed as mean ± SEM. 
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5.5 Results 
The midpoint of melatonin expression occurred 3:17 ±0:14, and 3:11 ±0:16 hours before 
waketime in the baseline and final evaluations, respedively (Figure 5.1). During these 
blood sampling sessions, the fitted maximum of cortisol occurred 3:07 ± 0:37, and 3:29 ± 
0:40 hours after waketime, respedively. The alignment of melatonin and cortisol rhythms 
with the sleep/wake cycle were comparable in the baseline and final evaluations (t-test, 
p=0.7 and p=0.9, respectively). As observed in night shift workers receiving a similar 
intervention (2, 3), these markers displayed an appropriate alignment to the sleep/wake 
cycle in night and daytime sleep schedules (Figure 5.2). 
During the baseline evaluation, the time of fitted maximum of HPERI, HPER2 
and HBMAL 1 occurred at 2:53 ± 3:16, 8:00 ± 2:35 and 10:14 ± 0:30 hours after 
waketime, respectively. At the end of nine days on the shifted sleep/wake schedule, the 
fitted peak of HPERI and HPER2 expression occurred 5:35 ± 2:40 and 0:40 ±0:44 after 
waketime, respectively. The fitted peak of HBMAL 1 expression occurred 9:21 ± 4:20 
before awakening. The alignment of HPERI and HPER2 maxima to the sleep/wake 
schedule were comparable in the initial and final conditions (Hest, p=0.6 and p=0.2, 
respectively), although these phase angles were more variable than those calculated for 
hormonal rhythms (Figure 5.51). The alignment of HBMAL 1 expression tended to differ 
in the initial and final conditions (p=0.07). 
5.6 Discussion 
This study has demonstrated an alignment of clock gene expression (particularly 
HPER2) to a shifted schedule in an experiment of light-induced phase shifts of the 
endogenous melatonin and cortisol rhythms. The time, duration, and intensity our 
lightldarkness intervention were expected to promote rapid and large delays in the 
expression of the central circadian pacemaker (13). Changes in the profile of clock gene 
expression occurred as of 3 days on the night shift schedule such that a greater 
proportion of the expressed rhythms were of significant amplitudes and in their habituai 
relationships to the sleep/wake cycle after 9 days of simulated night shift work (Figure 
5.2). 
Inter-subject variability in HPERI and HPER2 expression at baseline resulted in 
little rhythmicity in the group mean of gene expression (Figure 5.2). By the final 
evaluation, group means of HPERI and HPER2 expression demonstrated clear 
rhythmicity throughout the day, and both reached maximal levels in the early hours of 
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the wake period. This observation is in line with what has previously been described for 
the pattern of HPER1 and HPER2 expression in PBMCs under constant conditions and 
in the presence of a habituai sleep/wake schedule (9, 10). Conversely, the group mean 
pattern of HBMAL 1 expression demonstrated rhythmic changes throughout the day at 
baseline and was more variable at the end of the experiment although the fitted peak of 
HBMAL 1 expression occurs la te in the wake-period as we would expect (5). 
Clock gene polymorphisms may contribute to diurnal preference and certain 
sleep/wake disorders (5) and an observed segregation in the times of peak HPER2 
expression in PBMCs has been attributed to the existence of molecular phenotypes that 
may in turn explain the heterogeneity in clock gene expression (8). Although none of our 
participants demonstrated extreme diurnal preferences, we cannot determine the extent 
to which these factors contributed to the variability we observed in the initial condition. 
ln rodents, the pattern of light exposure has been shown to affect the expression 
of clock genes in the SCN and in peripheral oscillators. However, the time required for 
phase shifts in extra-SCN oscillators may be longer and associated with a temporary 
internai desynchrony (14, 15). In jaundiced neonates with covered eyes, blue light 
therapy appears to reduce mean HBMAL 1 expression in PBMCs when samples 
collected before and after light exposure are compared (16). While the result suggests 
that it may be possible to entrain oscillators in human PBMCs without the involvement of 
the SCN, significant inter-individual variability in the expression makes this interpretation 
tenuous. Blue light that suppresses plasma melatonin concentration was reported to 
induce HPER2 expression in oral mucosa samples during a 2-hour exposure (17). The 
specifie wavelength used led the authors to suggest that the effects on HPER2 are 
mediated via the SCN. The factors by which the SCN coordinates clock gene expression 
in PBMCs are yet unknown. In our experiments, we tightly controlled behavioural and 
environmental conditions. However, unknown factors might still be present and reflected 
in our results. Interestingly, a number of experiments suggest that glucocorticoids may 
play a role in the communication between the SCN and peripheral oscillators in vivo 
(18). In humans, HPER1 is induced in PBMCs sampled following prednisolone therapy 
(19). Here, we report a co-occurrence of the entrainment of the cortisol and clock gene 
expression rhythms. Future investigations are required to elucidate the nature of this 
relationship in PBMCs since the net effect of synchronizers acting on PBMC oscillators 
was variable rhythmicity at the tirst evaluation. 
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Changes in rodent feeding schedules may shift the oscillation of peripheral clocks 
without shifting SCN-driven rhythms and there may be an interaction between photic and 
non-photic resetting factors on peripheral clock gene expression (20). We cannot 
determine from our experiment the specifie contributions of the shifted sleep/wake and 
meal schedule and of the light intervention on clock gene expression. It is tempting to 
suggest that in the presence of the light intervention, an SCN-directed entrainment 
signal was powerfu1 enough to reduce inter-individual differences contributing to the 
variability observed in the baseline conditions and entrain clock gene expression to the 
shifted sleep/wake schedule. Future study will be required to partial out the nature of 
synchronizers of peripheral circadian oscillators, and to quantify their relative strength. It 
remains of interest that clock gene expression was in a conventional alignment relative 
to sleep times by the final evaluation. 
The molecular clock is thought to interact with the regulation of the cell cycle and 
tumorigenesis (5). Moreover, cancerous cells may demonstrate abnormalities in 
circadian clock genes (5). In light of recent evidence associating increased risk of certain 
cancers with night shift work (5), our results demonstrate that circadian adaptation to 
night shift work may be advantageous on a fundamentallevel. 
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Figure 5.1 
Experimental protocol and mean shifts in circadian markers. A: Participants remained in 
a time-free environ ment for 6 days. They maintained their habituai sleep/wake schedules 
for the first night in the laboratory and were placed on a schedule of simulated night work 
and a daytime sleep as of Experimental day 3. This schedule, delayed by 10 hours 
relative to habituai sleep/wake times, was maintained for the remainder of the 12-day 
study. On the day of laboratory admission participants remained in ordinary indoor room 
light (mean ±SD, in the angle of gaze 144±62 lux). Thereafter, ambient light levels during 
periods of wakefulness remained dim (6±3 lux) except when subjects were exposed to 
bright full-spectrum light (6,036± 728 lux) during their 8-hour simulated night shifts 
(shown as open rectangles with symbol). Participants slept in darkness (-0.03 lux, 
shown as black rectangles). Subjects returned home in the evening of day 6. During the 
ambulatory segment of the investigation, full spectrum white light was provided by 
portable lamps equipped with fluorescent bulbs covered with an ultraviolet filter (Sunbox 
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Company, Gaithersburg, MD, U.S.A) throughout each 8-hour simulated night shift. 
Participants slept in their own darkened bedrooms, and reduced their exposure to 
morning light in the two hours preceding sleep/darkness by wearing sunglasses with 5% 
visual light transmission (The Litebook Company, Medicine Hat, AB). The maintenance 
of sleep/darkness schedules was verified by sleep/wake logs, regular telephone calls to 
the laboratory and wristactigraphy monitoring. Subjects returned to the laboratory on the 
evening of day 10 for the final circadian assessment. The expression of markers of the 
endogenous circadian pacemaker and of dock gene in PBMCs were measured by 24-
hour blood sampling sessions performed before the start of simulated night shifts 
(experimental day 2), after three days on the shifted schedule (experimental days 5-6), 
and at the end of the shifted schedule (experimental days 11-12). Blood sampling 
periods are shown as horizontal lines overlaid on the protocol. Each sampling period 
included a 16-hour constant posture (CP) period shown as grey rectangles. For 
iIIustrative purposes, bedtimes for nighttime and daytime sleep episodes were assigned 
relative dock times of 00:00 and 10:00, respectively. Ali studies were performed in the 
months of July and August 2005. B-F: Mean phase of each marker is shown relative to 
night or daytime sleep periods (hatched boxes representing night and day sleep 
episodes). To demonstrate the relationship between the sleep/wake schedule and 
circadian phase, phase angles were calculated as: (waketime) - (circadian phase) for 
each individual. Thus, positive and negative phase angles indicate that the circadian 
marker occurred before and after waketime, respectively. Group mean phase angles are 
shown in decimal hours ±SEM. One subject did not participate in the final evaluation, 
thus results of this evaluation are given for n=4 subjects, while n=5 for the first two 
evaluations. See Figure 5.S1 for individual results. 
102 
BASElINE 
NightSfeep 
SHIFT (1) 
Day51eep 
SHlFT(2) 
Oay51eep 
Figure 5.2 
MLT 
(pglml) 
CORT 
(pgldt) 
HPER1 
(o/cmax) 
HPER2 
(%max) 
HBMAL1 
(%max) 
Expression of circadian markers throughout the sleep/wake cycle. Individual data was 
first aligned to the time of habituai awakening, and each data point was assigned to a 4-
hour bin representing Wake (W1-W4) or Sleep (S1-S2) periods throughout the 24-hour 
day, and then averaged across ail subjects. For each clock gene evaluation, the fraction 
of individuals for whom a significant circadian amplitude of expression was detected is 
shown in the upper left corner of each cell. One subject did not participate in the final 
evaluation, thus results for this evaluation are given for n=4 subjects. ANOVA for 
repeated measures performed on daily rhythms for ail three blood sampling sessions 
revealed a significant time of day x blood sampling session interaction for melatonin 
(F1O.55=2.40, p=0.02), and a significant effect of time of day for cortisol (F5.55=50.01, 
p<0.0001). No statistically significant effects or interactions were detected by ANOVA for 
HPER1. A significant time of day x blood sampling session interaction was detected for 
HPER2 rhythms (F1O•55=2.99, p=0.004) where simple main effects analyses revealed a 
significant effect of time of day at the final blood sampling session (p=0.001). A 
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significant interaction was also detected for HBMAL 1 (F1O.ss=3.34, p=0.002, 
respectively), where simple main effects analyses revealed a significant effect of time of 
day at the first blood sampling session (p=0.0006). 
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5.7 Supplementary materials 
RNA Extraction and real-time PCR 
Peripheral blood mononuclear cells were isolated from whole blood samples drawn 
every -120 minutes on a density gradient (Histopaque-1077, Sigma-Aldrich Canada, 
Oakville, ON, Canada) and stored at -800C in Trizol reagent (Invitrogen Canada, 
Burlington, ON, Canada). RNA was extracted and reverse transcribed using MultiScribe 
Reverse Transcriptase (Applied Biosystems, Foster City, CA, USA). Quantification of 
clock gene expression was performed by real-time PCR using SYBR Green chemistry 
(Applied Biosystems, Foster City, CA, USA). The expression of clock genes HPERI, 
HPER2, HBMAL 1 was described relative to the expression of HCDK4 using the following 
primers: 
HPERI 
Forward: 5'-TGGCTATCCACAAGAAGATTC-3' 
Reverse: 5'-GGTCAAAGGGCTGGCCCG-3' 
HPER2 
Forward: 5'-GGCCATCCACAAAAAGATCCTGC-3' 
Reverse: 5' -GAAACCGAA TGGGAGAA TAGTCG-3' 
HBMALI 
Forward: 5' -GGCTCA T AGA TGCAAAAACTGG-3' 
Reverse: 5'-CTCCAGAACATAATCGAGATGG-3' 
HCDK4 
Forward: 5'-ATCCCAA TGTTGTCCGGCTG-3' 
Reverse: 5'-TGATCTCCCGGTCAGTTCGG-3' 
Sleep/Darkness schedule 
During the screening phase preceding the start of the experiment, participants 
maintained stable sleep schedules including a single night-time sleep episode and 
restricting naps. Participants recorded times in and out of bed in sleep/wake logs and 
left voice messages with the laboratory to confirm these times. Sleep/wake schedules 
were also verified using wrist actigraphy. Mean reported times in bed are shown in Table 
S1. During the pre-study period, Mean sleep period lengths were within 10 minutes of 
the 8-hour target sleep/darkness period. 
During the ambulatory segment of the investigation, participants maintained the 
night shift worker's sleep/wake schedule while at home. Times in and out of bed were 
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verified as in the pre-study segment of the investigation. During this ambulatory 
segment, participants reported sleep/darkness periods within 10 minutes of the 8-hour 
target period length. 
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T02 
T04 
T05 
T06 
Table 5.51 
Baseline 
Time in bed Time out of bed 
23:25 7:30 
22:01 6:04 
00:00 8:01 
23:26 7:29 
23:58 8:08 
Night shift schedule 
Time in bed Time out of bed 
9:30 17:28 
8:05 16:05 
10:02 18:06 
9:29 17:36 
Mean times in and out of bed reported in sleep/wake logs for each participant. During 
the baseline period, subjects maintained a habituai day-oriented sleep-wake schedule 
prior to their admission to the laboratory. During the ambulatory phase of the 
investigation (experimental days 6-10), participants maintained a night-oriented schedule 
by remaining awake at night and sleeping during the day. 5ubject T06 did not 
participate in the last segment of the investigation (experimental days 6-12). 
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Individual circadian phase markers during each blood sampling session of the 
experimental protocol. The experimental protocol is shown in panel A as in Figure 5.1. 
ln panels B-F, phase markers for each individual are shown relative to night or daytime 
sleep periods (hatched boxes representing night and day sleep episodes). To 
demonstrate the relationship between the sleep/wake schedule and circadian phase, 
phase angles were calculated as: (waketime) - (circadian phase) for each individual. 
Individual data are shown in separate colors. Group mean phase angles are shown in 
decimal hours ±5EM. 5ubject T06 did not participate in the final evaluation, thus results 
of this evaluation are given for n=4 subjects, while n=5 for the tirst two evaluations. 
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CHAPTER 6 
General Discussion 
6.1 Characteristics and implications of an en doge nous peripheral oscillator in 
PBMCs 
The rhythmic and circadian expression of elements of the clock mechanism is taken to 
mean that the molecular loop that comprises the clock is functional. In recent years, 
evidence has been rapidly accumulating for the presence of rhythmic clock gene 
expression and a functional peripheral clock in a number of human tissues. 
There was prior evidence to suggest that human fibroblast and skin cell culture 
could express clock gene mRNA or proteins [216], and that human vascular smooth 
muscle cells [215], fibroblasts [226] or neural cells [218] in culture could demonstrate an 
oscillation of clock genes following serum shock. However, none of these prior 
investigations used tissue harvested from humans at regular intervals. Thus, the 
presence of a functional clock could only be confirmed with repeated sampling 
throughout a circadian cycle. Bjarnason and colleagues used oral mucosa and skin 
sampling at 4-hour intervals for 24 hours and demonstrated that significant circadian 
rhythms in clock gene expression could be measured in vivo in these cells [219]. They 
were thus the first to identify a functional peripheral circadian oscillator in humans [219]. 
There was evidence to suggest the presence of diurnal changes in clock gene 
expression in the immune system. In rat mononuclear cells, Per2 mRNA peaks at the 
beginning of the dark period [273]. A change in HPERI and HPER2 expression was 
reported in human lymphocytes sampled before and after surgery. However, the aim of 
this report was to determine the effects of surgery on PBMC clock gene expression 
rather than to measure diurnal variation [274]. It was also previously known that in 
PBMCs sampled at 09:00 and 21 :00, HCLOCK levels showed no significant difference 
while mean HPER2 levels were higher in the morning sample [220]. In the present 
thesis, it was demonstrated with repeated sampling of PBMCs from whole blood over a 
35-hour duration that HPERI, HPER2 and HBMAL Ilevels oscillate in the presence of a 
standard sleep/wake cycle (Chapter 3). The persistence of a significant oscillation under 
controlled behavioural and constant dim light conditions (Chapters 2 and 3) confirms the 
endogenous nature of this circadian rhythm. From the experiments published so far on 
clock gene expression in the human circulating immune cells, the morning peak of 
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HPER1 is comparable in mononuclear cells and polymorphonuclear cells [221]. 
However, the circadian phase of HPER2 and HBMAL 1 expression may be variable when 
sampled at 4-hour intervals from healthy adults in the presence of their habituai 
sleep/wake schedule [222]. 
To date, PBMC oscillators are also characterized by inter-individual variability in 
the patterns of clock gene expression. A number of specifie factors may regulate clock 
gene expression in PBMCs, as discussed below (section 6.2). However, it is also 
possible that characteristics specifie to an individual may significantly affect the presence 
of factors that would entrain peripheral clocks. The times of peak HPER2 and HBMAL 1 
expression during the sleep/wake cycle segregate into two groups which has led to the 
suggestion that molecular chronotypes may be defined based on PBMC clock gene 
expression [222]. This was not apparent from the investigations presented here, 
although significant inter-individual variability was present. Similarly, the polymorphisms 
that contribute to preferred diurnality [186-189] may also contribute to the variability in 
PBMC clock gene expression. The inclusion of participants of moderate diurnality in the 
present experiments makes it impossible to determine the extent of this influence. 
Circadian rhythms are also shiftable by definition. A study in which HCRY1 and 
HBMAL 1 are compared in PBMCs before and after 24-hours of phototherapy for 
jaundiced neonates, is difficult to interpret since the sampling frequency is insufficient to 
describe a circadian rhythm or reliably assess circadian phase [225]. Thus, there was no 
a priori evidence of the length of time required for light-induced phase shifts in human 
peripheral oscillators. The present investigations demonstrate that a change in the 
diurnal expression of clock genes in PBMCs can occur following a 9 days on shifted 
sleep/wake schedule. The synchronization that was observed suggests that a shift has 
occurred, although the mechanisms by which this shift was achieved remain unclear. 
Animal studies suggest that phase shifts in clock gene expression in the SCN precede 
those observed in peripheral tissues [195, 229]. However, stimuli such as feeding time 
can phase shift peripheral oscillators independently of the SCN [235]. Thus, the 
experimental paradigm presented in this thesis does not allow the distinction as to 
whether shifted peripheral rhythms are the result of bright light induced phase shifts of 
the SCN (as suggested by delays of cortisol and melatonin circadian rhythms) or other 
mechanisms su ch as the change in the sleep/wake and meal-timing schedules. 
Measuring clock gene expression in PBMCs in individuals who would undergo the same 
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experimental manipulation of the sleep/wake cycle but remain in constant dim light 
during wake periods could clarify this issue. Aiso relevant to this question, clock gene 
expression may be measured in the PBMCs of individuals lacking conscious and 
circadian vision in their naturalistic environment. As endogenous circadian phase drifts 
away from the 24-hour day, the peripheral oscillator will betray whether it remains in 
phase with the sleep/wake cycle or drifts in an out of phase with SCN-driven rhythms 
such as melatonin or cortisol secretion. 
Intuitively, peripheral oscillators should serve to optimize the function of the 
peripheral tissues. Indeed, a tissue's function may be regulated by the molecular clock to 
a significant extent as measured in the number of rhythmic transcripts throughout the 
day in the liver [275], the heart [276], the adrenals [277] or in adipose tissue [278]. In 
support of this, ablating the SCN or changing the hormonal environ ment has different 
consequences for different tissues [179, 279-282]. Ce Ils harvested from the femur-
derived bone marrow of mice demonstrate differences in Pert and Per2 expression 
based on the relative differentiation of the cell in the marrow [283-285]. In a similar 
fashion, peripheral oscillators in PBMCs may serve to optimize the function of PBMCs. 
It is possible that differences in clock gene expression confer some advantage to 
subsets of cells in their specific function. A secondary peak expression of HPERt in 
polymorphonuclear cells as observed under modified CR conditions is not present in 
mononuclear cells sampled simultaneously [221]. Similarly, the response of cultured 
human monocytes and lymphocytes to glucocorticoid stimulation is not the same [286]. 
Conversely, estimating clock gene expression from a more heterogeneous population 
(such as from the RNA extracted from non-separated whole blood cells) may result in 
mean circadian rhythms of lower amplitude [224]. 
ln a functional sense, the clock in the immune system may contribute to the 
diurnal rhythmicity in cell numbers or even the variation in PBMC cellular subsets [80-82, 
287-289]. It may also play a role in the function of white blood cells. Under constant 
darkness conditions and in the presence of 12h:12h lighUdarkness schedule, rat NK 
cells demonstrate a circadian rhythm in clock gene expression with Pert and Per2 peaks 
occurring early in the subjective day and a Smalt peak occurring in anti-phase [290, 
291]. The rhythmic expression of the molecular clock components is associated with 
mRNA and protein for cytolytic factors essential to NK cell activity [290]. Using RNA 
interference to knock down rPER2 levels in an NK cell line results in a significant 
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reduction in detected granzyme Band perforin prote in [291]. The expression of IFN-y in 
response to a lipopolysaccharide challenge is reduced in Per2 knockout mice compared 
to wild-type mice [292]. Similarly, the maturation of B lymphocytes is altered in 8ma/1 
knockout mice [293]. 8ma/1 knockout mice demonstrate specifie changes in the cell 
population of the immune system: the proportion of neutrophils and monocytes is 
significantly increased in 40-week old animais [294]. 
If the peripheral oscillators are specifie to the tissue's function, then it may be 
advantageous that a peripheral oscillator can dissociate itself from the SCN. Following 
an abrupt shift in the lightldarkness schedule, laboratory rodents demonstrate rhythmic 
Perl expression in the SCN that adapts more rapidly than Perl expression in the liver 
[195]. However, restricting food availability to a few hours during the light period can 
rapidly entrain peripheral clocks in the liver without affecting phase of clock gene 
expression in the SCN [233, 234]. It is known that clock gene expression in peripheral 
tissues may be directly related to functions such as fatty acid metabolism [278, 295] or 
phospholipid biosynthesis [296]. The rapid adaptation of a peripheral clock to a stimulus 
that is closely related to its function may therefore be useful to the organism. In this 
manner, the rapid response of the liver clock to a restricted feeding regimen [235] is 
consistent with the tissue's role in the response to food. Despite the advantage 
conferred by this organization, there may nevertheless be consequences to the internai 
desynchronization resulting from differences in the adaptation rates in central and 
peripheral clocks. Specifically, internai desynchronization may result in conflicting 
entrainment signais in peripheral clocks. Arguably, this may contribute to the chronic 
health consequences in populations prone to internai desynchronization such as night 
shift workers [240]. 
The present assays in humans principally discuss mRNA transcription as a 
surrogate for expression. The regulation of individual clock genes or clock controlled 
genes can differ between tissues in post-transcriptional modifications [297-299] and in 
the amplitude [279] or variability [209] of expression. Disruption of the CLOCK protein in 
the mouse SCN results in a reduction, but not an abrogation, in the amplitude of clock 
gene expression while locomotor rhythms remain robust [280]. In peripheral tissues, a 
similar disruption of CLOCK may have more severe consequences on the phase and 
amplitude of expression of specifie clock genes in the liver clock, for example [280, 300]. 
DEC1 is known to bind the Perl promoter and regulate its expression [301, 302] but this 
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gene demonstrates little circadian rhythmicity in PBMCs under constant conditions 
(Chapter 2). Dec1 expression in Clock mutant animais is arrhythmic in the heart while it 
maintains the circadian rhythm in its expression (although of reduced amplitude and 
phase delayed relative to wild type) in skeletal muscle [303]. Recent technical advances 
in the study of animais models, including RNA interference to knock down the translation 
of a specific gene transcript and measurement of clock gene-driven luminescence for 
multiple clock genes in a single tissue [200] may produce useful answers to the tissue-
specific and clock gene specifie regulation that occurs in peripheral osci"ators. 
6.2 Factors involved in the synchronization of human peripheral oscillators 
The usefulness of assessing peripheral elock gene expression in PBMCs is limited by 
our understanding of the signais that entrain it. A circadian reporter construct including 
the mouse 8mal1 promoter provided evidence for the oscillation of clock gene 
expression in autopsied skin fibroblasts, monocytes and keratinocytes and determined 
that the standard deviation in the estimated period is over 8 times higher between 
individuals than within several cultures from a single individual [223]. This would suggest 
that within an individual, there exists some mechanism by which peripheral clocks are 
coordinated. The variability in the clock gene expression [222], (Chapters 2, 3 & 5) may 
persist beeause the factors that contribute to the condition are not sufficiently reduced in 
the habituai sleep/wake cycle or under CR conditions. There is no circadian clock gene 
expression rhythm detected in horse PBMCs [304], which suggests that either no 
peripheral clock exists in horse PBMCs or, more likely, that under habituallight darkness 
sampling conditions, clock gene expression was not coordinated [304]. In the same 
animais, a functional circadian pacemaker was observed in adipose tissue [304]. Just as 
peripheral oscillators perform specific functions, they may also be coordinated in a 
specific way in different tissues. 
A number of different factors contribute to the ce"ular environ ment of PBMCs: 
from regional blood flow [305] to ce"ular subtype trafficking [80]. SCN coordination of 
peripheral rhythms might be achieved via the rhythms it controls, su ch as cortisol or 
melatonin, both of which contribute to the peripheral blood environment [211]. 
Glucocorticoid rhythms can alter the expression of PBMCs in culture and in vivo [286]. 
Glucocorticoids may specifica"y affect the expression of molecular clocks in certain 
tissues more than others: adrenalectomy selectively abolishes PER2 rhythms in the 
central nucleus of the amygdala but not the basolateral amygdala or the dentate gyrus 
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[306]. Dexamethasone stimulates Per1 expression in human bronchial epithelial ce Ils 
and in PBMCs in vitro. [228]. Glucocorticoid receptors in the immune system are weil 
identified [307, 308]. 
Melatonin also has specific properties in the immune system and is a reasonable 
means by which peripheral clocks may be entrained [309, 310]. PBMCs can synthesize 
their own melatonin under in vitro stimulation thus may also contribute to their own 
cellular environ ment [311, 312]. In sufficient doses in vitro, melatonin can increase T 
lymphocyte and NK cell activity and increase the transcription of cytokines in human 
monocytes [56]. Differences in dock gene expression are apparent in the adrenals of 
melatonin proficient and deficient mouse strains [313], and importantly it appears that 
any effect of melatonin is tissue-specific [314]. 
Alternatively, cellular docks may be reset by mechanisms not driven by the SCN. 
ln rat fibroblasts, signalling via pathways involving cAMP-dependant kinases, protein 
kinase C, Ca++ or glucocorticoids can induce Per1 or Per2 dock gene expression [315] 
and it appears that the amplitude and sustained rhythmicity of Per2 expression depends 
on the signal used [316]. Further, the expression of genes for nudear receptors, 
induding glucocorticoid receptors, may be regulated in a circadian manner that is also 
tissue-specific [317], thereby presenting another level of regulation in which the 
expression of peripheral circadian oscillators may be controlled bya specific factor. 
Just as hormonal rhythms are driven by the SCN to different extents, peripheral 
clocks may be more or less dependant on the SCN for their synchronization. It is more 
likely that photic and non-photic stimuli interact in producing the rhythmicity that is 
observed, much in the sa me way as mice on a time and calorie-restricted diet 
demonstrate larger light-induced phase advances in locomotor activity than mice fed ad 
libitum [318J. As suggested above, elements that are a part of the sleep/wake cycle may 
significantly affect the cellular environ ment of PBMCs and ultimately their dock 
expression. 
6.3 A model for the regulation of clock gene expression in human PBMCs 
Figure 6.1A presents a model for the factors that may influence the circadian rhythmicity 
in human PBMCs. This rhythmicity is the result of the effects of factors, which may 
indude hormonal rhythms as weil as yet unidentified tissue-specific blood-borne signais. 
The findings discussed in the present thesis show that under constant conditions and in 
the presence of a sleep/wake cycle, the resulting rhythmicity is observable. 
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A strong SCN stimulus may be induced in the presence of a powerfu1 SCN 
synchronizer su ch as bright light (Figure 6.18). This in turn may result in the 
synchronisation of peripheral oscillators and increased mean amplitude in the population 
of cells. Thus, just as a serum shock restores apparent rhythmicity in a group of cells 
despite the initial phase of desynchronized cells [210], a powerful light stimulus may 
invoke a powerful resetting stimulus in the periphery. This situation could explain the 
resynchronization in PBMC oscillators discussed in Chapter 5, in which a bright light 
stimulus was applied for 9 days. This relationship could be tested in an experiment that 
compares the effect of strong versus weak SCN entraining signais on readaptation to a 
shifted sleep/wake schedule. The rate of adaptation of PBMC oscillators may be 
compared in the presence of light stimuli versus a timed exercise regimen or sound cue, 
for example. The relative strength of the stimulus and the magnitude of the shift in the 
sleep/wake schedule may be varied to challenge the resetting capacity of peripheral 
oscillators. Depending on the length of the experiment and the number of blood 
sampling periods, it may be determined whether a weak SCN stimulus implies that it 
takes longer for peripheral rhythms to become synchronized to reveal an observable 
rhythmicity. 
As discussed previously, a number of factors may contribute to the expression of 
clock genes in PBMCs. Blood-borne signais may differentially affect PBMC 
subpopulations and contribute to an increased variability and reduced amplitude of clock 
gene expression (Figure 6.1 C). Differences in the presence of receptors in PBMC 
subtypes may also modulate the entrainment of peripheral clocks. Experiments in which 
primary PBMC cultures are maintained and studied may elucidate this relationship. The 
response of specific white blood cell subpopulations to glucocorticoids may be examined 
in vitro. If the glucocorticoid concentration applied to the cells is controlled to mimic the 
endogenous circadian rhythm, we may learn more about the relative contribution of 
endogenous cortisol levels to the regulation of PB MC molecular clocks. 
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Further, experiments examining the presence of glucocorticoid receptors at different 
times of day in different cell populations may also significantly contribute to our 
understanding of this relationship. Finally, the contribution of inter-individual factors to 
the presence of non-specific signaIs is also of importance. 
6.4 Outlook: the future of human peripheral clock study and the implications for 
human health 
Considering the relationship of peripheral oscillators to tissue function, an easily 
accessible peripheral oscillator in humans, su ch as those in PBMCs, has potential use 
as a diagnostic tool to provide information on the tissue's function or its relationship to 
markers of the central circadian pacemaker. In an analogy to how cortisol and melatonin 
hormonal rhythms are accepted surrogates for estimating the activity of the SCN, 
measuring clock gene expression may be an additional indicator of tissue function 
proper. This may be considered in a number of ways. There is now evidence to 
demonstrate that peripheral oscillators become desynchronized in disease. Progressive 
stages of Alzheimer's disease is characterized by altered clock gene expression [319] 
and loss of rhythmicity in pineal and cerebrospinal fluid melatonin [320-322]. Cancerous 
tissue also demonstrates alterations in the pattern of HPER protein expression [323]. 
Thus, detecting desynchronized clock gene expression in human peripheral tissues may 
be a clinically-relevant indicator of disease severity. Indeed, differences in tumour clock 
gene expression relative to healthy cells may be useful in targeting chemotherapy [323]. 
One may, therefore, easily imagine how understanding the function of clocks in PBMCs 
may contribute to significant observations on susceptibility to infection, for example. 
Sampling peripheral circadian oscillators may also be relevant in understanding 
the long-term effects of circadian misalignment such as in night shift work. The relative 
breast cancer risk posed by night shift work is thought to exceed that caused by well-
known risks such as a diet high in fat or the use oral contraceptives, for example [244]. 
HPERI expression is thought to regulate the progression of the cell cycle and human 
colon cancer cell lines with knocked-down HPERI expression demonstrate a reduced 
apoptotic response following high dose irradiation [324]. In certain murine carcinoma cell 
lines, Per2 over-expression reduces cell proliferation and increases apoptotic events 
[325]. The expression of peripheral clocks may therefore be an important mechanism by 
which cellular division and death are controlled as weil as a valuable diagnostic tool. 
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Given that the phase of clock gene expression in whole blood cells may be 
altered in hypersomnia [326] and non-24 hour sleep/wake syndrome [224], it will be of 
interest to associate the expression of peripheral circadian oscillators with known 
sleep/wake disorders. It may also be of interest to investigate how circadian 
disturbances in psychiatrie populations [327] affect peripheral clocks. 
The present thesis contributes to the early stages of understanding human 
peripheral circadian oscillators. The potential benefits of this line of investigation may be 
significant. Exploring the expression of peripheral clocks in other human tissues may 
result in the characterization of a human peripheral oscillator that are less invasely 
sampled (e.g. keratinocytes [223]). This may be facilitated by improvements in PCR 
techniques that may allow the assessment of many clock genes in minute amounts of 
tissue. There may exist human peripheral oscillators that are more homogeneous than 
PBMCs with a variability of expression that is more easily controlled. This may provide a 
background on which significant advances may be made in our understanding of the 
regulation of human peripheral oscillators. It may even be possible to be able to gather 
useful information from a single sample of a peripheral clock. For example, introducing 
luminescent reporters in the sample and then evaluating the ability of specifie agents to 
induce clock gene expression in the sample may be useful to better understand the state 
of the tissue. 
For some time, the health consequences of night shift work have suggested that 
circadian disorganization could be a cause of physiological dysfunction- although the 
precise mechanism is yet unknown. In this application as in others, the continued 
exploration of peripheral oscillators in humans is likely to yield valuable observations at 
the interface between circadian clock function and proper function of the organism as a 
whole. 
121 
References 
1. Pittendrigh CS 1993 Temporal organization: reflections of a Darwinian clock-
watcher. Annu Rev PhysioI55:16-54 
2. Moore-Ede MC, Sulzman FM, Fuller CA 1982 The Clocks That Time Us. 
Physiology of the Circadian Timing System. Cambridge, MA: Harvard University 
Press 
3. Halberg F 1994 Introduction to Chronobiology. Variability: from foe to friend, of 
mice and men. In: Cornélissen G, Halberg F eds. Medtronic Chronobiology 
Seminar #7: University of Minnesota 
4. Sharma VK 2003 Adaptive significance of circadian clocks. Chronobiol Int 
20:901-919 
5. de Mairan JO 1729 Observation botanique. Histoire de l'Académie royale des 
sciences:35-36 
6. Paranjpe DA, Sharma VK 2005 Evolution of temporal order in living organisms. J 
Circadian Rhythms 3:7 
7. DeCoursey PJ, Krulas JR, Mele G, Holley DC 1997 Circadian performance of 
suprachiasmatic nuclei (SCN)-Iesioned antelope ground squirrels in a desert 
enclosure. Physiol Behav 62:1099-1108 
8. DeCoursey PJ, Walker JK, Smith SA 2000 A circadian pacemaker in free-living 
chipmunks: essential for survival? J Comp Physiol [A] 186:169-180 
9. Stephan FK, Zucker 1 1972 Circadian rhythms in drinking behavior and locomotor 
activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 
69:1583-1586 
10. Moore RY, Eichler VB 1972 Loss of a circadian adrenal corticosterone rhythm 
following suprachiasmatic lesions in the rat. Brain Res 42:201-206 
11. van Esseveldt KE, Lehman MN, Boer GJ 2000 The suprachiasmatic nucleus and 
the circadian time-keeping system revisited. Brain Res Brain Res Rev 33:34-77 
12. Weaver DR 1998 The suprachiasmatic nucleus: a 25-year retrospective. J Biol 
Rhythms 13:100-112 
122 
~ .. 
13. Silver R, Lehman MN, Gibson M, Gladstone WR, Bittman EL 1990 Dispersed cell 
suspensions of fetal SCN restore circadian rhythmicity in SCN-Iesioned adult 
hamsters. Brain Res 525:45-58 
14. Lehman MN, Silver R, Gladstone WR, Kahn RM, Gibson M, Bittman EL 1987 
Circadian rhythmicity restored by neural transplant. Immunocytochemical 
characterization of the graft and its integration with the host brain. J Neurosci 
7:1626-1638 
15. Ralph MR, Foster RG, Davis FC, Menaker M 1990 Transplanted suprachiasmatic 
nucleus determines circadian period. Science 247:975-978 
16. Viswanathan N, Davis FC 1995 Suprachiasmatic nucleus grafts restore circadian 
function in aged hamsters. Brain Res 686:10-16 
17. Inouye ST, Kawamura H 1979 Persistence of circadian rhythmicity in a 
mammalian hypothalamic "island" containing the suprachiasmatic nucleus. Proc 
Natl Acad Sci USA 76:5962-5966 
18. Gillette MU 1991 SCN electrophysiology in vitra. rhythmic activity and 
endogenous clock propoerties. In: Klein DC, Moore RY, Reppert SM eds. 
Suprachiasmatic Nucleus: The Mind's Clock. New York Oxford University Press; 
125-156 
19. Green OJ, Gillette R 1982 Circadian rhythm of firing rate recorded from single 
cells in the rat suprachiasmatic brain slice. Brain Res 245: 198-200 
20. Schwartz WJ, Gainer H 1977 Suprachiasmatic nucleus: use of 14C-labeled 
deoxyglucose uptake as a functional marker. Science 197:1089-1091 
21. Schwartz WJ, Reppert SM, Eagan SM, Moore-Ede MC 1983 ln vivo metabolic 
activity of the suprachiasmatic nuclei: a comparative study. Brain Res 274:184-
187 
22. Liu C, Weaver DR, Strogatz SH, Reppert SM 1997 Cellular construction of a 
circadian clock: period determination in the suprachiasmatic nuclei. Cell 91 :855-
860 
23. Welsh OK, Logothetis DE, Meister M, Reppert SM 1995 Individual neurons 
dissociated from rat suprachiasmatic nucleus express independently phased 
circadian firing rhythms. Neuron 14:697-706 
123 
24. Lydic R, Schoene WC, Czeisler CA, Moore-Ede MC 1980 Suprachiasmatic 
region of the human hypothalamus: homolog to the primate circadian 
pacemaker? Sleep 2:355-361 
25. Dai J, Swaab DF, Van der Vliet J, Buijs RM 1998 Postmortem tracing reveals the 
organization of hypothalamic projections of the suprachiasmatic nucleus in the 
human brain. J Comp NeuroI400:87-102 
26. Bloch KE, Brack T, Wirz-Justice A 2005 Transient short free running circadian 
rhythm in a case of aneurysm near the suprachiasmatic nuclei. J Neurol 
Neurosurg Psychiatry 76: 1178-1180 
27. Schwartz WJ, Busis NA, Hedley-Whyte ET 1986 A discrete les ion of ventral 
hypothalamus and optic chiasm that disturbed the daily temperature rhythm. J 
NeuroI233:1-4 
28. Quinto C, Gellido C, Masdeu J, Chokroverty S 2000 Comment: PosUraumatic 
delayed sleep phase syndrome. Neurology 55:902-903 
29. 
30. 
Hofman MA, Fliers E, Goudsmit E, Swaab DF 1988 Morphometric analysis of the 
suprachiasmatic and paraventricular nuclei in the human brain: sex differences 
and age-de pende nt changes. J Anat 160:127-143 
Colin J, Timbal J, Boutelier C, Houdas Y, Siffre M 1968 Rhythm of the rectal 
temperature during a 6-month free-running experiment. J Appl Physiol 25:170-~ 
176 
31. Aschoff J 1965 Circadian Rhythms in Man. Science 148:1427-1432 
32. Weitzman ED, Moline ML, Czeisler CA, Zimmerman JC 1982 Chronobiology of 
aging: temperature, sleep-wake rhythms and entrain ment. Neurobiol Aging 
3:299-309 
33. Gilbert 55, van den Heuvel CJ, Ferguson SA, Dawson D 2004 Thermoregulation 
as a sleep signalling system. Sleep Med Rev 8:81-93 
34. Krauchi K, Wirz-Justice A 1994 Circadian rhythm of heat production, heart rate, 
and skin and core temperature under unmasking conditions in men. Am J Physiol 
267:R819-829 
35. Dawson D, Lushington K, Lack L, Campbell S, Matthews C 1992 The variability 
in circadian phase and amplitude estimates derived from sequential constant 
routines. Chronobiol Int 9:362-370 
124 
36. Czeisler CA, Dumont M, Duffy JF, Steinberg JO, Richardson GS, Brown EN, 
Sanchez R, Rios CD, Ronda JM 1992 Association of sleep-wake habits in older 
people with changes in output of circadian pacemaker. Lancet 340:933-936 
37. Kittrell EMW 1991 Disorders of circadian function and the human circadian timing 
system. In: Klein OC, Moore RY, Reppert SM eds. Suprachiasmatic Nucleus: 
The Mind's Clock. New York: Oxford University Press; 233-245 
38. Scheer FA, Pirovano C, Van Someren EJ, Buijs RM 2005 Environmental light 
and suprachiasmatic nucleus interact in the regulation of body temperature. 
Neuroscience 132:465-477 
39. Gooley JJ, Saper CB 2005 Anatomy of the mammalian circadian system. In: 
Kryger MH, Roth T, Dement WC eds. Principles and Practice of Sleep Medicine 
Philadelphia: Elsevier; 340-350 
40. Moore RY 1995 Organization of the mammalian circadian system. In: Chadwick 
DJ, Ackrill K eds. Circadian clocks and their adjustment. Chichester: John Wiley 
& SOns; 88-106 
41. 
42. 
Krauchi K, Knoblauch V, Wirz-Justice A, Cajochen C 2006 Challenging the sleep 
homeostat does not influence the thermoregulatory system in men: evidence 
from a nap vs. sleep-deprivation study. Am J Physiol Regul Integr Comp Physiol 
290:R1 052-1 061 
Cajochen C, Munch M, Kobialka S, Krauchi K, Steiner R, Oelhafen P, Orgul S, 
Wirz-Justice A 2005 High sensitivity of human melatonin, alertness, 
thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol 
Metab 90:1311-1316 
43. Waterhouse J, Drust B, Weinert D, Edwards B, Gregson W, Atkinson G, Kao S, 
Aizawa S, Reilly T 2005 The circadian rhythm of core temperature: origin and 
some implications for exercise performance. Chronobiollnt 22:207-225 
44. Krauchi K, Cajochen C, Wirz-Justice A 1997 A relationship between heat loss 
and sleepiness: effects of postural change and melatonin administration. J Appl 
Physiol 83: 134-139 
45. Waterhouse J, Weinert D, Minors D, Folkard S, Owens D, Atkinson G, 
Macdonald " Sytnik N, Tucker P, Reilly T 2000 A comparison of some different 
methods for purifying core temperature data from humans. Chronobiol Int 
17:539-566 
125 
46. Carrier J, Monk TH 1997 Estimating the endogenous circadian temperature 
rhythm without keeping people awake. J Biol Rhythms 12:266-277 
47. Klerman EB, Lee Y, Czeisler CA, Kronauer RE 1999 Linear demasking 
techniques are unreliable for estimating the circadian phase of ambulatory 
temperature data. J Biol Rhythms 14:260-274 
48. Barrett J, Lack L, Morris M 1993 The sleep-evoked decrease of body 
temperature. Sleep 16:93-99 
49. Miyazaki T, Hashimoto S, Masubuchi S, Honma S, Honma KI 2001 Phase-
advance shifts of human circadian pacemaker are accelerated by daytime 
physical exercise. Am J Physiol Regullntegr Comp PhysioI281:R197-205 
50. Duffy JF, Dijk DJ 2002 Getting through to circadian oscillators: why use constant 
routines? J Biol Rhythms 17:4-13 
51. Mills JN, Minors DS, Waterhouse JM 1978 Adaptation to abrupt time shifts of the 
oscillator(s) controlling human circadian rhythms. J PhysioI285:455-470 
52. Czeisler CA, Allan JS, Strogatz SH, Ronda JM, Sanchez R, Rios CD, Freitag 
WC, Richardson GS, Kronauer RE 1986 Bright light resets the human circadian 
pacemaker inde pendent of the timing of the sleep-wake cycle. Science 233:667-
671 
53. Teclemariam-Mesbah R, Ter Horst GJ, Poste ma F, Wortel J, Buijs RM 1999 
Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway. J 
Comp NeuroI406:171-182 
54. IIInerova H, Sumova A, Travnickova Z, Jac M, Jelinkova D 2000 Hormones, 
subjective night and season of the year. Physiol Res 49 Suppl 1 :S1-10 
55. Boivin DB 2005 Disturbances of hormonal circadian rhythms in shift workers ln: 
Cardinali DP, Pandi-Perumal SR eds. Neuroendocrine correlates of 
sleep/wakefulness. New York: Springer; 325-354 
56. Simonneaux V, Ribelayga C 2003 Generation of the melatonin endocrine 
message in mammals: a review of the complex regulation of melatonin synthesis 
by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 
55:325-395 
57. Benloucif S, Guico MJ, Reid KJ, Wolfe LF, L'Hermite-Baleriaux M, Zee PC 2005 
Stability of melatonin and temperature as circadian phase markers and their 
relation to sleep times in humans. J Biol Rhythms 20: 178-188 
126 
58. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP 1980 Light 
suppresses melatonin secretion in humans. Science 210:1267-1269 
59. Abe K, Kroning J, Greer MA, Critchlow V 1979 Effects of destruction of the 
suprachiasmatic nuclei on the circadian rhythms in plasma corticosterone, body 
temperature, feeding and plasma thyrotropin. Neuroendocrinology 29:119-131 
60. Yehuda R, Halligan SL, Yang RK, Guo LS, Makotkine " Singh B, Pickholtz D 
2003 Relationship between 24-hour urinary-free cortisol excretion and salivary 
cortisol levels sampled from awakening to bedtime in healthy subjects. Life Sci 
73:349-358 
61. von Treuer K, Norman TR, Armstrong SM 1996 Overnight human plasma 
melatonin, cortisol, prolactin, TSH, under conditions of normal sleep, sleep 
deprivation, and sleep recovery. J Pineal Res 20:7-14 
62. Engeland WC, Arnhold MM 2005 Neural circuitry in the regulation of adrenal 
corticosterone rhythmicity. Endocrine 28:325-332 
63. Spath-Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL 1991 Sleep disruption 
alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 29:575-584 
64. Leproult R, Copinschi G, Buxton 0, Van Cauter E 1997 Sleep loss results in an 
elevation of cortisollevels the next evening. Sleep 20:865-870 
65. Salin-Pascual RJ, Ortega-Soto H, Huerto-Delgadillo L, Camacho-Arroyo " 
Roldan-Roldan G, Tamarkin L 1988 The effect of total sleep deprivation on 
plasma melatonin and cortisol in healthy human volunteers. Sleep 11 :362-369 
66. Davidson JR, Moldofsky H, Lue FA 1991 Growth hormone and cortisol secretion 
in relation to sleep and wakefulness. J Psychiatry Neurosci 16:96-102 
67. Gronfier C, Simon C, Piquard F, Ehrhart J, Brandenberger G 1999 
Neuroendocrine processes underlying ultradian sleep regulation in man. J Clin 
Endocrinol Metab 84:2686-2690 
68. Steiger A 2002 Sleep and the hypothalamo-pituitary-adrenocortical system. 
Sleep Med Rev 6:125-138 
69. Hennig J, Friebe J, Ryl " Kramer B, Bottcher J, Netter P 2000 Upright posture 
influences salivary cortisol. Psychoneuroendocrinology 25:69-83 
70. Saito M, Nishimura K, Kato H 1989 Modifications of circadian cortisol rhythm by 
cyclic and continuous total enterai nutrition. J Nutr Sci Vitaminol (Tokyo) 35:639-
647 
127 
71. Dijk DJ, Duffy JF, Czeisler CA 1992 Circadian and sleep/wake dependent 
aspects of subjective alertness and cognitive performance. J Sleep Res 1: 112-
117 
72. Akerstedt T, Folkard S 1995 Validation of the Sand C components of the three-
process model of alertness regulation. Sleep 18:1-6 
73. Wyatt JK, Ritz-De Cecco A, Czeisler CA, Dijk DJ 1999 Circadian temperature 
and melatonin rhythms, sleep, and neurobehavioral function in humans living on 
a 20-h day. Am J PhysioI277:R1152-1163 
74. Wright KP, Jr., Hull JT, Czeisler CA 2002 Relationship between alertness, 
performance, and body temperature in humans. Am J Physiol Regul Integr Comp 
PhysioI283:R1370-1377 
75. Graw P, Krauchi K, Knoblauch V, Wirz-Justice A, Cajochen C 2004 Circadian 
and wake-dependent modulation of fastest and slowest reaction times during the 
psychomotor vigilance task. Physiol Behav 80:695-701 
76. Boivin DB, Czeisler CA, Dijk DJ, Duffy JF, Folkard S, Minors DS, Totterdell P, 
Waterhouse JM 1997 Complex interaction of the sleep-wake cycle and circadian 
phase modulates mood in healthy subjects. Arch Gen Psychiatry 54:145-152 
77. Cajochen C, Knoblauch V, Wirz-Justice A, Krauchi K, Graw P, Wallach D 2004 
Circadian modulation of sequence learning under high and low sleep pressure 
conditions. Behav Brain Res 151 :167-176 
78. Mills JN 1964 Circadian Rhythms During and after Three Months in Solitude 
Underground. J PhysioI174:217-231 
79. Spengler CM, Czeisler CA, Shea SA 2000 An endogenous circadian rhythm of 
respiratory control in humans. J Physiol 526 Pt 3:683-694 
80. Haus E 1996 Biologie rhythms in hematology. Pathol Biol (Paris) 44:618-630 
81. Vagnucci AH, Winkelstein A 1993 Circadian rhythm of lymphocytes and their 
glucocorticoid receptors in HIV-infected homosexual men. J Acquir Immune Defic 
Syndr 6:1238-1247 
82. Born J, Lange T, Hansen K, Molle M, Fehm HL 1997 Effects of sleep and 
circadian rhythm on human circulating immune cells. J Immunol 158:4454-4464 
83. Holi RW, Hartman ML, Veldhuis JD, Taylor WM, Thomer MO 1991 Thirty-second 
sampling of plasma growth hormone in man: correlation with sleep stages. J Clin 
Endocrinol Metab 72:854-861 
128 
84. Gronfier C, Luthringer R, Follenius M, Schaltenbrand N, Macher JP, Muzet A, 
Brandenberger G 1996 A quantitative evaluation of the relationships between 
growth hormone secretion and delta wave electroencephalographic activity 
during normal sleep and after enrichment in delta waves. Sleep 19:817-824 
85. Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL 1995 Nocturnal 
augmentation of growth hormone (GH) secretion is preserved during repetitive 
bolus administration of GH-releasing hormone: potential involvement of 
endogenous somatostatin--a clinical research center study. J Clin Endocrinol 
Metab 80:3321-3326 
86. Mistlberger RE 2005 Circadian regulation of sleep in mammals: role of the 
suprachiasmatic nucleus. Brain Res Brain Res Rev 49:429-454 
87. Borbely M 1982 A two process model of sleep regulation. Hum NeurobioI1:195-
204 
88. Borbely M, Achermann P 1999 Sleep homeostasis and models of sleep 
regulation. J Biol Rhythms 14:557-568 
89. Daan S, Beersma DG, Borbely M 1984 Timing of human sleep: recovery 
process gated by a circadian pacemaker. Am J PhysioI246:R161-183 
90. Akerstedt T, Folkard S 1996 Predicting duration of sleep from the three process 
model of regulation of alertness. Occup Environ Med 53:136-141 
91. Dijk DJ, Czeisler CA 1994 Paradoxical timing of the circadian rhythm of sleep 
propensity serves to consolidate sleep and wakefulness in humans. Neurosci 
Lett 166:63-68 
92. Dijk DJ, Franken P 2005 Interaction of sleep homeostasis and circadian 
rhythmicity: Dependent or independent systems? ln: Kryger MH, Roth T, Dement 
WC eds. Principles and Practice of Sleep Medicine. Philadelphia: Elsevier; 418-
434 
93. Duffy JF, Dijk DJ, Hall EF, Czeisler CA 1999 Relationship of endogenous 
circadian melatonin and temperature rhythms to self-reported preference for 
morning or evening activity in young and older people. J Investig Med 47:141-
150 
94. Dijk DJ, Czeisler CA 1995 Contribution of the circadian pacemaker and the sleep 
homeostat to sleep propensity, sleep structure, electroencephalographic slow 
waves, and sleep spindle activity in humans. J Neurosci 15:3526-3538 
129 
95. Czeisler CA, Weitzman E, Moore-Ede MC, Zimmerman JC, Knauer RS 1980 
Human sleep: its duration and organization de pend on its circadian phase. 
Science 210:1264-1267 
96. Duffy JF, Kronauer RE, Czeisler CA 1996 Phase-shifting human circadian 
rhythms: influence of sleep timing, social contact and light exposure. J Physiol 
495 ( Pt 1 ):289-297 
97. Kubota T, Uchiyama M, Suzuki H, Shibui K, Kim K, Tan X, Tagaya H, Okawa M, 
Inoue S 2002 Effects of nocturnal bright light on saliva melatonin, core body 
temperature and sleep propensity rhythms in human subjects. Neurosci Res 
42:115-122 
98. Kudo Y, Uchiyama M, Okawa M, Shibui K, Kamei Y, Hayakawa T, Kim K, 
Ishibashi K 1999 Correlation between the circadian sleep propensity rhythm and 
hormonal rhythms under ultra-short sleep-wake cycle. Psychiatry Clin Neurosci 
53:253-255 
99. Zulley J, Wever R, Aschoff J 1981 The dependence of onset and duration of 
sleep on th circadian rhythm of rectal temperature. Pflugers Arch 391 :314-318 
100. Akerstedt T, Hume K, Minors D, Waterhouse J 1993 Regulation of sleep and 
naps on an irregular schedule. Sleep 16:736-743 
101. Czeisler CA, Kronauer RE, Allan JS, Duffy JF, Jewett ME, Brown EN, Ronda JM 
1989 Bright light induction of strong (type 0) resetting of the human circadian 
pacemaker. Science 244: 1328-1333 
102. Boivin DB, Duffy JF, Kronauer RE, Czeisler CA 1996 Dose-response 
relationships for resetting of human circadian clock by light. Nature 379:540-542 
103. Jewett ME, Kronauer RE, Czeisler CA 1991 Light-induced suppression of 
endogenous circadian amplitude in humans. Nature 350:59-62 
104. Boivin DB, Duffy JF, Kronauer RE, Czeisler CA 1994 Sensitivity of the human 
circadian pacemaker to moderately bright light. J Biol Rhythms 9:315-331 
105. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C 2000 Sensitivity of the 
human circadian pacemaker to nocturnal light: melatonin phase resetting and 
suppression. J Physiol526 Pt 3:695-702 
106. Morin LP, Allen CN 2006 The circadian visual system, 2005. Brain Res Brain Res 
Rev 51:1-60 
130 
"~, 
107. 
108. 
109. 
110. 
111. 
Minors OS, Waterhouse JM, Wirz-Justice A 1991 A human phase-response 
curve to light. Neurosci Lett 133:36-40 
Honma K, Honma S 1988 A human phase response curve for bright light pulses. 
Jpn J Psychiatry NeuroI42:167-168 
Khalsa SB, Jewett ME, Cajochen C, Czeisler CA 2003 A phase response curve 
to single bright light pulses in human subjects. J Physiol 549:945-952 
Shanahan TL, Zeitzer JM, Czeisler CA 1997 Resetting the melatonin rhythm with 
light in humans. J Biol Rhythms 12:556-567 
Khalsa SBS, Jewett ME, Duffy JF, Czeisler CA 2000 The timing of the human 
circadian clock is accurately represented by the core body temperature rhythm 
following phase shifts to a three-cycle light stimulus near the critical zone. J Biol 
Rhythms 15:524-530 
112. Boivin DB, Czeisler CA 1998 Resetting of circadian melatonin and cortisol 
rhythms in humans by ordinary room light. Neuroreport 9:779-782 
113. Jewett ME, Rimmer DW, Duffy JF, Klerman EB, Kronauer RE, Czeisler CA 1997 
Human circadian pacemaker is sensitive to light throughout subjective day 
without evidence oftransients. Am J PhysioI273:R1800-1809 
114. Waterhouse J, Minors D, Folkard S, Owens D, Atkinson G, Macdonald 1, Reilly T, 
Sytnik N, Tucker P 1998 Light of domestic intensity produces phase shifts of the 
circadian oscil/ator in humans. Neurosci LeU 245:97-100 
115. Trinder J, Armstrong SM, O'Brien C, Luke D, Martin MJ 1996 Inhibition of 
melatonin secretion onset by low levels of illumination. J Sleep Res 5:77-82 
116. Bojkowski CJ, Aldhous ME, English J, Franey C, Poulton AL, Skene DJ, Arendt J 
1987 Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by 
bright and dim light in man. Horm Metab Res 19:437-440 
117. Boivin DB, James FO 2002 Phase-dependent effect of room light exposure in a 
5-h advance of the sleep-wake cycle: implications for jet lag. J Biol Rhythms 
17:266-276 
118. Burgess HJ, Eastman CI 2006 Short nights reduce light-induced circadian phase 
delays in humans. Sleep 29:25-30 
119. Burgess HJ, Eastman CI 2005 Short nights attenuate light-induced circadian 
phase advances in humans. J Clin Endocrinol Metab 90:4437-4440 
131 
120. Jasser SA, Hanifin JP, Rollag MD, Brainard GC 2006 Dim light adaptation 
attenuates acute melatonin suppression in humans. J Biol Rhythms 21 :394-404 
121. Smith KA, Schoen MW, Czeisler CA 2004 Adaptation of human pineal melatonin 
suppression by recent photic history. J Clin Endocrinol Metab 89:3610-3614 
122. Gronfier C, Wright KP, Jr., Kronauer RE, Jewett ME, Czeisler CA 2004 Efficacy 
of a single sequence of intermittent bright light pulses for delaying circadian 
phase in humans. Am J Physiol Endocrinol Metab 287:E174-181 
123. Rimmer DW, Boivin DB, Shanahan TL, Kronauer RE, Duffy JF, Czeisler CA 2000 
Dynamic resetting of the human circadian pacemaker by intermittent bright light. 
Am J Physiol Regullntegr Comp PhysioI279:R1574-1579 
124. Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, 
Ronda JM, Silva EJ, Allan JS, Emens JS, Dijk DJ, Kronauer RE 1999 Stability, 
precision, and near-24-hour period of the human circadian pacemaker. Science 
284:2177-2181 
125. Orth ON, Besser GM, King PH, Nicholson WE 1979 Free-running circadian 
plasma cortisol rhythm in a blind human subject. Clin Endocrinol (Oxf) 10:603-
617 
126. Nakagawa H, Sack RL, Lewy AJ 1992 Sleep propensity free-runs with the 
temperature, melatonin and cortisol rhythms in a totally blind person. Sleep 
15:330-336 
127. Wright KP, Jr., Hughes RJ, Kronauer RE, Dijk DJ, Czeisler CA 2001 Intrinsic 
near-24-h pacemaker period determines limits of circadian entrain ment to a weak 
synchronizer in humans. Proc Natl Acad Sci USA 98:14027-14032 
128. Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, 
Klein T, Rizzo JF, 3rd 1995 Suppression of melatonin secretion in some blind 
patients by exposure to bright Iight. N Engl J Med 332:6-11 
129. Freedman MS, Lucas RJ, Soni B, von Schantz M, Munoz M, David-Gray Z, 
Foster R 1999 Regulation of mammalian circadian behavior by non-rod, non-
cone, ocular photoreceptors. Science 284:502-504 
130. Lucas RJ, Freedman MS, Munoz M, Garcia-Fernandez JM, Foster RG 1999 
Regulation of the mammalian pineal by non-rod, non-cone, ocular 
photoreceptors. Science 284:505-507 
132 
131. Gooley JJ, Lu J, Fischer D, Saper CB 2003 A broad role for melanopsin in 
nonvisual photoreception. J Neurosei 23:7093-7106 
132. Panda S, Provencio l, Tu OC, Pires SS, Rollag MD, Castrucci AM, Pletcher MT, 
Sato TK, Wiltshire T, Andahazy M, Kay SA, Van Gelder RN, Hogenesch-JB 2003 
Melanopsin is required for non-image-forming photic responses in blind mice. 
Science 301 :525-527 
133. Provencio l, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD 2000 A 
novel human opsin in the inner retina. J Neurosci 20:600-605 
134. Panda S, Sato TK, Castrucci AM, Rollag MD, DeGrip WJ, Hogenesch JB, 
Provencio l, Kay SA 2002 Melanopsin (Opn4) requirement for normal Iight-
induced circadian phase shifting. Science 298:2213-2216 
135. Hatlar S, Lucas RJ, Mrosovsky N, Thompson S, Douglas RH, Hankins MW, Lem 
J, Biel M, Hofmann F, Foster RG, Vau KW 2003 Melanopsin and rod-cone 
photoreceptive systems account for ail major accessory visual functions in mice. 
Nature 424:76-81 
136. Berson DM, Dunn FA, Takao M 2002 Phototransduction by retinal ganglion cells 
that set the eircadian dock. Science 295:1070-1073 
137. Newman LA, Walker MT, Brown RL, Cronin TW, Robinson PR 2003 Melanopsin 
forms a functional short-wavelength photopigment. Biochemistry 42: 12734-12738 
138. Takahashi JS, DeCoursey PJ, Bauman L, Menaker M 1984 Spectral sensitivity of 
a novel photoreceptive system mediating entrain ment of mammalian eircadian 
rhythms. Nature 308:186-188 
139. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag 
MD 2001 Action spectrum for melatonin regulation in humans: evidence for a 
novel eircadian photoreceptor. J Neurosci 21 :6405-6412 
140. Thapan K, Arendt J, Skene DJ 2001 An action spectrum for melatonin 
suppression: evidence for a novel non-rod, non-cone photoreceptor system in 
humans. J PhysioI535:261-267 
141. Dkhissi-Benyahya 0, Rieux C, Hut RA, Cooper HM 2006 Immunohistochemical 
evidence of a melanopsin cone in human retina. Invest Ophthalmol Vis Sei 
47:1636-1641 
133 
142. Brainard GC, Hanifin JP, Rollag MO, Greeson J, Byrne B, Glickman G, Gerner E, 
Sanford B 2001 Human melatonin regulation is not mediated by the three cone 
photopic visual system. J Clin Endocrinol Metab 86:433-436 
143. Sasseville A, Paquet N, Sevigny J, Hebert M 2006 Blue blocker glasses impede 
the capacity of bright light to suppress melatonin production. J Pineal Res 41 :73-
78 
144. Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro 
CM 2005 Blocking low-wavelength light prevents nocturnal melatonin 
suppression with no adverse effect on performance during simulated shift work. J 
Clin Endocrinol Metab 90:2755-2761 
145. Lockley SW, Brainard GC, Czeisler CA 2003 High sensitivity of the human 
circadian melatonin rhythm to resetting by short wavelength light. J Clin 
Endocrinol Metab 88:4502-4505 
146. Reveil VL, Arendt J, Terman M, Skene OJ 2005 Short-wavelength sensitivity of 
the human circadian system to phase-advancing light. J Biol Rhythms 20:270-
272 
147. Klerman EB, Rimmer OW, Oijk OJ, Kronauer RE, Rizzo JF, 3rd, Czeisler CA 
1998 Nonphotic entrain ment of the human circadian pacemaker. Am J Physiol 
274: R991-996 
148. Van Cauter E, Sturis J, Byrne MM, Blackman JO, Scherberg NH, Leproult R, 
Refetoff S, Van Reeth 0 1993 Preliminary studies on the immediate phase-
shifting effects of light and exercise on the human circadian clock. J Biol 
Rhythms 8 Suppl:S99-108 
149. Eastman CI, Hoese EK, Youngstedt SO, Liu L 1995 Phase-shifting human 
circadian rhythms with exercise during the night shift. Physiol Behav 58:1287-
1291 
150. Baehr EK, Eastman CI, Revelle W, Oison SH, Wolfe LF, Zee PC 2003 Circadian 
phase-shifting effects of nocturnal exercise in older compared with young adults. 
Am J Physiol Regullntegr Comp PhysioI284:R1542-1550 
151. Barger LK, Wright KP, Jr., Hughes RJ, Czeisler CA 2004 Daily exercise 
facilitates phase delays of circadian melatonin rhythm in very dim light. Am J 
Physiol Regullntegr Comp PhysioI286:R1077-1084 
134 
152. Krauchi K, Cajochen C, Werth E, Wirz-Justice A 2002 Alteration of internai 
circadian phase relationships after morning versus evening carbohydrate-rich 
meals in humans. J Biol Rhythms 17:364-376 
153. Goel N 2005 Late-night presentation of an auditory stimulus phase delays human 
circadian rhythms. Am J Physiol Regullntegr Comp Physiol 289:R209-216 
154. Lockley SW, Skene DJ, James K, Thapan K, Wright J, Arendt J 2000 Melatonin 
administration can entrain the free-running circadian system of blind subjects. J 
EndocrinoI164:R1-6 
155. Mistlberger RE, Skene DJ 2005 Nonphotic entrainment in humans? J Biol 
Rhythms 20:339-352 
156. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, 
Takahashi JS, Weitz CJ 1998 Role of the CLOCK protein in the mammalian 
circadian mechanism. Science 280:1564-1569 
157. Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch 
JB, Simon MC, Takahashi JS, Bradfield CA 2000 Mop3 is an essential 
component of the master circadian pacemaker in mammals. Cell 103: 1009-1017 
158. Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR 2001 
Differentiai functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. 
Neuron 30:525-536 
159. Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun ZS, 
Eichele G, Bradley A, Lee CC 2001 Nonredundant roles of the mPer1 and mPer2 
genes in the mammalian circadian clock. CeIl105:683-694 
160. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, 
Hastings MH, Reppert SM 1999 mCRY1 and mCRY2 are essential components 
of the negative limb of the circadian clock feedback loop. Cell 98: 193-205 
161. Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves l, Zheng B, Kume K, 
Lee CC, van der Horst GT, Hastings MH, Reppert SM 2000 Interacting molecular 
loops in the mammalian circadian clock. Science 288:1013-1019 
162. Young MW, Kay SA 2001 Time zones: a comparative genetics of circadian 
clocks. Nat Rev Genet 2:702-715 
163. Looby P, Loudon AS 2005 Gene duplication and complex circadian clocks in 
mammals. Trends Genet 21 :46-53 
135 
164. Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM 1999 A 
molecular mechanism regulating rhythmic output from the suprachiasmatic 
circadian clock. Cell 96:57-68 
165. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM 2001 
Posttranslational mechanisms regulate the mammalian circadian clock. Cell 
107:855-867 
166. Sato TK, Yamada RG, Ukai H, Baggs JE, Miraglia LJ, Kobayashi TJ, Welsh OK, 
Kay SA, Ueda HR, Hogenesch JB 2006 Feedback repression is required for 
mammalian circadian clock function. Nat Genet 38:312-319 
167. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, 
Schibler U 2002 The orphan nuclear receptor REV-ERBalpha controls circadian 
transcription within the positive limb of the mammalian circadian oscillator. Cell 
110:251-260 
168. Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, 
FitzGerald GA, Kay SA, Hogenesch JB 2004 A functional genomics strategy 
reveals Rora as a component of the mammalian circadian clock. Neuron 43:527-
r- ~7 
169. Triqueneaux G, Thenot S, Kakizawa T, Antoch MP, Safi R, Takahashi JS, 
Delaunay F, Laudet V 2004 The orphan receptor Rev-erbalpha gene is a target 
of the circadian clock pacemaker. J Mol Endocrinol 33:585-608 
170. Akashi M, Takumi T 2005 The orphan nuclear receptor RORalpha regulates 
circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 
12:441-448 
171. Guillaumond F, Dardente H, Giguere V, Cermakian N 2005 Differentiai control of 
Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol 
Rhythms 20:391-403 
172. Caldelas l, Poirel VJ, Sicard B, Pevet P, Challet E 2003 Circadian profile and 
photic regulation of clock genes in the suprachiasmatic nucleus of a diurnal 
mammal Arvicanthis ansorgei. Neuroscience 116:583-591 
173. Cermakian N, Monaco L, Pando MP, Dierich A, Sassone-Corsi P 2001 Altered 
behavioral rhythms and clock gene expression in mice with a targeted mutation 
in the Period1 gene. Embo J 20:3967-3974 
136 
174. Zheng B, Larkin DW, Albrecht U, Sun ZS, Sage M, Eichele G, Lee CC, Bradley A 
1999 The mPer2 gene encodes a functional component of the mammalian 
circadian clock. Nature 400: 169-173 
175. King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP, 
Steeves TD, Vitaterna MH, Kornhauser JM, Lowrey PL, Turek FW, Takahashi JS 
1997 Positional cloning of the mou se circadian clock gene. Cell 89:641-653 
176. Ralph MR, Menaker M 1988 A mutation of the circadian system in golden 
hamsters. Science 241: 1225-1227 
177. Lowrey PL, Shimomura K, Antoch MP, Yamazaki S, Zemenides PD, Ralph MR, 
Menaker M, Takahashi JS 2000 Positional syntenic cloning and functional 
characterization of the mammalian circadian mutation tau. Science 288:483-492 
178. Sujino M, Masumoto KH, Yamaguchi S, van der Horst GT, Okamura H, Inouye 
ST 2003 Suprachiasmatic nucleus grafts restore circadian behavioral rhythms of 
genetica/ly arrhythmic mice. Curr Biol 13:664-668 
179. Guo H, Brewer JM, Lehman MN, Bittman EL 2006 Suprachiasmatic regulation of 
circadian rhythms of gene expression in hamster peripheral organs: effects of 
transplanting the pacemaker. J Neurosci 26:6406-6412 
180. Jones CR, Campbell SS, Zone SE, Cooper F, DeSano A, Murphy PJ, Jones B, 
Czajkowski L, Ptacek LJ 1999 Familial advanced sleep-phase syndrome: A 
short-period circadian rhythm variant in humans. Nat Med 5:1062-1065 
181. Xu Y, Padiath as, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptacek 
LJ, Fu YH 2005 Functional consequences of a CKldelta mutation causing familial 
advanced sleep phase syndrome. Nature 434:640-644 
182. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, ptacek LJ, Fu YH 
2001 An hPer2 phosphorylation site mutation in familial advanced sleep phase 
syndrome. Science 291:1040-1043 
183. Satoh K, Mishima K, Inoue y, Ebisawa T, Shimizu T 2003 Two pedigrees of 
familial advanced sleep phase syndrome in Japan. Sleep 26:416-417 
184. Ebisawa T, Uchiyama M, Kajimura N, Mishima K, Kamei Y, Katoh M, Watanabe 
T, Sekimoto M, Shibui K, Kim K, Kudo Y, Ozeki Y, Sugishita M, Toyoshima R, 
Inoue Y, Yamada N, Nagase T, Ozaki N, Ohara 0, Ishida N, Okawa M, 
Takahashi K, Yamauchi T 2001 Association of structural polymorphisms in the 
human period3 gene with delayed sleep phase syndrome. EMBO Rep 2:342-346 
137 
185. Takano A, Uchiyama M, Kajimura N, Mishima K, Inoue Y, Kamei Y, Kitajima T, 
Shibui K, Katoh M, Watanabe T, Hashimotodani Y, Nakajima T, Ozeki Y, Hori T, 
Yamada N, Toyoshima R, Ozaki N, Okawa M, Nagai K, Takahashi K, Isojima Y, 
Yamauchi T, Ebisawa T 2004 A missense variation in human casein kinase 1 
epsilon gene that induces functional alteration and shows an inverse association 
with circadian rhythm sleep disorders. Neuropsychopharmacology 29:1901-1909 
186. Mishima K, Tozawa T, Satoh K, Saitoh H, Mishima Y 2005 The 3111T/C 
polymorphism of hClock is associated with evening preference and delayed 
sleep timing in a Japanese population sample. Am J Med Genet B 
Neuropsychiatr Genet 133:101-104 
187. Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, Mignot E 1998 A 
CLOCK polymorphism associated with human diurnal preference. Sleep 21 :569-
576 
188. Carpen JD, Archer SN, Skene DJ, Smits M, von Schantz M 2005 A single-
nucleotide polymorphism in the 5'-untranslated region of the hPER2 gene is 
associated with diurnal preference. J Sleep Res 14:293-297 
189. Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, von Schantz 
M 2003 A length polymorphism in the circadian clock gene Per3 is linked to 
delayed sleep phase syndrome and extreme diurnal preference. Sleep 26:413-
415 
190. Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppa T, Lichtermann 
D, Praschak-Rieder N, Neumeister A, Nilsson LG, Kasper S, Peltonen L, 
Adolfsson R, Schalling M, Partonen T 2003 Circadian clock-related 
polymorphisms in seasonal affective disorder and their relevance to diurnal 
preference. Neuropsychopharmacology 28:734-739 
191. Balsalobre A, Damiola F, Schibler U 1998 A serum shock induces circadian gene 
expression in mammalian tissue culture cells. Cell 93:929-937 
192. Oishi K, Sakamoto K, Okada T, Nagase T, Ishida N 1998 Antiphase circadian 
expression between BMAL 1 and period homologue mRNA in the 
suprachiasmatic nucleus and peripheral tissues of rats. Biochem Biophys Res 
Commun 253:199-203 
193. Yagita K, Tamanini F, van Der Horst GT, Okamura H 2001 Molecular 
mechanisms of the biological clock in cultured fibroblasts. Science 292:278-281 
138 
194. Yamamoto T, Nakahata Y, Soma H, Akashi M, Mamine T, Takumi T 2004 
Transcriptional oscillation of canonical clock genes in mou se peripheral tissues. 
BMC Mol Biol 5:18 
195. Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block GD, 
Sakaki Y, Menaker M, Tei H 2000 Resetting central and peripheral circadian 
oscillators in transgenic rats. Science 288:682-685 
196. Zylka MJ, Shearman LP, Weaver DR, Reppert SM 1998 Three period homologs 
in mammals: differential light responses in the suprachiasmatic circadian clock 
and oscillating transcripts outside of brain. Neuron 20:1103-1110 
197. Sun ZS, Albrecht U, Zhuchenko 0, Bailey J, Eichele G, Lee CC 1997 RIGUI, a 
putative mammalian ortho log of the Drosophila period gene. Cell 90:1003-1011 
198. Tei H, Okamura H, Shigeyoshi Y, Fukuhara C, Ozawa R, Hirose M, Sakaki Y 
1997 Circadian oscillation of a mammalian homologue of the Drosophila period 
gene. Nature 389:512-516 
199. Amir S, Lamont EW, Robinson B, Stewart J 2004 A circadian rhythm in the 
expression of PERIOD2 protein reveals a nover SCN-controlled oscillator in the 
,/- oval nucleus of the bed nucleus of the stria terminalis. J Neurosci 24:781-790 
200. Nishide SV, Honma S, Nakajima y, Ikeda M, Baba K, Ohmiya Y, Honma K 2006 
New reporter system for Per1 and Bmal1 expressions revealed self-sustained 
circadian rhythms in peripheral tissues. Genes Ce Ils 11: 1173-1182 
201. Karman BN, Tischkau SA 2006 Circadian clock gene expression in the ovary: 
Effects of luteinizing hormone. Biol Reprod 75:624-632 
202. Nonaka H, Emoto N, Ikeda K, Fukuya H, Rohman MS, Raharjo SB, Yagita K, 
Okamura H, Yokoyama M 2001 Angiotensin " induces circadian gene expression 
of clock genes in cultured vascular smooth muscle cells. Circulation 104:1746-
1748 
203. Asai M, Yoshinobu Y, Kaneko S, Mori A, Nikaido T, Moriya T, Akiyama M, 
Shibata S 2001 Circadian profile of Per gene mRNA expression in the 
suprachiasmatic nucleus, paraventricular nucleus, and pineal body of aged rats. 
J Neurosci Res 66: 1133-1139 
204. Pando MP, Morse D, Cermakian N, Sassone-Corsi P 2002 Phenotypic rescue of 
a peripheral clock genetic defect via SCN hierarchical dominance. Cell 110:107-
117 
139 
205. Sakamoto K, Nagase T, Fukui H, Horikawa K, Okada T, Tanaka H, Sato K, 
Miyake Y, Ohara 0, Kako K, Ishida N 1998 Multitissue circadian expression of rat 
period homolog (rPer2) mRNA is govemed by the mammalian circadian c1ock, 
the suprachiasmatic nucleus in the brain. J Biol Chem 273:27039-27042 
206. Guo H, Brewer JM, Champhekar A, Harris RB, Bittman EL 2005 DifferentiaI 
control of peripheral circadian rhythms by suprachiasmatic-dependent neural 
signais. Proc Natl Acad Sei USA 102:3111-3116 
207. Allen G, Rappe J, Eamest DJ, Cassone VM 2001 Oscillating on borrowed time: 
diffusible signais from immortalized suprachiasmatic nucleus cells regulate 
eircadian rhythmieity in cultured fibroblasts. J Neurosei 21 :7937-7943 
208. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, Menaker M, Block 
GD 2002 Circadian rhythms in isolated brain regions. J Neurosci 22:350-356 
209. Welsh DK, Yoo SH, Liu AC, Takahashi JS, Kay SA 2004 Bioluminescence 
imaging of individual fibroblasts reveals persistent, independently phased 
circadian rhythms of clock gene expression. Curr Biol 14:2289-2295 
210. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U 2004 Circadian gene 
expression in individual fibroblasts: cell-autonomous and self-sustained 
oscillators pass time to daughter cells. Cell 119:693-705 
211. Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, Siepka SM, 
Hong HK, Oh WJ, Yoo OJ, Menaker M, Takahashi JS 2004 
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals 
persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sei 
USA 101:5339-5346 
212. Si/ver R, LeSauter J, Tresco PA, Lehman MN 1996 A diffusible coupling signal 
from the transplanted suprachiasmatic nucleus controlling circadian locomotor 
rhythms. Nature 382:810-813 
213. Terazono H, Mutoh T, Yamaguchi S, Kobayashi M, Akiyama M, Udo R, Ohdo S, 
Okamura H, Shibata S 2003 Adrenergic regulation of clock gene expression in 
mouse Jiver. Proc Natl Acad Sei USA 100:6795-6800 
214. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, 
Schutz G, Schibler U 2000 Resetting of circadian time in peripheral tissues by 
glucocorticoid signa Jing. Science 289:2344-2347 
140 
215. McNamara P, Seo SP, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA 2001 
Regulation of CLOCK and MOP4 by nuclear hormone receptors in the 
vasculature: a humoral mechanism to reset a peripheral clock. Cell 105:877-889 
216. Zanello SB, Jackson DM, Holick MF 2000 Expression of the circadian clock 
genes clock and period1 in human skin. J Invest DermatoI115:757-760 
217. Pardini L, Kaeffer B, Trubuil A, Bourreille A, Galmiche JP 2005 Human intestinal 
circadian clock: expression of clock genes in colonocytes Iining the crypt. 
Chronobiollnt 22:951-961 
218. Maronde E, Motzkus D 2003 Oscillation of human period 1 (hPER1) reporter 
gene activity in human neuroblastoma cells in vivo. Chronobiollnt 20:671-681 
219. Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky 
WJ, Ben-David Y 2001 Circadian expression of clock genes in human oral 
mucosa and skin: association with specifie cell-cycle phases. Am J Pathol 
158:1793-1801 
220. Takata M, Burioka N, Ohdo S, Takane H, Terazono H, Miyata M, Sako T, 
Suyama H, Fukuoka Y, Tomita K, Shimizu E 2002 Daily expression of mRNAs 
~' for the mammalian Clock genes Per2 and clock in mouse suprachiasmatic nuclei 
and Iiver and human peripheral blood mononuclear cells. Jpn J Pharmacol 
90:263-269 
221. Kusanagi H, Mishima K, Satoh K, Echizenya M, Katoh T, Shimizu T 2004 Similar 
profiles in human period1 gene expression in peripheral mononuclear and 
polymorphonuclear cells. Neurosci Lett 365:124-127 
222. Teboul M, Barrat-Petit MA, Li XM, Claustrat B, Formento JL, Delaunay F, Levi F, 
Milano G 2005 Atypical patterns of circadian clock gene expression in human 
peripheral blood mononuclear cells. J Mol Med 83:693-699 
223. Brown SA, Fleury-Olela F, Nagoshi E, Hauser C, Juge C, Meier CA, 
Chicheportiche R, Dayer JM, Albrecht U, Schibler U 2005 The period length of 
fibroblast circadian gene expression varies widely among human individuals. 
PLoS Biol 3:e338 
224. Takimoto M, Hamada A, Tomoda A, Ohdo S, Ohmura T, Sakato H, Kawatani J, 
Jodoi T, Nakagawa H, Terazono H, Koyanagi S, Higuchi S, Kimura M, Tukikawa 
H, Irie S, Saito H, Miike T 2005 Daily expression of clock genes in whole blood 
141 
cells in healthy subjects and a patient with circadian rhythm sleep disorder. Am J 
Physiol Regullntegr Comp PhysioI289:R1273-1279 
225. Chen A, Du L, Xu Y, Chen L, Wu Y 2005 The effect of blue light exposure on the 
expression of circadian genes: bmal1 and cryptochrome 1 in peripheral blood 
mononuclear cells of jaundiced neonates. Pediatr Res 58:1180-1184 
226. Miyazaki K, Nagase T, Mesaki M, Narukawa J, Ohara 0, Ishida N 2004 
Phosphorylation of clock protein PER1 regulates its circadian degradation in 
normal human fibroblasts. Biochem J 380:95-103 
227. Takata M, Burioka N, Ohdo S, Fukuoka Y, Miyata M, Endo M, Suyama H, 
Shimizu E 2005 Beta2-adrenoceptor agonists induce the mammalian clock gene, 
hPer1, mRNA in cultured human bronchial epithelium cells in vitro. Chronobiol Int 
22:777-783 
228. Burioka N, Takata M, Okano Y, Ohdo S, Fukuoka Y, Miyata M, Takane H, Endo 
M, Suyama H, Shimizu E 2005 Dexamethasone influences human clock gene 
expression in bronchial epithelium and peripheral blood mononuclear cells in 
vitro. Chronobiollnt 22:585-590 
229. Sakamoto K, Ishida N 2000 Light-induced phase-shifts in the circadian 
expression rhythm of mammalian period genes in the mouse heart. Eur J 
Neurosci 12:4003-4006 
230. Sakamoto K, Kadota K, Oishi K 2004 Light-induced phase-shifting of the 
peripheral circadian oscillator in the hearts of food-deprived mice. Exp Anim 
53:471-474 
231. Ishida A, Mutoh T, Ueyama T, Bando H, Masubuchi S, Nakahara D, Tsujimoto G, 
Okamura H 2005 Light activates the adrenal gland: timing of gene expression 
and glucocorticoid release. Cell Metab 2:297-307 
232. Cajochen C, Jud C, Munch M, Kobialka S, Wirz-Justice A, Albrecht U 2006 
Evening exposure to blue light stimulates the expression of the clock gene PER2 
in humans. Eur J Neurosci 23:1082-1086 
233. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M 2001 Entrainment of the 
circadian clock in the liver by feeding. Science 291 :490-493 
234. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U 2000 
Restricted feeding uncouples circadian oscillators in peripheral tissues from the 
central pacemaker in the suprachiasmatic nucleus. Genes Dev 14:2950-2961 
142 
235. Hara R, Wan K, Wakamatsu H, Aida R, Moriya T, Akiyama M, Shibata S 2001 
Restricted feeding entrains liver c10ck without participation of the suprachiasmatic 
nucleus. Genes Cells 6:269-278 
236. Le Minh N, Damiola F, Tronche F, Schutz G, Schibler U 2001 Glucocorticoid 
hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. 
Embo J 20:7128-7136 
237. Wakamatsu H, Yoshinobu Y, Aida R, Moriya T, Akiyama M, Shibata S 2001 
Restricted-feeding-induced anticipatory activity rhythm is associated with a 
phase-shift of the expression of mPer1 and mPer2 mRNA in the cerebral cortex 
and hippocampus but not in the suprachiasmatic nucleus of mice. Eur J Neurosci 
13:1190-1196 
238. Waddington Lamont E, Harbour VL, Barry-Shaw J, Renteria Diaz L, Robinson B, 
Stewart J, Amir S 2006 Restricted access to food, but not sucrose, saccharine, or 
salt, synchronizes the expression of Period2 protein in the limbic forebrain. 
Neuroscience 
239. 
240. 
241. 
Brown SA, Zumbrunn G, Fleury-Olela F, Preitner N, Schibler U 2002 Rhythms of 
mammalian body temperature can sustain peripheral circadian clocks. Curr Biol 
12:1574-1583 
Knutsson A 2003 Health disorders of shift workers. Occup Med (Lond) 53:103-
108 
Kawachi " Colditz GA, Stampfer MJ, Willett WC, Manson JE, Speizer FE, 
Hennekens CH 1995 Prospective study of shift work and risk of coronary heart 
disease in women. Circulation 92:3178-3182 
242. Nagaya T, Yoshida H, Takahashi H, Kawai M 2002 Markers of insulin resistance 
in day and shift workers aged 30-59 years. Int Arch Occup Environ Health 
75:562-568 
243. Costa G 1996 The impact of shift and night work on health. Appl Ergon 27:9-16 
244. Moser M, Schaumberger K, Schernhammer E, Stevens RG 2006 Cancer and 
rhythm. Cancer Causes Control 17:483-487 
245. Hansen J 2001 Increased breast cancer risk among women who work 
predominantly at night. Epidemiology 12:74-77 
143 
246. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi 1, 
Fuchs CS, Colditz GA 2003 Night-shift work and risk of colorectal cancer in the 
nurses' health study. J Natl Cancer Inst 95:825-828 
247. Xu X, Ding M, Li B, Christiani OC 1994 Association of rotating shiftwork with 
preterm births and low birth weight among never smoking women textile workers 
in China. Occup Environ Med 51:470-474 
248. Shields M 2002 Shift work and health. Health Rep 13:11-33 
249. Wei bel L, Brandenberger G 1998 Disturbances in hormonal profiles of night 
workers during their usual sleep and work times. J Biol Rhythms 13:202-208 
250. Roden M, Koller M, Pirich K, Vierhapper H, Waldhauser F 1993 The circadian 
melatonin and cortisol secretion pattern in permanent night shift workers. Am J 
Physiol 265:R261-267 
251. Koller M, Harma M, Laitinen JT, Kundi M, Piegler B, Haider M 1994 Different 
patterns of light exposure in relation to melatonin and cortisol rhythms and sleep 
of night workers. J Pineal Res 16:127-135 
252. Sack RL, Blood ML, Lewy AJ 1992 Melatonin rhythms in night shift workers. 
Sleep 15:434-441 
253. Hennig J, Kieferdorf P, Moritz C, Huwe S, Netter P 1998 Changes in cortisol 
secretion during shiftwork: implications for tolerance to shiftwork? Ergonomies 
41:610-621 
254. Costa G, Bertoldi A, Kovacic M, Ghirlanda G, Minors OS, Waterhouse JM 1997 
Hormonal Secretion of Nurses Engaged in Fast-rotating Shift Systems. Int J 
Occup Environ Health 3:S35-S39 
255. Czeisler CA, Johnson MP, Duffy JF, Brown EN, Ronda JM, Kronauer RE 1990 
Exposure to bright light and darkness to treat physiologie maladaptation to night 
work. N Engl J Med 322:1253-1259 
256. Eastman CI 1992 High-intensity light for circadian adaptation to a 12-h shift of the 
sleep schedule. Am J Physiol 263:R428-436 
257. Burgess HJ, Crowley SJ, Gazda CJ, Fogg LF, Eastman CI 2003 Preflight 
adjustment to eastward travel: 3 days of advancing sleep with and without 
morning bright light. J Biol Rhythms 18:318-328 
144 
~ ... 
258. Horowitz TS, Cade BE, Wolfe JM, Czeisler CA 2001 Efficacy of bright light and 
sleep/darkness scheduling in alleviating circadian maladaptation to night work. 
Am J Physiol Endocrinol Metab 281 :E384-391 
259. Campbell SS 1995 Effects of timed bright-light exposure on shift-work adaptation 
in middle-aged subjects. Sleep 18:408-416 
260. Martin SK, Eastman CI 1998 Medium-intensity light produces circadian rhythm 
adaptation to simulated night-shift work. Sleep 21 :154-165 
261. Deacon S, Arendt J 1996 Adapting to phase shifts, 1. An experimental model for 
jet lag and shift work. Physiol Behav 59:665-673 
262. Baehr EK, Fogg LF, Eastman CI 1999 Intermittent bright light and exercise to 
entrain human circadian rhythms to night work. Am J PhysioI277:R1598-1604 
263. Eastman CI, Liu L, Fogg LF 1995 Circadian rhythm adaptation to simulated night 
shift work: effect of nocturnal bright-light duration. Sleep 18:399-407 
264. Mitchell PJ, Hoese EK, Liu L, Fogg LF, Eastman CI 1997 Conflicting bright light 
exposure during night shifts impedes circadian adaptation. J Biol Rhythms 12:5-
15 
265. Dumont M, Benhaberou-Brun D, Paquet J 2001 Profile of 24-h light exposure 
and circadian phase of melatonin secretion in night workers. J Biol Rhythms 
16:502-511 
266. Eastman CI, Stewart KT, Mahoney MP, Liu L, Fogg LF 1994 Dark goggles and 
bright light improve circadian rhythm adaptation to night-shift work. Sleep 17:535-
543 
267. Bjorvatn B, Kecklund G, Akerstedt T 1999 Bright light treatment used for 
adaptation to night work and re-adaptation back to day life. A field study at an oil 
platform in the North Sea. J Sleep Res 8:105-112 
268. Hakola T, Harma MI, Laitinen JT 1996 Circadian adjustment of men and women 
to night work. Scand J Work Environ Health 22: 133-138 
269. Crowley SJ, Lee C, Tseng CY, Fogg LF, Eastman CI 2004 Complete or partial 
circadian re-entrainment improves performance, alertness, and mood during 
night-shift work. Sleep 27: 1 077-1087 
270. James FO, Chevrier E, Boivin DB 2002 Improvement of daytime sleep in shift 
workers by judicious light exposure. In: 16th meeting of the Associated 
Professional Sleep Societies. Seattle, WA: Sleep, vol. 25, Abstact supplement 
145 
271. 2006 Histopaque-1077 Product Information. In: Sigma Aldrich, Inc. 
272. Horne JA, Ostberg 0 1976 A self-assessment questionnaire to determine 
morningness-eveningness in human circadian rhythms. Int J ChronobioI4:97-110 
273. Oishi K, Sakamoto K, Okada T, Nagase T, Ishida N 1998 Humoral signais 
mediate the circadian expression of rat period homologue (rPer2) mRNA in 
peripheral tissues. Neurosci Lett 256:117-119 
274. Azama T, Yano M, Nishimura S, Takiguchi S, Yasuda T, Iwanaga H, Fujiwara Y, 
Monden M 2002 Major surgical stress affects the circadian HPER2 expression 
and sleeping time. In: 24th European Society of Parenteral and Enterai Nutrition. 
Glasgow, Scotland 
275. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay 
SA, Takahashi JS, Hogenesch JB 2002 Coordinated transcription of key 
pathways in the mouse by the circadian clock. CeU 109:307-320 
276. Martino T, Arab S, Straume M, Belsham DD, Tata N, Cai F, Liu P, Trivieri M, 
Ralph M, Sole MJ 2004 Day/night rhythms in gene expression of the normal 
murine heart. J Mol Med 82:256-264 
277. Oster H, Damerow S, Hut RA, Eichele G 2006 Transcriptional profiling in the 
adrenal gland reveals circadian regulation of hormone biosynthesis genes and 
nucleosome assembly genes. J Biol Rhythms 21 :350-361 
278. Zvonic S, Ptitsyn AA, Conrad SA, Scott LK, Floyd ZE, Kilroy G, Wu X, Goh BC, 
Mynatt RL, Gimble JM 2006 Characterization of peripheral circadian clocks in 
adipose tissues. Diabetes 55:962-970 
279. Oishi K, Fukui H, Ishida N 2000 Rhythmic expression of BMAL 1 mRNA is altered 
in Clock mutant mice: differential regulation in the suprachiasmatic nucleus and 
peripheral tissues. Biochem Biophys Res Commun 268:164-171 
280. Debruyne JP, Noton E, Lambert CM, Maywood ES, Weaver DR, Reppert SM 
2006 A clock shock: mouse CLOCK is not required for circadian oscillator 
function. Neuron 50:465-477 
281. Amir S, Robinson B 2006 Thyroidectomy alters the daily pattern of expression of 
the clock protein, PER2, in the oval nucleus of the bed nucleus of the stria 
termina lis and central nucleus of the amygdala in rats. Neurosci LeU 407:254-257 
146 
282. Carr AJ, Johnston JO, Semikhodskii AG, Nolan T, Cagampang FR, Stirland JA, 
Loudon AS 2003 Photoperiod differentially regulates circadian oscillators in 
central and peripheral tissues of the Syrian hamster. Curr Biol 13: 1543-1548 
283. Chen YG, Mantalaris A, Bourne P, Keng P, Wu JH 2000 Expression of mPer1 
and mPer2, two mammalian clock genes, in murine bone marrow. Biochem 
Biophys Res Commun 276:724-728 
284. Tsinkalovsky 0, Filipski E, Rosenlund B, Sothern RB, Eiken HG, Wu MW, 
Claustrat B, Bayer J, Levi F, Laerum 00 2006 Circadian expression of clock 
genes in purified hematopoietic stem cells is developmentally regulated in mouse 
bone marrow. Exp HematoI34:1249-1261 
285. Granda TG, Liu XH, Smaaland R, Cermakian N, Filipski E, Sassone-Corsi P, 
Levi F 2005 Circadian regulation of cell cycle and apoptosis proteins in mouse 
bone marrow and tumor. Faseb J 19:304-306 
286. Fukuoka Y, Burioka N, Takata M, Ohdo S, Miyata M, Endo M, Shimizu E 2005 
Glucocorticoid administration increases hPer1 mRNA levels in human peripheral 
blood mononuclear cells in vitro or in vivo. J Biol Rhythms 20:550-553 
287. Selmaoui B, Bogdan A, Auzeby A, Lambrozo J, Touitou Y 1996 Acute exposure 
to 50 Hz magnetic field does not affect hematologic or immunologie functions in 
healthy young men: a circadian study. Bioelectromagnetics 17:364-372 
288. Northern AL, RuHer SM, Peterson CM 1994 Cyclic changes in the concentrations 
of peripheral blood immune cells during the normal menstrual cycle. Proc Soc 
Exp Biol Med 207:81-88 
289. Abo T, Kawate T, Itoh K, Kumagai K 1981 Studies on the bioperiodicity of the 
immune response. 1. Circadian rhythms of human T, B, and K cell traffic in the 
peripheral blood. J ImmunoI126:1360-1363 
290. Arjona A, Sarkar OK 2005 Circadian oscillations of clock genes, cytolytic factors, 
and cytokines in rat NK cells. J ImmunoI174:7618-7624 
291. Arjona A, Sarkar OK 2006 Evidence supporting a circadian control of natural 
killer cell function. Brain Behav Immun 20:469-476 
292. Liu J, Mankani G, Shi X, Meyer M, Cunningham-Runddles S, Ma X, Sun ZS 2006 
The circadian clock Period 2 gene regulates gamma interferon production of NK 
cells in host response to lipopolysaccharide-induced endotoxic shock. Infect 
Immun 74:4750-4756 
147 
293. Sun Y, Yang Z, Niu Z, Peng J, Li Q, Xiong W, Langnas AN, Ma MY, Zhao Y 2006 
MOP3, a component of the molecular clock, regulates the development of B 
cells. Immunology 
294. Kondratov RV, Kondratova M, Gorbacheva VY, Vykhovanets OV, Antoch MP 
2006 Early aging and age-related pathologies in mice deficient in BMAL 1, the 
core componentof the circadian clock. Genes Dev 20: 1868-1873 
295. Durgan DJ, Trexler NA, Egbejimi 0, McElfresh TA, Suk HY, Petterson LE, Shaw 
CA, Hardin PE, Bray MS, Chandler MP, Chow CW, Young ME 2006 The 
circadian clock within the cardiomyocyte is essential for responsiveness of the 
heart to fatty acids. J Biol Chem 281 :24254-24269 
296. Marquez S, Crespo P, Carlini V, Garbarino-Pico E, Baler R, Caputto BL, Guido 
ME 2004 The metabolism of phospholipids oscillates rhythmically in cultures of 
fibroblasts and is regulated by the clock protein PERIOD 1. Faseb J 18:519-521 
297. 
298. 
299. 
300. 
Yamamoto Y, Yagita K, Okamura H 2005 Role of cyclic mPer2 expression in the 
mammalian cellular clock. Mol Cell Biol 25:1912-1921 
Fujimoto Y, Yagita K, Okamura H 2006 Does mPER2 protein oscillate without its 
coding mRNA cycling?: post-transcriptional regulation by cell clock. Genes Ce Ils 
11:525-530 
Belanger V, Picard N, Cermakian N 2006 The circadian regulation of Presenilin-2 
gene expression. Chronobiollnt 23:747-766 
Kennaway DJ, Owens JA, Voultsios A, Varcoe T J 2006 Functional central 
rhythmicity and light entrain ment, but not liver and muscle rhythmicity, are Clock 
independent. Am J Physiol Regullntegr Comp Physiol291 :R1172-1180 
301. Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, 
Honma K 2002 Dec1 and Dec2 are regulators of the mammalian molecular clock. 
Nature 419:841-844 
302. Li Y, Song X, Ma Y, Liu J, Yang D, Yan B 2004 DNA binding, but not interaction 
with Bmal1, is responsible for DEC1-mediated transcription regulation of the 
circadian gene mPer1. Biochem J 382:895-904 
303. Noshiro M, Furukawa M, Honma S, Kawamoto T, Hamada T, Honma K, Kato Y 
2005 Tissue-specifie disruption of rhythmic expression of Dec1 and Dec2 in clock 
mutant mice. J Biol Rhythms 20:404-418 
148 
304. Murphy BA, Vick MM, Sessions DR, Cook RF, Fitzgerald BP 2006 Evidence of 
an oscillating peripheral clock in an equine fibroblast cell line and adipose tissue 
but not in peripheral blood. J Comp Physiol A Neuroethol Sens Neural Behav 
PhysioI192:743-751 
305. Kaneko M, Zechman FW, Smith RE 1968 Circadian variation in human 
peripheral blood flow levels and exercise responses. J Appl PhysioI25:109-114 
306. Lamont EW, Robinson B, Stewart J, Amir S 2005 The central and basolateral 
nuelei of the amygdala exhibit opposite diurnal rhythms of expression of the clock 
protein Period2. Proc Natl Aead Sei USA 102:4180-4184 
307. Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D, Bienert M, 
Radbruch A, Burmester GR, Lauster R, Scheffold A, Buttgereit F 2004 
Membrane glueocortieoid receptors (mGCR) are expressed in normal human 
peripheral blood mononuclear cells and up-regulated after in vitro stimulation and 
in patients with rheumatoid arthritis. Faseb J 18:70-80 
308. 
309. 
Lewis-Tuffin LJ, Cidlowski JA 2006 The physiology of human glucoeortieoid 
receptor beta (hGRbeta) and glueocorticoid resistance. Ann N Y Acad Sei 
1069:1-9 
Rogers N, van den Heuvel C, Dawson D 1997 Effeet of melatonin and 
corticosteroid on in vitro cellular immune function in humans. J Pineal Res 22:75-
80 
310. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ 2005 A review of the 
multiple actions of melatonin on the immune system. Endocrine 27:189-200 
311. Finocchiaro LM, Nahmod VE, Launay JM 1991 Melatonin biosynthesis and 
metabolism in peripheral blood mononuclear leucocytes. Bioehem J 280 ( Pt 
3):727-731 
312. Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, Garcia-Maurino S, Reiter RJ, 
Guerrero JM 2004 Evidence of melatonin synthesis by human lymphocytes and 
its physiologieal significanee: possible role as intracrine, autocrine, and/or 
paraerine substance. Faseb J 18:537-539 
313. Torres-Fartan C, Seron-Ferre M, Dinet V, Kort HW 2006 Immunoeytochemical 
demonstration of day/night changes of elock gene protein levels in the murine 
adrenal gland: differences between melatonin-proficient (C3H) and melatonin-
deficient (C57BL) mice. J Pineal Res 40:64-70 
149 
314. Amir S, Harbour VL, Robinson B 2006 Pinealectomy does not affect diurnal 
PER2 expression in the rat limbic forebrain. Neurosci Lett 399:147-150 
315. Balsalobre A, Marcacci L, Schibler U 2000 Multiple signaling pathways elicit 
circadian gene expression in cultured Rat-1 fibroblasts. Curr Biol 10:1291-1294 
316. Izumo M, Sato TR, Straume M, Johnson CH 2006 Quantitative Analyses of 
Circadian Gene Expression in Mammalian Cell Cultures. PLoS Comput Biol 2 
317. Yang X, Oownes M, Yu RT, Bookout AL, He W, Straume M, Mangelsdorf OJ, 
Evans RM 2006 Nuclear receptor expression links the circadian clock to 
metabolism. CeIl126:801-810 
318. Mendoza J, Graff C, Oardente H, Pevet P, Challet E 2005 Feeding cues alter 
clock gene oscillations and photic responses in the suprachiasmatic nuclei of 
mice exposed to a light/dark cycle. J Neurosci 25:1514-1522 
319. Wu YH, Fischer OF, Kalsbeek A, Garidou-Boof ML, van der Vliet J, van 
Heijningen C, Liu RY, Zhou JN, Swaab OF 2006 Pineal clock gene oscillation is 
disturbed in Alzheimer's disease, due to functional disconnection from the 
"master clock". Faseb J 20:1874-1876 
320. Wu YH, Feenstra MG, Zhou JN, Liu RY, Torano JS, Van Kan HJ, Fischer OF, 
Ravid R, Swaab OF 2003 Molecular changes underlying reduced pineal 
melatonin levels in Alzheimer disease: alterations in preclinical and clinical 
stages. J Clin Endocrinol Metab 88:5898-5906 
321. Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab OF 1999 Decreased 
melatonin levels in postmortem cerebrospinal fluid in relation to aging, 
Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol 
Metab 84:323-327 
322. Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M 1999 
Melatonin secretion rhythm disorders in patients with senile dementia of 
Alzheimer's type with disturbed sleep-waking. Biol Psychiatry 45:417-421 
323. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG 2005 Deregulated 
expression of the PER1, PER2 and PER3 genes in breast cancers. 
Carcinogenesis 26:1241-1246 
324. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP 2006 The circadian 
gene per1 plays an important role in cell growth and DNA damage control in 
human cancer cells. Mol Cell 22:375-382 
150 
325. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-
Guillaume G, Halberg F 2006 Circadian gene mPer2 overexpression induces 
cancer cell apoptosis. Cancer Sci 97:589-596 
326. Tomoda A, Joudoi T, Kawatani J, Ohmura T, Hamada A, Tonooka S, Miike T 
2003 Case study: differences in human Per2 gene expression, body 
temperature, cortisol, and melatonin parameters in remission and hypersomnia in 
a patient with recurrent hypersomnia. Chronobiollnt 20:893-900 
327. Boivin DB 2000 Influence of sleep-wake and circadian rhythm disturbances in 
psychiatric disorders. J Psychiatry Neurosci 25:446-458 
151 
APPENDIXA 
Article reprints 
Circadian clock genes oscillate in human peripheral blood mononuclear cells. Diane B. 
Boivin, Francine O. James, Aibin Wu, Park F. Cho-Park, Huabao Xiong and Zhong S. 
Sun. Blood (2003) 102:4143-5. © 2003 by The American Society of Hematology 
Controlled exposure to light and darkness realigns the salivary cortisol rhythm in night 
shift workers. Francine O. James, Claire-Dominique Walker and Diane B. Boivin. 
Chronobiollnternational. (2004) 21:961-72. © 2004 by Marcel Dekker Inc. 
152 
APPENDIX B 
Copyright permissions 
Circadian clock genes oscillate in human peripheral blood mononuclear ceUs. Diane B. 
Boivin, Francine O. James, Aibin Wu, Park F. Cho-Park, Huabao Xiong and Zhong S. 
Sun. Blood (2003) 102:4143-5. © 2003 by The American Society of Hematology 
ControUed exposure to light and darkness realigns the salivary cortisol rhythm in night 
shift workers. Francine O. James, Claire-Dominique Walker and Diane B. Boivin. 
Chronobiollnternational. (2004) 21 :961-72. © 2004 by Marcel Dekker Inc. Requested. 
168 
APPENDIX C 
Douglas Hospital Research Ethics Board approval for studies performed 
173 
